1	The	DT	O	the	det	4	SENT_1	[p1l673t81r718b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l737t83r822b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l841t83r1029b102],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_1	[p1l1048t83r1228b109],
5	af	IN	O	af	_	0	SENT_1	[p1l1247t81r1276b108],
6	MEDICINE	NNP	O	MEDICINE	prep_af	4	SENT_1	[p1l1288t83r1487b102],

1	E	NN	O	e	nn	2	SENT_2	[p1l895t257r923b289],
2	D	NN	O	d	_	0	SENT_2	[p1l938t257r974b289],
3	I	PRP	O	I	dep	2	SENT_2	[p1l987t257r1004b289],
4	T	NN	O	t	nn	6	SENT_2	[p1l1018t257r1049b289],
5	O	NN	O	o	nn	6	SENT_2	[p1l1063t257r1098b290],
6	R	NN	O	r	dep	3	SENT_2	[p1l1112t257r1148b290],
7	I	PRP	O	I	dep	3	SENT_2	[p1l1161t257r1178b289],
8	A	DT	O	a	det	9	SENT_2	[p1l1192t257r1226b289],
9	L	NN	O	l	dep	2	SENT_2	[p1l1241t257r1268b289],

1	E	NN	O	e	nn	2	SENT_3	[p1l1051t403r1064b420],
2	N	NN	O	n	_	0	SENT_3	[p1l1092t403r1117b426],
3	;	:	O	;	_	0	SENT_3	[p1l1092t403r1117b426],
4	‘	CD	NUMBER	‘	num	5	SENT_3	[p1l1012t417r1069b464],
5	K.	NNP	O	K.	dep	2	SENT_3	[p1l1012t417r1069b464],
6	/	:	O	/	punct	9	SENT_3	[p1l1084t415r1143b461],
7	'	''	O	'	_	0	SENT_3	[p1l1084t415r1143b461],
8	5	CD	NUMBER	5	num	9	SENT_3	[p1l1012t466r1027b481],
9	mzamzts	NNS	O	mzamzt	dep	5	SENT_3	[p1l1037t461r1120b484],
10	,2	CD	NUMBER	,2	num	11	SENT_3	[p1l1129t459r1145b479],
11	g.	NN	O	g.	dep	9	SENT_3	[p1l1015t488r1031b497],
12	/	:	O	/	punct	9	SENT_3	[p1l1056t485r1062b493],
13	.	.	O	.	_	0	SENT_3	[p1l1096t487r1101b494],

1	A	DT	O	a	predet	3	SENT_4	[p1l1125t480r1141b491],
2	a	DT	O	a	det	3	SENT_4	[p1l1021t495r1091b529],
3	)	NN	O	)	_	0	SENT_4	[p1l1021t495r1091b529],
4	V192a	NN	O	v192a	dep	3	SENT_4	[p1l1021t495r1091b529],
5	5	CD	PERCENT	5	number	6	SENT_4	[p1l1114t492r1137b517],
6	%	NN	PERCENT	%	amod	8	SENT_4	[p1l1114t492r1137b517],
7	mo	NN	DURATION	mo	nn	8	SENT_4	[p1l1068t514r1111b537],
8	‘	NN	O	‘	dep	4	SENT_4	[p1l1068t514r1111b537],

1	Personalized	VBN	O	personalize	_	0	SENT_5	[p1l341t624r671b673],
2	Medicine	NN	O	medicine	nn	6	SENT_5	[p1l696t624r936b673],
3	and	CC	O	and	_	0	SENT_5	[p1l954t624r1049b673],
4	Inhibition	NN	O	inhibition	nn	6	SENT_5	[p1l1073t624r1323b673],
5	ofEGFR	NN	O	ofegfr	nn	6	SENT_5	[p1l1343t624r1562b673],
6	Signaling	NN	O	signaling	dobj	1	SENT_5	[p1l1577t624r1824b688],
7	in	IN	O	in	_	0	SENT_5	[p1l882t699r926b746],
8	Lung	NN	O	lung	nn	9	SENT_5	[p1l951t702r1080b761],
9	Cancer	NN	O	cancer	prep_in	6	SENT_5	[p1l1097t702r1281b746],

1	Adi	NNP	PERSON	Adi	nn	3	SENT_6	[p1l907t802r961b833],
2	F.	NNP	PERSON	F.	nn	3	SENT_6	[p1l980t805r1005b833],
3	Gazdar	NNP	PERSON	Gazdar	_	0	SENT_6	[p1l1021t802r1151b838],
4	,	,	O	,	_	0	SENT_6	[p1l1021t802r1151b838],
5	M.D.	NNP	O	M.D.	appos	3	SENT_6	[p1l1170t805r1250b833],

1	The	DT	O	the	det	2	SENT_7	[p1l8t1019r169b1098],
2	concept	NN	O	concept	nsubj	8	SENT_7	[p1l212t1036r548b1120],
3	underlying	VBG	O	underlie	partmod	2	SENT_7	[p1l586t1019r1051b1120],
4	much	RB	O	much	dobj	3	SENT_7	[p1l1090t1019r1328b1098],
5	of	IN	O	of	_	0	SENT_7	[p1l1372t1019r1471b1098],
6	cancer	NN	O	cancer	nn	7	SENT_7	[p1l1496t1045r1777b1098],
7	therapy	NN	O	therapy	prep_of	4	SENT_7	[p1l1817t1019r2138b1120],
8	is	VBZ	O	be	_	0	SENT_7	[p1l11t1148r77b1226],
9	that	IN	O	that	complm	20	SENT_7	[p1l116t1147r288b1226],
10	patients	NNS	O	patient	nsubjpass	20	SENT_7	[p1l319t1148r660b1248],
11	with	IN	O	with	_	0	SENT_7	[p1l694t1147r889b1226],
12	specific	JJ	O	specific	amod	13	SENT_7	[p1l928t1147r1257b1248],
13	types	NNS	O	type	prep_with	10	SENT_7	[p1l1293t1164r1516b1248],
14	and	CC	O	and	_	0	SENT_7	[p1l1555t1147r1712b1226],
15	stages	NNS	O	stage	conj_and	13	SENT_7	[p1l1751t1164r2013b1248],
16	of	IN	O	of	_	0	SENT_7	[p1l2052t1147r2152b1226],
17	cancer	NN	O	cancer	prep_of	13	SENT_7	[p1l12t1301r293b1354],
18	should	MD	O	should	aux	20	SENT_7	[p1l332t1275r619b1354],
19	be	VB	O	be	auxpass	20	SENT_7	[p1l659t1275r756b1354],
20	treated	VBN	O	treat	ccomp	8	SENT_7	[p1l797t1275r1095b1354],
21	according	VBG	O	accord	_	0	SENT_7	[p1l1134t1275r1561b1376],
22	to	TO	O	to	prepc_according_to	20	SENT_7	[p1l1598t1292r1680b1354],
23	standardized	JJ	O	standardized	amod	26	SENT_7	[p1l1723t1275r2133b1354, p1l11t1403r216b1499],
24	,	,	O	,	_	0	SENT_7	[p1l1723t1275r2133b1354, p1l11t1403r216b1499],
25	predetermined	JJ	O	predetermined	amod	26	SENT_7	[p1l258t1403r907b1504],
26	protocols	NNS	O	protocol	pobj	20	SENT_7	[p1l944t1403r1381b1504],
27	.	.	O	.	_	0	SENT_7	[p1l944t1403r1381b1504],

1	However	RB	O	however	advmod	39	SENT_8	[p1l1423t1411r1826b1499],
2	,	,	O	,	_	0	SENT_8	[p1l1423t1411r1826b1499],
3	recent	JJ	O	recent	amod	4	SENT_8	[p1l1869t1420r2139b1482],
4	advances	NNS	O	advance	nsubj	39	SENT_8	[p1l11t1531r390b1610],
5	in	IN	O	in	_	0	SENT_8	[p1l427t1532r510b1609],
6	drug	NN	O	drug	nn	7	SENT_8	[p1l546t1531r747b1632],
7	development	NN	O	development	prep_in	4	SENT_8	[p1l781t1531r1338b1632],
8	,	,	O	,	_	0	SENT_8	[p1l781t1531r1338b1632],
9	pharmacogenom	NN	O	pharmacogenom	nn	11	SENT_8	[p1l1378t1531r2133b1632],
10	—	NN	O	—	nn	11	SENT_8	[p1l1378t1531r2133b1632],
11	ics	NNS	O	ic	conj_and	7	SENT_8	[p1l11t1659r146b1753],
12	,	,	O	,	_	0	SENT_8	[p1l11t1659r146b1753],
13	and	CC	O	and	_	0	SENT_8	[p1l186t1658r342b1736],
14	the	DT	O	the	det	16	SENT_8	[p1l376t1658r506b1736],
15	molecular	JJ	O	molecular	amod	16	SENT_8	[p1l541t1658r965b1737],
16	characterization	NN	O	characterization	conj_and	7	SENT_8	[p1l997t1658r1680b1736],
17	of	IN	O	of	_	0	SENT_8	[p1l1715t1658r1814b1736],
18	tumors	NNS	O	tumor	prep_of	4	SENT_8	[p1l1830t1675r2132b1737],
19	—	CD	NUMBER	—	num	18	SENT_8	[p1l8t1831r116b1839],
20	including	VBG	O	include	_	0	SENT_8	[p1l146t1786r557b1887],
21	genomewide	JJ	O	genomewide	amod	28	SENT_8	[p1l588t1786r1134b1887],
22	RNA	NN	MISC	rna	nn	28	SENT_8	[p1l1169t1793r1377b1870],
23	expression	NN	O	expression	nn	28	SENT_8	[p1l1410t1787r1889b1887],
24	,	,	O	,	_	0	SENT_8	[p1l1410t1787r1889b1887],
25	DNA	NN	O	dna	dep	28	SENT_8	[p1l1929t1793r2137b1865],
26	copy	NN	O	copy	nn	28	SENT_8	[p1l12t1914r579b2015],
27	—	NN	O	—	nn	28	SENT_8	[p1l12t1914r579b2015],
28	number	NN	O	number	prep_including	18	SENT_8	[p1l12t1914r579b2015],
29	and	CC	O	and	_	0	SENT_8	[p1l612t1914r769b1993],
30	sequence	NN	O	sequence	nn	31	SENT_8	[p1l807t1940r1195b2015],
31	analyses	NNS	O	analysis	prep_including	18	SENT_8	[p1l1231t1914r1614b2015],
32	,	,	O	,	_	0	SENT_8	[p1l1231t1914r1614b2015],
33	and	CC	O	and	_	0	SENT_8	[p1l1655t1914r1813b1993],
34	microRNA	NN	O	microrna	prep_including	18	SENT_8	[p1l1849t1915r2133b1993, p1l11t2049r220b2126],
35	and	CC	O	and	_	0	SENT_8	[p1l250t2042r408b2121],
36	proteomic	JJ	O	proteomic	amod	37	SENT_8	[p1l440t2043r881b2143],
37	profiling	NN	O	profiling	conj_and	28	SENT_8	[p1l913t2042r1302b2143],
38	—	CD	NUMBER	—	num	37	SENT_8	[p1l1329t2087r1436b2095],
39	have	VBP	O	have	_	0	SENT_8	[p1l1467t2042r1656b2121],
40	the	DT	O	the	det	41	SENT_8	[p1l1691t2042r1823b2121],
41	potential	JJ	O	potential	dobj	39	SENT_8	[p1l1857t2059r2133b2143, p1l12t2170r148b2249],
42	to	TO	O	to	aux	43	SENT_8	[p1l184t2187r264b2249],
43	allow	VB	O	allow	dep	41	SENT_8	[p1l301t2170r532b2250],
44	individualized	JJ	O	individualized	amod	45	SENT_8	[p1l563t2170r1164b2249],
45	selection	NN	O	selection	dobj	43	SENT_8	[p1l1201t2170r1572b2249],
46	of	IN	O	of	_	0	SENT_8	[p1l1608t2170r1707b2249],
47	treatment	NN	O	treatment	prep_of	45	SENT_8	[p1l1725t2187r2140b2249],
48	as	IN	O	as	mark	49	SENT_8	[p1l11t2325r96b2377],
49	determined	VBN	O	determine	advcl	39	SENT_8	[p1l149t2298r643b2377],
50	by	IN	O	by	_	0	SENT_8	[p1l692t2298r789b2399],
51	the	DT	O	the	det	52	SENT_8	[p1l835t2298r967b2377],
52	characteristics	NNS	O	characteristic	prep_by	49	SENT_8	[p1l1017t2298r1638b2377],
53	of	IN	O	of	_	0	SENT_8	[p1l1690t2298r1790b2377],
54	the	DT	O	the	det	55	SENT_8	[p1l1821t2298r1954b2377],
55	patient	NN	O	patient	prep_of	52	SENT_8	[p1l2001t2324r2133b2399, p1l12t2428r209b2506],
56	and	CC	O	and	_	0	SENT_8	[p1l242t2427r399b2506],
57	the	DT	O	the	det	58	SENT_8	[p1l437t2427r570b2506],
58	tumor	NN	O	tumor	conj_and	55	SENT_8	[p1l608t2444r894b2506],
59	.	.	O	.	_	0	SENT_8	[p1l608t2444r894b2506],

1	In	IN	O	in	_	0	SENT_9	[p1l140t2563r228b2633],
2	principle	NN	O	principle	prep_in	4	SENT_9	[p1l264t2555r665b2656],
3	,	,	O	,	_	0	SENT_9	[p1l264t2555r665b2656],
4	targeted	VBN	O	target	_	0	SENT_9	[p1l708t2555r1063b2656],
5	therapies	NNS	O	therapy	nn	7	SENT_9	[p1l1100t2555r1489b2656],
6	attack	NN	O	attack	nn	7	SENT_9	[p1l1528t2555r1791b2635],
7	cancercell	NN	O	cancercell	dobj	4	SENT_9	[p1l1823t2581r2133b2634, p1l12t2683r561b2784],
8	—	CD	NUMBER	—	num	10	SENT_9	[p1l1823t2581r2133b2634, p1l12t2683r561b2784],
9	specific	JJ	O	specific	amod	10	SENT_9	[p1l1823t2581r2133b2634, p1l12t2683r561b2784],
10	attributes	NNS	O	attribute	dep	7	SENT_9	[p1l628t2683r1048b2762],
11	that	WDT	O	that	nsubj	25	SENT_9	[p1l1120t2683r1296b2762],
12	are	VBP	O	be	cop	13	SENT_9	[p1l1359t2709r1489b2762],
13	essential	JJ	O	essential	rcmod	7	SENT_9	[p1l1560t2683r1943b2762],
14	for	IN	O	for	_	0	SENT_9	[p1l2012t2683r2137b2762],
15	growth	NN	O	growth	prep_for	13	SENT_9	[p1l12t2811r331b2912],
16	or	CC	O	or	_	0	SENT_9	[p1l386t2837r474b2890],
17	survival	NN	O	survival	nn	20	SENT_9	[p1l525t2811r857b2891],
18	(	CD	NUMBER	(	num	20	SENT_9	[p1l914t2816r1393b2912],
19	“	NN	O	“	nn	20	SENT_9	[p1l914t2816r1393b2912],
20	oncogene	NN	O	oncogene	conj_or	15	SENT_9	[p1l914t2816r1393b2912],
21	addiction	NN	O	addiction	nn	23	SENT_9	[p1l1445t2811r1920b2903],
22	”	CD	NUMBER	”	num	23	SENT_9	[p1l1445t2811r1920b2903],
23	)	NN	O	)	dep	20	SENT_9	[p1l1445t2811r1920b2903],
24	and	CC	O	and	_	0	SENT_9	[p1l1977t2811r2134b2890],
25	avoid	VB	O	avoid	rcmod	7	SENT_9	[p1l11t2939r233b3018],
26	the	DT	O	the	det	30	SENT_9	[p1l280t2939r413b3018],
27	potentially	RB	O	potentially	advmod	28	SENT_9	[p1l460t2939r924b3040],
28	severe	JJ	O	severe	amod	30	SENT_9	[p1l969t2965r1226b3018],
29	side	JJ	O	side	amod	30	SENT_9	[p1l1276t2939r1440b3018],
30	effects	NNS	O	effect	dobj	25	SENT_9	[p1l1489t2939r1769b3018],
31	of	IN	O	of	_	0	SENT_9	[p1l1819t2939r1920b3018],
32	conventional	JJ	O	conventional	amod	34	SENT_9	[p1l1949t2965r2133b3018, p1l7t3067r398b3146],
33	cytotoxic	JJ	O	cytotoxic	amod	34	SENT_9	[p1l443t3068r821b3168],
34	treatments	NNS	O	treatment	prep_of	30	SENT_9	[p1l866t3084r1343b3146],
35	.	.	O	.	_	0	SENT_9	[p1l866t3084r1343b3146],

1	Successful	JJ	O	successful	amod	2	SENT_10	[p1l1395t3067r1832b3146],
2	examples	NNS	O	example	nsubj	6	SENT_10	[p1l1877t3093r2133b3146, p1l11t3195r178b3296],
3	of	IN	O	of	_	0	SENT_10	[p1l219t3195r319b3274],
4	targeted	VBN	O	target	amod	5	SENT_10	[p1l339t3195r694b3296],
5	therapy	NN	O	therapy	prep_of	2	SENT_10	[p1l732t3195r1054b3296],
6	include	VBP	O	include	_	0	SENT_10	[p1l1087t3195r1397b3274],
7	imatinib	NN	O	imatinib	dobj	6	SENT_10	[p1l1435t3195r1804b3274],
8	for	IN	O	for	_	0	SENT_10	[p1l1843t3195r1966b3274],
9	the	DT	O	the	det	10	SENT_10	[p1l2001t3195r2134b3274],
10	treatment	NN	O	treatment	prep_for	7	SENT_10	[p1l12t3340r436b3402],
11	of	IN	O	of	_	0	SENT_10	[p1l478t3323r578b3402],
12	BCR	NN	O	bcr	prep_of	10	SENT_10	[p1l604t3324r1382b3424],
13	.	.	O	.	_	0	SENT_10	[p1l604t3324r1382b3424],

1	—	NN	O	—	_	0	SENT_11	[p1l604t3324r1382b3424],
2	.	.	O	.	_	0	SENT_11	[p1l604t3324r1382b3424],

1	ABL	NNP	ORGANIZATION	ABL	_	0	SENT_12	[p1l604t3324r1382b3424],
2	.	.	O	.	_	0	SENT_12	[p1l604t3324r1382b3424],

1	—	NN	O	—	_	0	SENT_13	[p1l604t3324r1382b3424],
2	.	.	O	.	_	0	SENT_13	[p1l604t3324r1382b3424],

1	positive	JJ	O	positive	amod	4	SENT_14	[p1l604t3324r1382b3424],
2	chronic	JJ	O	chronic	amod	4	SENT_14	[p1l1430t3323r1753b3402],
3	myeloid	JJ	O	myeloid	amod	4	SENT_14	[p1l1799t3323r2134b3424],
4	leukemia	NN	O	leukemia	_	0	SENT_14	[p1l11t3451r406b3531],
5	and	CC	O	and	_	0	SENT_14	[p1l452t3451r610b3530],
6	the	DT	O	the	det	25	SENT_14	[p1l658t3451r791b3530],
7	reversible	JJ	O	reversible	amod	25	SENT_14	[p1l840t3451r1247b3530],
8	tyrosine	NN	O	tyrosine	nn	10	SENT_14	[p1l1296t3452r1642b3552],
9	kinase	NN	O	kinase	nn	10	SENT_14	[p1l1691t3451r1969b3531],
10	inhibitors	NNS	O	inhibitor	tmod	7	SENT_14	[p1l2018t3452r2133b3529, p1l12t3579r368b3675],
11	,	,	O	,	_	0	SENT_14	[p1l2018t3452r2133b3529, p1l12t3579r368b3675],
12	erlotinib	NN	O	erlotinib	conj_and	10	SENT_14	[p1l409t3579r776b3658],
13	and	CC	O	and	_	0	SENT_14	[p1l811t3579r969b3658],
14	gefitinib	NN	O	gefitinib	conj_and	10	SENT_14	[p1l1003t3579r1397b3680],
15	,	,	O	,	_	0	SENT_14	[p1l1003t3579r1397b3680],
16	for	IN	O	for	_	0	SENT_14	[p1l1437t3579r1560b3658],
17	blocking	VBG	O	block	prepc_for	7	SENT_14	[p1l1592t3579r1969b3680],
18	the	DT	O	the	det	19	SENT_14	[p1l2001t3579r2134b3658],
19	gene	NN	O	gene	dobj	17	SENT_14	[p1l12t3733r211b3808],
20	that	WDT	O	that	nsubj	21	SENT_14	[p1l262t3707r434b3786],
21	encodes	VBZ	O	encode	rcmod	19	SENT_14	[p1l480t3707r822b3786],
22	epidermal	JJ	O	epidermal	amod	24	SENT_14	[p1l876t3707r1308b3808],
23	growth	NN	O	growth	nn	24	SENT_14	[p1l1357t3707r1672b3808],
24	factor	NN	O	factor	dobj	21	SENT_14	[p1l1722t3707r1973b3786],
25	receptor	NN	O	receptor	conj_and	4	SENT_14	[p1l2020t3733r2133b3786, p2l12t38r278b122],

1	(	JJ	O	(	amod	3	SENT_15	[p2l315t28r572b113],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_15	[p2l315t28r572b113],
3	)	NN	O	)	_	0	SENT_15	[p2l315t28r572b113],
4	in	IN	O	in	_	0	SENT_15	[p2l613t22r696b99],
5	subgroups	NNS	O	subgroup	prep_in	3	SENT_15	[p2l733t21r1171b122],
6	of	IN	O	of	_	0	SENT_15	[p2l1210t21r1309b100],
7	patients	NNS	O	patient	prep_of	3	SENT_15	[p2l1325t22r1659b122],
8	with	IN	O	with	_	0	SENT_15	[p2l1693t21r1885b100],
9	nonsmall	JJ	O	nonsmall	amod	13	SENT_15	[p2l1921t47r2138b100, p2l13t149r432b228],
10	—	NN	O	—	nn	13	SENT_15	[p2l1921t47r2138b100, p2l13t149r432b228],
11	cell	NN	O	cell	nn	13	SENT_15	[p2l1921t47r2138b100, p2l13t149r432b228],
12	lung	NN	O	lung	nn	13	SENT_15	[p2l468t149r661b250],
13	cancer	NN	O	cancer	prep_with	7	SENT_15	[p2l697t175r995b228],
14	.	.	O	.	_	0	SENT_15	[p2l697t175r995b228],

1	Initially	RB	O	initially	advmod	22	SENT_16	[p2l140t277r473b378],
2	,	,	O	,	_	0	SENT_16	[p2l140t277r473b378],
3	the	DT	O	the	det	4	SENT_16	[p2l520t277r648b356],
4	basis	NN	O	basis	nsubj	22	SENT_16	[p2l690t277r893b356],
5	for	IN	O	for	_	0	SENT_16	[p2l937t277r1055b356],
6	the	DT	O	the	det	8	SENT_16	[p2l1094t277r1222b356],
7	selective	JJ	O	selective	amod	8	SENT_16	[p2l1265t277r1604b356],
8	response	NN	O	response	prep_for	4	SENT_16	[p2l1645t303r2011b378],
9	to	TO	O	to	_	0	SENT_16	[p2l2053t294r2132b356],
10	tyrosine	NN	O	tyrosine	nn	12	SENT_16	[p2l12t406r358b506],
11	kinase	NN	O	kinase	nn	12	SENT_16	[p2l399t405r678b485],
12	inhibitors	NNS	O	inhibitor	prep_to	8	SENT_16	[p2l718t405r1139b484],
13	in	IN	O	in	_	0	SENT_16	[p2l1181t406r1264b483],
14	patients	NNS	O	patient	prep_in	12	SENT_16	[p2l1303t406r1644b506],
15	with	IN	O	with	_	0	SENT_16	[p2l1682t405r1878b484],
16	nonsmall	JJ	O	nonsmall	amod	20	SENT_16	[p2l1918t431r2137b484, p2l13t533r412b612],
17	—	NN	O	—	nn	20	SENT_16	[p2l1918t431r2137b484, p2l13t533r412b612],
18	cell	NN	O	cell	nn	20	SENT_16	[p2l1918t431r2137b484, p2l13t533r412b612],
19	lung	NN	O	lung	nn	20	SENT_16	[p2l448t533r635b634],
20	cancer	NN	O	cancer	prep_with	14	SENT_16	[p2l670t559r940b612],
21	was	VBD	O	be	cop	22	SENT_16	[p2l971t560r1129b612],
22	unknown	JJ	O	unknown	_	0	SENT_16	[p2l1169t533r1591b613],
23	.	.	O	.	_	0	SENT_16	[p2l1169t533r1591b613],

1	Subsequently	RB	O	subsequently	advmod	24	SENT_17	[p2l1636t533r2133b634, p2l11t661r95b762],
2	,	,	O	,	_	0	SENT_17	[p2l1636t533r2133b634, p2l11t661r95b762],
3	the	DT	O	the	det	4	SENT_17	[p2l136t661r268b740],
4	identification	NN	O	identification	nsubj	24	SENT_17	[p2l301t661r885b740],
5	of	IN	O	of	_	0	SENT_17	[p2l919t661r1019b740],
6	mutations	NNS	O	mutation	prep_of	4	SENT_17	[p2l1035t662r1469b740],
7	in	IN	O	in	_	0	SENT_17	[p2l1504t662r1587b739],
8	the	DT	O	the	det	11	SENT_17	[p2l1622t661r1754b740],
9	tyrosine	NN	O	tyrosine	nn	11	SENT_17	[p2l1788t662r2134b762],
10	kinase	NN	O	kinase	nn	11	SENT_17	[p2l12t789r279b869],
11	domain	NN	O	domain	prep_in	6	SENT_17	[p2l322t789r641b868],
12	of	IN	O	of	_	0	SENT_17	[p2l683t789r780b868],
13	EGFR	NN	ORGANIZATION	egfr	prep_of	11	SENT_17	[p2l801t796r1007b869],
14	that	WDT	O	that	nsubj	15	SENT_17	[p2l1041t789r1208b868],
15	resulted	VBD	O	result	rcmod	6	SENT_17	[p2l1243t789r1571b868],
16	in	IN	O	in	_	0	SENT_17	[p2l1611t790r1692b867],
17	ligand	NN	O	ligand	nn	18	SENT_17	[p2l1732t789r2133b890],
18	—	NN	O	—	prep_in	15	SENT_17	[p2l1732t789r2133b890],
19	in	IN	O	in	_	0	SENT_17	[p2l1732t789r2133b890],
20	—	NN	O	—	nn	23	SENT_17	[p2l1732t789r2133b890],
21	dependent	JJ	O	dependent	amod	23	SENT_17	[p2l12t917r463b1018],
22	gene	NN	O	gene	nn	23	SENT_17	[p2l500t943r699b1018],
23	activation	NN	O	activation	prep_in	15	SENT_17	[p2l741t918r1158b996],
24	provided	VBD	O	provide	_	0	SENT_17	[p2l1199t917r1573b1018],
25	a	DT	O	a	det	28	SENT_17	[p2l1614t944r1659b996],
26	seemingly	RB	O	seemingly	advmod	27	SENT_17	[p2l1701t917r2139b1018],
27	rational	JJ	O	rational	amod	28	SENT_17	[p2l12t1045r340b1124],
28	basis	NN	O	basis	dobj	24	SENT_17	[p2l380t1045r586b1124],
29	for	IN	O	for	_	0	SENT_17	[p2l627t1045r749b1124],
30	the	DT	O	the	det	31	SENT_17	[p2l785t1045r915b1124],
31	response	NN	O	response	prep_for	28	SENT_17	[p2l955t1071r1350b1146],
32	.	.	O	.	_	0	SENT_17	[p2l955t1071r1350b1146],

1	The	DT	O	the	det	3	SENT_18	[p2l1391t1045r1550b1124],
2	vast	JJ	O	vast	amod	3	SENT_18	[p2l1584t1062r1751b1124],
3	majority	NN	O	majority	nsubj	10	SENT_18	[p2l1785t1046r2138b1146],
4	of	IN	O	of	_	0	SENT_18	[p2l12t1173r110b1252],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_18	[p2l134t1180r340b1253],
6	mutations	NNS	O	mutation	prep_of	3	SENT_18	[p2l377t1174r794b1252],
7	are	VBP	O	be	cop	10	SENT_18	[p2l840t1199r964b1252],
8	either	RB	O	either	advmod	10	SENT_18	[p2l1009t1173r1245b1252],
9	a	DT	O	a	det	10	SENT_18	[p2l1285t1200r1329b1252],
10	deletion	NN	O	deletion	_	0	SENT_18	[p2l1373t1173r1702b1252],
11	of	IN	O	of	_	0	SENT_18	[p2l1747t1173r1844b1252],
12	a	DT	O	a	prep_of	10	SENT_18	[p2l1869t1200r1913b1252],
13	conserved	VBN	O	conserve	partmod	12	SENT_18	[p2l1956t1199r2133b1252, p2l13t1301r273b1380],

1	sequence	NN	O	sequence	_	0	SENT_19	[p2l307t1327r679b1402],
2	in	IN	O	in	_	0	SENT_19	[p2l711t1302r792b1379],
3	exon	NN	O	exon	prep_in	1	SENT_19	[p2l825t1327r1018b1380],
4	19	CD	NUMBER	19	num	3	SENT_19	[p2l1053t1307r1147b1380],
5	or	CC	O	or	_	0	SENT_19	[p2l1181t1327r1267b1380],
6	a	DT	O	a	det	9	SENT_19	[p2l1295t1328r1340b1380],
7	single	JJ	O	single	amod	9	SENT_19	[p2l1372t1301r1613b1402],
8	point	NN	O	point	nn	9	SENT_19	[p2l1644t1302r1865b1402],
9	mutation	NN	O	mutation	conj_or	1	SENT_19	[p2l1892t1318r2133b1380, p2l12t1430r185b1508],
10	in	IN	O	in	_	0	SENT_19	[p2l232t1430r317b1507],
11	exon	NN	O	exon	prep_in	9	SENT_19	[p2l365t1455r568b1508],
12	21	CD	NUMBER	21	number	13	SENT_19	[p2l617t1435r717b1507],
13	(	CD	NUMBER	(	dep	1	SENT_19	[p2l770t1435r1134b1521],
14	L858R	NN	O	l858r	nn	15	SENT_19	[p2l770t1435r1134b1521],
15	)	NN	O	)	dep	13	SENT_19	[p2l770t1435r1134b1521],
16	.	.	O	.	_	0	SENT_19	[p2l770t1435r1134b1521],

1	These	DT	O	these	det	3	SENT_20	[p2l1184t1429r1440b1508],
2	activating	VBG	O	activate	amod	3	SENT_20	[p2l1488t1430r1919b1530],
3	mutations	NNS	O	mutation	nsubj	18	SENT_20	[p2l1964t1455r2133b1508, p2l12t1558r313b1636],
4	result	VBP	O	result	_	0	SENT_20	[p2l359t1557r608b1636],
5	in	IN	O	in	_	0	SENT_20	[p2l647t1558r731b1635],
6	ligand	NN	O	ligand	nn	7	SENT_20	[p2l774t1557r1636b1658],
7	—	NN	O	—	prep_in	4	SENT_20	[p2l774t1557r1636b1658],
8	independent	JJ	O	independent	amod	12	SENT_20	[p2l774t1557r1636b1658],
9	tumor	NN	O	tumor	nn	12	SENT_20	[p2l1676t1557r2135b1636],
10	—	NN	O	—	nn	12	SENT_20	[p2l1676t1557r2135b1636],
11	cell	NN	O	cell	nn	12	SENT_20	[p2l1676t1557r2135b1636],
12	dependence	NN	O	dependence	dep	7	SENT_20	[p2l13t1685r528b1786],
13	on	IN	O	on	_	0	SENT_20	[p2l572t1711r678b1764],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_20	[p2l719t1692r935b1765],
15	signaling1	NN	O	signaling1	prep_on	12	SENT_20	[p2l972t1685r1419b1786],
16	and	CC	O	and	_	0	SENT_20	[p2l1460t1685r1621b1764],
17	simultaneously	RB	O	simultaneously	advmod	4	SENT_20	[p2l1664t1685r2133b1764, p2l12t1813r235b1914],
18	provide	VBP	O	provide	conj_and	4	SENT_20	[p2l267t1813r585b1914],
19	the	DT	O	the	det	20	SENT_20	[p2l624t1813r756b1892],
20	means	NNS	O	means	dobj	18	SENT_20	[p2l795t1839r1074b1892],
21	to	TO	O	to	aux	22	SENT_20	[p2l1114t1830r1195b1892],
22	inhibit	VB	O	inhibit	xcomp	18	SENT_20	[p2l1234t1813r1524b1892],
23	the	DT	O	the	det	24	SENT_20	[p2l1557t1813r1690b1892],
24	tumor	NN	O	tumor	dobj	22	SENT_20	[p2l1729t1830r2014b1892],
25	.	.	O	.	_	0	SENT_20	[p2l1729t1830r2014b1892],

1	It	PRP	O	it	nsubj	4	SENT_21	[p2l139t1949r203b2020],
2	soon	RB	O	soon	advmod	4	SENT_21	[p2l239t1967r441b2020],
3	became	VBD	O	become	cop	4	SENT_21	[p2l481t1941r805b2020],
4	obvious	JJ	O	obvious	_	0	SENT_21	[p2l845t1941r1192b2037],
5	,	,	O	,	_	0	SENT_21	[p2l845t1941r1192b2037],
6	however	RB	O	however	advmod	4	SENT_21	[p2l1237t1941r1607b2037],
7	,	,	O	,	_	0	SENT_21	[p2l1237t1941r1607b2037],
8	that	IN	O	that	complm	22	SENT_21	[p2l1652t1941r1822b2020],
9	the	DT	O	the	det	10	SENT_21	[p2l1857t1941r1988b2020],
10	association	NN	O	association	nsubj	22	SENT_21	[p2l2027t1968r2145b2020, p2l12t2071r404b2149],
11	between	IN	O	between	_	0	SENT_21	[p2l440t2070r800b2149],
12	mutations	NNS	O	mutation	prep_between	10	SENT_21	[p2l835t2071r1273b2149],
13	and	CC	O	and	_	0	SENT_21	[p2l1309t2070r1469b2149],
14	responsiveness	NN	O	responsiveness	prep_between	10	SENT_21	[p2l1504t2071r2145b2171],
15	to	TO	O	to	_	0	SENT_21	[p2l11t2215r94b2277],
16	tyrosine	NN	O	tyrosine	nn	18	SENT_21	[p2l153t2199r509b2299],
17	kinase	NN	O	kinase	nn	18	SENT_21	[p2l566t2198r852b2278],
18	inhibitors	NNS	O	inhibitor	prep_to	10	SENT_21	[p2l908t2198r1343b2277],
19	was	VBD	O	be	cop	22	SENT_21	[p2l1397t2225r1564b2277],
20	much	RB	O	much	advmod	22	SENT_21	[p2l1622t2198r1865b2277],
21	more	RBR	O	more	advmod	22	SENT_21	[p2l1922t2224r2146b2277],
22	complex	JJ	O	complex	ccomp	4	SENT_21	[p2l11t2326r380b2427],
23	than	IN	O	than	mark	26	SENT_21	[p2l435t2326r636b2405],
24	had	VBD	O	have	aux	26	SENT_21	[p2l694t2326r854b2405],
25	been	VBN	O	be	auxpass	26	SENT_21	[p2l912t2326r1118b2405],
26	envisioned	VBN	O	envision	ccomp	22	SENT_21	[p2l1177t2326r1669b2405],
27	.	.	O	.	_	0	SENT_21	[p2l1177t2326r1669b2405],

1	Although	IN	O	although	mark	3	SENT_22	[p2l1730t2326r2147b2427],
2	mutations	NNS	O	mutation	nsubj	3	SENT_22	[p2l11t2455r456b2533],
3	correlated	VBD	O	correlate	advcl	15	SENT_22	[p2l512t2454r955b2533],
4	well	RB	O	well	advmod	3	SENT_22	[p2l1004t2454r1186b2533],
5	with	IN	O	with	_	0	SENT_22	[p2l1234t2454r1433b2534],
6	responsiveness	NN	O	responsiveness	prep_with	4	SENT_22	[p2l1486t2455r2144b2555],
7	and	CC	O	and	_	0	SENT_22	[p2l10t2582r167b2661],
8	tumor	NN	O	tumor	prep_with	4	SENT_22	[p2l202t2582r657b2661],
9	—	CD	NUMBER	—	num	11	SENT_22	[p2l202t2582r657b2661],
10	free	JJ	O	free	amod	11	SENT_22	[p2l202t2582r657b2661],
11	survival	NN	O	survival	dobj	3	SENT_22	[p2l694t2582r1042b2678],
12	,	,	O	,	_	0	SENT_22	[p2l694t2582r1042b2678],
13	overall	JJ	O	overall	amod	14	SENT_22	[p2l1083t2582r1364b2661],
14	survival	NN	O	survival	nsubj	15	SENT_22	[p2l1400t2582r1726b2662],
15	appeared	VBD	O	appear	_	0	SENT_22	[p2l1760t2582r2147b2683],
16	to	TO	O	to	aux	17	SENT_22	[p2l11t2727r92b2789],
17	correlate	VB	O	correlate	xcomp	15	SENT_22	[p2l128t2710r495b2789],
18	better	JJR	O	better	dobj	17	SENT_22	[p2l530t2710r778b2789],
19	with	IN	O	with	_	0	SENT_22	[p2l804t2710r997b2789],
20	increased	VBN	O	increase	amod	23	SENT_22	[p2l1030t2710r1432b2789],
21	gene	NN	O	gene	nn	23	SENT_22	[p2l1465t2736r1662b2811],
22	copy	NN	O	copy	nn	23	SENT_22	[p2l1696t2736r1891b2811],
23	number	NN	O	number	prep_with	17	SENT_22	[p2l1920t2736r2145b2789, p2l11t2838r149b2917],
24	and	CC	O	and	_	0	SENT_22	[p2l183t2838r342b2917],
25	possibly	RB	O	possibly	xcomp	15	SENT_22	[p2l377t2838r733b2939],
26	with	IN	O	with	_	0	SENT_22	[p2l761t2838r957b2918],
27	the	DT	O	the	det	29	SENT_22	[p2l995t2838r1129b2917],
28	copy	NN	O	copy	nn	29	SENT_22	[p2l1167t2864r1365b2939],
29	number	NN	O	number	prep_with	25	SENT_22	[p2l1398t2838r1738b2917],
30	of	IN	O	of	_	0	SENT_22	[p2l1773t2838r1874b2917],
31	HERZ	NN	ORGANIZATION	herz	prep_of	29	SENT_22	[p2l1891t2845r2142b2934],
32	,	,	O	,	_	0	SENT_22	[p2l1891t2845r2142b2934],
33	another	DT	O	another	det	34	SENT_22	[p2l10t2966r354b3045],
34	member	NN	O	member	nsubj	47	SENT_22	[p2l400t2966r765b3045],
35	of	IN	O	of	_	0	SENT_22	[p2l812t2966r913b3045],
36	the	DT	O	the	det	39	SENT_22	[p2l944t2966r1080b3045],
37	EGFR	NN	ORGANIZATION	egfr	nn	39	SENT_22	[p2l1127t2973r1344b3046],
38	family	NN	O	family	nn	39	SENT_22	[p2l1387t2966r1783b3067],
39	.2	NN	NUMBER	.2	prep_of	34	SENT_22	[p2l1387t2966r1783b3067],
40	’	CD	NUMBER	’	number	41	SENT_22	[p2l1387t2966r1783b3067],
41	3	CD	NUMBER	3	dep	39	SENT_22	[p2l1387t2966r1783b3067],
42	Not	RB	O	not	neg	45	SENT_22	[p2l1832t2974r1996b3045],
43	all	DT	O	all	det	45	SENT_22	[p2l2040t2966r2147b3045],
44	EGFR	NN	ORGANIZATION	egfr	nn	45	SENT_22	[p2l9t3101r223b3174],
45	mutations	NNS	O	mutation	dep	41	SENT_22	[p2l260t3095r698b3173],
46	are	VBP	O	be	cop	47	SENT_22	[p2l744t3120r873b3173],
47	equal	JJ	O	equal	ccomp	15	SENT_22	[p2l920t3094r1175b3195],
48	,	,	O	,	_	0	SENT_22	[p2l920t3094r1175b3195],
49	and	CC	O	and	_	0	SENT_22	[p2l1225t3094r1383b3173],
50	some	DT	O	some	nsubj	59	SENT_22	[p2l1430t3120r1678b3190],
51	,	,	O	,	_	0	SENT_22	[p2l1430t3120r1678b3190],
52	especially	RB	O	especially	advmod	50	SENT_22	[p2l1729t3094r2151b3195],
53	insertion	NN	O	insertion	nn	54	SENT_22	[p2l10t3223r384b3301],
54	mutations	NNS	O	mutation	dep	50	SENT_22	[p2l415t3223r834b3301],
55	in	IN	O	in	_	0	SENT_22	[p2l868t3223r949b3300],
56	exon	NN	O	exon	prep_in	54	SENT_22	[p2l981t3248r1176b3301],
57	20	CD	NUMBER	20	num	56	SENT_22	[p2l1207t3228r1325b3318],
58	,	,	O	,	_	0	SENT_22	[p2l1207t3228r1325b3318],
59	confer	VBP	O	confer	conj_and	15	SENT_22	[p2l1363t3222r1628b3301],
60	intrinsic	JJ	O	intrinsic	amod	61	SENT_22	[p2l1656t3223r2001b3301],
61	resistance	NN	O	resistance	dobj	59	SENT_22	[p2l2032t3248r2145b3301, p2l12t3353r341b3431],
62	on	IN	O	on	_	0	SENT_22	[p2l377t3378r481b3431],
63	tumor	NN	O	tumor	nn	64	SENT_22	[p2l516t3369r776b3431],
64	cells	NNS	O	cell	prep_on	59	SENT_22	[p2l808t3352r1011b3431],
65	.	.	O	.	_	0	SENT_22	[p2l808t3352r1011b3431],

1	A	DT	O	a	det	3	SENT_23	[p2l1047t3360r1113b3430],
2	further	JJ	O	further	amod	3	SENT_23	[p2l1144t3352r1442b3431],
3	confounder	NN	O	confounder	nsubj	6	SENT_23	[p2l1474t3352r1954b3431],
4	was	VBD	O	be	cop	6	SENT_23	[p2l1981t3379r2144b3431],
5	the	DT	O	the	det	6	SENT_23	[p2l11t3480r142b3559],
6	ﬁnding	NN	O	ﬁnding	_	0	SENT_23	[p2l172t3480r489b3581],
7	that	WDT	O	that	nsubj	8	SENT_23	[p2l517t3480r686b3559],
8	activating	VBG	O	activate	rcmod	6	SENT_23	[p2l710t3481r1121b3581],
9	mutations	NNS	O	mutation	nsubj	18	SENT_23	[p2l1148t3481r1574b3559],
10	in	IN	O	in	_	0	SENT_23	[p2l1605t3481r1688b3558],
11	the	DT	O	the	det	15	SENT_23	[p2l1719t3480r1849b3559],
12	downstream	JJ	O	downstream	amod	15	SENT_23	[p2l1881t3480r2145b3559, p2l12t3625r299b3687],
13	KRAS	NNP	ORGANIZATION	KRAS	nn	15	SENT_23	[p2l329t3614r555b3688],
14	gene	NN	O	gene	nn	15	SENT_23	[p2l583t3634r778b3709],
15	(	NN	O	(	prep_in	9	SENT_23	[p2l815t3608r1135b3709],
16	usually	RB	O	usually	advmod	18	SENT_23	[p2l815t3608r1135b3709],
17	mutually	RB	O	mutually	advmod	18	SENT_23	[p2l1162t3608r1535b3709],
18	exclusive	JJ	O	exclusive	xcomp	8	SENT_23	[p2l1563t3608r1926b3687],
19	with	IN	O	with	prep	18	SENT_23	[p2l1954t3608r2147b3688],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_24	[p3l9t28r216b101],
2	mutations	NNS	O	mutation	nsubj	3	SENT_24	[p3l237t22r681b112],
3	)	VBP	O	)	_	0	SENT_24	[p3l237t22r681b112],
4	also	RB	O	also	advmod	3	SENT_24	[p3l713t21r880b100],
5	conferred	VBN	O	confer	dep	3	SENT_24	[p3l909t21r1308b100],
6	intrinsic	JJ	O	intrinsic	amod	7	SENT_24	[p3l1335t22r1681b100],
7	resistance	NN	O	resistance	dobj	5	SENT_24	[p3l1708t22r2140b100],
8	.	.	O	.	_	0	SENT_24	[p3l1708t22r2140b100],

1	Almost	RB	O	almost	advmod	7	SENT_25	[p3l7t149r327b228],
2	all	DT	O	all	det	7	SENT_25	[p3l367t149r472b228],
3	non	JJ	O	non	amod	7	SENT_25	[p3l517t149r1164b228],
4	—	CD	NUMBER	—	num	7	SENT_25	[p3l517t149r1164b228],
5	small	JJ	O	small	amod	6	SENT_25	[p3l517t149r1164b228],
6	—	JJ	O	—	amod	7	SENT_25	[p3l517t149r1164b228],
7	cell	NN	O	cell	_	0	SENT_25	[p3l517t149r1164b228],
8	lung	NN	O	lung	nn	9	SENT_25	[p3l1209t149r1403b250],
9	cancers	NNS	O	cancer	dep	7	SENT_25	[p3l1447t175r1769b228],
10	that	WDT	O	that	nsubj	20	SENT_25	[p3l1818t149r1991b228],
11	respond	VBP	O	respond	rcmod	9	SENT_25	[p3l2032t175r2145b228, p3l12t277r268b378],
12	initially	RB	O	initially	advmod	11	SENT_25	[p3l304t277r632b378],
13	to	TO	O	to	_	0	SENT_25	[p3l665t294r746b356],
14	tyrosine	NN	O	tyrosine	nn	16	SENT_25	[p3l784t278r1125b378],
15	kinase	NN	O	kinase	nn	16	SENT_25	[p3l1162t277r1437b357],
16	inhibitors	NNS	O	inhibitor	prep_to	11	SENT_25	[p3l1474t277r1888b356],
17	eventually	RB	O	eventually	advmod	18	SENT_25	[p3l1928t303r2145b356, p3l11t405r250b506],
18	relapse	NN	O	relapse	rcmod	16	SENT_25	[p3l274t405r572b506],
19	and	CC	O	and	_	0	SENT_25	[p3l600t405r756b484],
20	resist	VB	O	resist	conj_and	11	SENT_25	[p3l786t406r1012b484],
21	further	JJ	O	further	amod	22	SENT_25	[p3l1035t405r1339b484],
22	treatment	NN	O	treatment	dobj	20	SENT_25	[p3l1366t422r1803b484],
23	.	.	O	.	_	0	SENT_25	[p3l1366t422r1803b484],

1	Known	VBN	O	know	_	0	SENT_26	[p3l1837t413r2147b486],
2	mechanisms	NNS	O	mechanism	dobj	1	SENT_26	[p3l11t533r557b612],
3	of	IN	O	of	_	0	SENT_26	[p3l616t533r717b612],
4	secondary	JJ	O	secondary	amod	5	SENT_26	[p3l756t533r1197b634],
5	resistance	NN	O	resistance	prep_of	2	SENT_26	[p3l1248t534r1679b612],
6	include	VBP	O	include	dep	1	SENT_26	[p3l1735t533r2048b612],
7	a	DT	O	a	det	10	SENT_26	[p3l2104t560r2148b612],
8	specific	JJ	O	specific	amod	10	SENT_26	[p3l12t661r343b762],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_26	[p3l380t668r594b741],
10	mutation	NN	O	mutation	dobj	6	SENT_26	[p3l626t662r1021b740],
11	(	CD	NUMBER	(	num	14	SENT_26	[p3l1064t667r1311b753],
12	T790	NN	O	t790	nn	14	SENT_26	[p3l1064t667r1311b753],
13	M	NN	O	m	nn	14	SENT_26	[p3l1347t668r1461b753],
14	)	NN	O	)	nsubj	1	SENT_26	[p3l1347t668r1461b753],
15	and	CC	O	and	_	0	SENT_26	[p3l1505t661r1664b740],
16	amplification	NN	O	amplification	nsubj	1	SENT_26	[p3l1702t661r2145b762, p3l11t790r181b868],
17	or	CC	O	or	_	0	SENT_26	[p3l220t815r310b868],
18	overexpression	NN	O	overexpression	conj_or	16	SENT_26	[p3l346t790r987b890],
19	of	IN	O	of	_	0	SENT_26	[p3l1026t789r1126b868],
20	the	DT	O	the	det	22	SENT_26	[p3l1147t789r1280b868],
21	MET	NN	O	met	nn	22	SENT_26	[p3l1317t795r1513b868],
22	gene	NN	O	gene	prep_of	16	SENT_26	[p3l1542t815r1766b890],
23	.	.	O	.	_	0	SENT_26	[p3l1542t815r1766b890],

1	Two	CD	NUMBER	two	num	2	SENT_27	[p3l137t923r315b997],
2	articles	NNS	O	article	nsubj	33	SENT_27	[p3l353t917r665b996],
3	in	IN	O	in	_	0	SENT_27	[p3l705t918r789b995],
4	this	DT	O	this	det	5	SENT_27	[p3l827t917r987b996],
5	issue	NN	O	issue	prep_in	2	SENT_27	[p3l1027t918r1240b996],
6	of	IN	O	of	_	0	SENT_27	[p3l1279t917r1379b996],
7	the	DT	O	the	det	9	SENT_27	[p3l1400t917r1533b996],
8	journal	NN	O	journal	nn	9	SENT_27	[p3l1554t917r1846b1018],
9	report	NN	O	report	prep_of	5	SENT_27	[p3l1883t934r2152b1018],
10	the	DT	O	the	det	11	SENT_27	[p3l11t1045r145b1124],
11	use	NN	O	use	dep	31	SENT_27	[p3l185t1072r326b1124],
12	of	IN	O	of	_	0	SENT_27	[p3l368t1045r468b1124],
13	tyrosine	NN	O	tyrosine	nn	15	SENT_27	[p3l490t1046r838b1146],
14	kinase	NN	O	kinase	nn	15	SENT_27	[p3l878t1045r1159b1125],
15	inhibitors	NNS	O	inhibitor	prep_of	11	SENT_27	[p3l1199t1045r1622b1124],
16	for	IN	O	for	_	0	SENT_27	[p3l1665t1045r1788b1124],
17	the	DT	O	the	det	19	SENT_27	[p3l1826t1045r1960b1124],
18	initial	JJ	O	initial	amod	19	SENT_27	[p3l2000t1046r2145b1123, p3l11t1173r147b1252],
19	treatment	NN	O	treatment	prep_for	15	SENT_27	[p3l182t1190r599b1252],
20	of	IN	O	of	_	0	SENT_27	[p3l629t1173r729b1252],
21	subgroups	NNS	O	subgroup	prep_of	19	SENT_27	[p3l746t1173r1186b1274],
22	of	IN	O	of	_	0	SENT_27	[p3l1223t1173r1323b1252],
23	patients	NNS	O	patient	prep_of	21	SENT_27	[p3l1337t1174r1673b1274],
24	with	IN	O	with	_	0	SENT_27	[p3l1705t1173r1898b1252],
25	nonsmall	JJ	O	nonsmall	amod	28	SENT_27	[p3l1932t1199r2149b1252, p3l12t1301r421b1380],
26	—	NN	O	—	nn	28	SENT_27	[p3l1932t1199r2149b1252, p3l12t1301r421b1380],
27	cell	NN	O	cell	nn	28	SENT_27	[p3l1932t1199r2149b1252, p3l12t1301r421b1380],
28	lung	NN	O	lung	prep_with	23	SENT_27	[p3l457t1301r648b1402],
29	cancer	NN	O	cancer	dep	31	SENT_27	[p3l683t1306r1069b1380],
30	.45	CD	NUMBER	.45	num	29	SENT_27	[p3l683t1306r1069b1380],
31	These	DT	O	these	dep	5	SENT_27	[p3l1107t1301r1355b1380],
32	studies	NNS	O	study	dep	31	SENT_27	[p3l1395t1301r1688b1380],
33	combined	VBN	O	combine	_	0	SENT_27	[p3l1728t1301r2147b1380],
34	molecular	JJ	O	molecular	amod	35	SENT_27	[p3l11t1429r447b1508],
35	analyses	NNS	O	analysis	dobj	33	SENT_27	[p3l487t1429r848b1530],
36	with	IN	O	with	_	0	SENT_27	[p3l889t1429r1086b1508],
37	therapy	NN	O	therapy	prep_with	33	SENT_27	[p3l1130t1429r1453b1530],
38	using	VBG	O	use	partmod	37	SENT_27	[p3l1492t1430r1731b1530],
39	gefitinib	NN	O	gefitinib	dobj	38	SENT_27	[p3l1771t1429r2145b1530],
40	or	CC	O	or	_	0	SENT_27	[p3l11t1583r101b1636],
41	erlotinib	NN	O	erlotinib	conj_or	39	SENT_27	[p3l146t1557r515b1636],
42	in	IN	O	in	_	0	SENT_27	[p3l564t1558r648b1635],
43	subgroups	NNS	O	subgroup	prep_in	38	SENT_27	[p3l697t1557r1146b1658],
44	of	IN	O	of	_	0	SENT_27	[p3l1197t1557r1298b1636],
45	patients	NNS	O	patient	prep_of	43	SENT_27	[p3l1326t1558r1669b1658],
46	who	WP	O	who	nsubjpass	48	SENT_27	[p3l1714t1557r1899b1636],
47	were	VBD	O	be	auxpass	48	SENT_27	[p3l1944t1583r2146b1636],
48	selected	VBN	O	select	rcmod	45	SENT_27	[p3l12t1685r354b1764],
49	from	IN	O	from	_	0	SENT_27	[p3l404t1685r616b1764],
50	more	JJR	O	more	mwe	51	SENT_27	[p3l666t1711r886b1764],
51	than	IN	O	than	quantmod	52	SENT_27	[p3l938t1685r1135b1764],
52	3300	CD	NUMBER	3300	num	53	SENT_27	[p3l1187t1691r1391b1764],
53	patients	NNS	O	patient	prep_from	48	SENT_27	[p3l1441t1686r1785b1786],
54	of	IN	O	of	_	0	SENT_27	[p3l1838t1685r1939b1764],
55	East	JJ	MISC	east	amod	59	SENT_27	[p3l1969t1693r2152b1764],
56	Asian	JJ	MISC	asian	amod	59	SENT_27	[p3l7t1814r253b1892],
57	or	CC	O	or	_	0	SENT_27	[p3l304t1839r393b1892],
58	European	JJ	MISC	european	amod	59	SENT_27	[p3l438t1821r854b1914],
59	origin	NN	O	origin	prep_of	53	SENT_27	[p3l905t1814r1165b1914],
60	who	WP	O	who	nsubj	61	SENT_27	[p3l1210t1813r1395b1893],
61	had	VBD	O	have	rcmod	59	SENT_27	[p3l1446t1813r1603b1892],
62	non	JJ	O	non	amod	65	SENT_27	[p3l1653t1813r2145b1892],
63	—	JJ	O	—	amod	65	SENT_27	[p3l1653t1813r2145b1892],
64	small	JJ	O	small	amod	65	SENT_27	[p3l1653t1813r2145b1892],
65	—	NN	O	—	dobj	61	SENT_27	[p3l1653t1813r2145b1892],
66	cell	NN	O	cell	nn	68	SENT_27	[p3l11t1941r155b2020],
67	lung	NN	O	lung	nn	68	SENT_27	[p3l191t1941r382b2042],
68	cancer	NN	O	cancer	dep	65	SENT_27	[p3l417t1967r712b2020],
69	.	.	O	.	_	0	SENT_27	[p3l417t1967r712b2020],

1	Both	DT	O	both	det	2	SENT_28	[p3l754t1941r956b2020],
2	studies	NNS	O	study	nsubj	3	SENT_28	[p3l996t1941r1291b2020],
3	showed	VBD	O	show	_	0	SENT_28	[p3l1333t1941r1652b2021],
4	significant	JJ	O	significant	amod	5	SENT_28	[p3l1692t1941r2152b2042],
5	increases	NNS	O	increase	dobj	3	SENT_28	[p3l10t2070r407b2148],
6	in	IN	O	in	_	0	SENT_28	[p3l455t2070r538b2147],
7	rates	NNS	O	rate	prep_in	3	SENT_28	[p3l585t2086r789b2148],
8	of	IN	O	of	_	0	SENT_28	[p3l838t2069r938b2148],
9	response	NN	O	response	nn	12	SENT_28	[p3l966t2095r1349b2170],
10	and	CC	O	and	_	0	SENT_28	[p3l1396t2069r1554b2148],
11	progressionfree	NN	O	progressionfree	nn	12	SENT_28	[p3l1599t2070r2145b2170, p3l11t2197r173b2276],
12	survival	NN	O	survival	prep_of	7	SENT_28	[p3l213t2197r547b2276],
13	in	IN	O	in	_	0	SENT_28	[p3l583t2198r667b2275],
14	patients	NNS	O	patient	prep_in	3	SENT_28	[p3l704t2198r1047b2298],
15	whose	WP$	O	whose	poss	16	SENT_28	[p3l1083t2197r1359b2276],
16	tumors	NNS	O	tumor	nsubj	17	SENT_28	[p3l1397t2214r1706b2276],
17	had	VBD	O	have	rcmod	14	SENT_28	[p3l1746t2197r1904b2276],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_28	[p3l1940t2204r2153b2277],
19	mutations	NNS	O	mutation	dobj	17	SENT_28	[p3l11t2326r463b2405],
20	.	.	O	.	_	0	SENT_28	[p3l11t2326r463b2405],

1	In	IN	O	in	_	0	SENT_29	[p3l504t2333r593b2403],
2	both	DT	O	both	det	3	SENT_29	[p3l631t2325r826b2404],
3	studies	NNS	O	study	prep_in	7	SENT_29	[p3l865t2325r1184b2421],
4	,	,	O	,	_	0	SENT_29	[p3l865t2325r1184b2421],
5	toxic	JJ	O	toxic	amod	6	SENT_29	[p3l1227t2326r1430b2404],
6	effects	NNS	O	effect	nsubj	7	SENT_29	[p3l1467t2325r1744b2404],
7	associat	VBP	O	associat	_	0	SENT_29	[p3l1783t2326r2145b2404],
8	—	CD	NUMBER	—	nsubj	16	SENT_29	[p3l1783t2326r2145b2404],
9	ed	VBN	O	ed	partmod	8	SENT_29	[p3l12t2454r108b2533],
10	with	IN	O	with	_	0	SENT_29	[p3l142t2454r339b2533],
11	therapy	NN	O	therapy	prep_with	9	SENT_29	[p3l377t2454r701b2555],
12	were	VBD	O	be	cop	13	SENT_29	[p3l730t2480r933b2533],
13	modest	JJ	O	modest	ccomp	7	SENT_29	[p3l971t2454r1292b2533],
14	and	CC	O	and	_	0	SENT_29	[p3l1325t2454r1483b2533],
15	well	RB	O	well	advmod	13	SENT_29	[p3l1517t2454r1695b2534],
16	tolerated	VBD	O	tolerate	conj_and	13	SENT_29	[p3l1733t2454r2136b2533],
17	.	.	O	.	_	0	SENT_29	[p3l1733t2454r2136b2533],

1	The	DT	O	the	det	4	SENT_30	[p3l137t2582r298b2661],
2	nonrandomized	JJ	O	nonrandomized	amod	4	SENT_30	[p3l352t2582r1047b2661],
3	European	JJ	MISC	european	amod	4	SENT_30	[p3l1099t2590r1514b2683],
4	study	NN	O	study	dep	10	SENT_30	[p3l1569t2582r1799b2683],
5	by	IN	O	by	_	0	SENT_30	[p3l1848t2582r1946b2683],
6	Ro	NN	O	ro	prep_by	4	SENT_30	[p3l1993t2589r2145b2666],
7	—	CD	NUMBER	—	num	8	SENT_30	[p3l1993t2589r2145b2666],
8	sell	NN	O	sell	dep	10	SENT_30	[p3l12t2710r156b2789],
9	et	FW	O	et	nn	10	SENT_30	[p3l214t2727r292b2789],
10	al.	FW	O	al.	dep	12	SENT_30	[p3l344t2710r485b2789],
11	4	CD	NUMBER	4	dep	10	SENT_30	[p3l344t2710r485b2789],
12	shows	VBZ	O	show	_	0	SENT_30	[p3l544t2710r810b2789],
13	the	DT	O	the	det	14	SENT_30	[p3l870t2710r1004b2789],
14	feasibility	NN	O	feasibility	dobj	12	SENT_30	[p3l1062t2710r1487b2811],
15	of	IN	O	of	_	0	SENT_30	[p3l1541t2710r1642b2789],
16	large	JJ	O	large	amod	19	SENT_30	[p3l1680t2710r2146b2811],
17	—	CD	NUMBER	—	tmod	16	SENT_30	[p3l1680t2710r2146b2811],
18	scale	NN	O	scale	nn	19	SENT_30	[p3l1680t2710r2146b2811],
19	screening	NN	O	screening	prep_of	14	SENT_30	[p3l12t2839r432b2939],
20	for	IN	O	for	_	0	SENT_30	[p3l484t2838r608b2917],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_30	[p3l659t2845r872b2918],
22	mutations	NNS	O	mutation	prep_for	19	SENT_30	[p3l921t2839r1359b2917],
23	in	IN	O	in	_	0	SENT_30	[p3l1415t2839r1499b2916],
24	patients	NNS	O	patient	prep_in	22	SENT_30	[p3l1553t2839r1897b2939],
25	with	IN	O	with	prep	12	SENT_30	[p3l1950t2838r2147b2918],

1	1013	CD	DATE	1013	num	4	SENT_31	[p3l149t2998r224b3019],
2	N	NN	O	n	nn	4	SENT_31	[p3l930t3008r944b3023],
3	ENGLJ	NN	O	englj	nn	4	SENT_31	[p3l958t3008r1036b3030],
4	MED	NN	O	med	_	0	SENT_31	[p3l1051t3008r1103b3023],
5	361	CD	NUMBER	361	dep	4	SENT_31	[p3l1113t3002r1191b3030],
6	;	:	O	;	_	0	SENT_31	[p3l1113t3002r1191b3030],
7	1o	CD	NUMBER	1o	num	9	SENT_31	[p3l1113t3002r1191b3030],
8	NEjM.ORG	NN	O	nejm.org	nn	9	SENT_31	[p3l1226t3008r1350b3030],
9	SEPTEMBER	NN	DATE	september	dep	5	SENT_31	[p3l1385t3008r1524b3023],
10	3	CD	DATE	3	dep	9	SENT_31	[p3l1534t3008r1552b3030],
11	,	,	DATE	,	_	0	SENT_31	[p3l1534t3008r1552b3030],
12	2009	CD	DATE	2009	appos	9	SENT_31	[p3l1563t3008r1627b3029],

1	EDITORIAL	NN	O	editorial	_	0	SENT_32	[p3l991t3229r1168b3248],

1	advanced	JJ	O	advanced	amod	3	SENT_33	[p3l11t3442r399b3521],
2	non	JJ	O	non	amod	3	SENT_33	[p3l430t3442r1059b3521],
3	—	NN	O	—	_	0	SENT_33	[p3l430t3442r1059b3521],
4	small	JJ	O	small	amod	8	SENT_33	[p3l430t3442r1059b3521],
5	—	NN	O	—	nn	8	SENT_33	[p3l430t3442r1059b3521],
6	cell	NN	O	cell	nn	8	SENT_33	[p3l430t3442r1059b3521],
7	lung	NN	O	lung	nn	8	SENT_33	[p3l1089t3442r1279b3543],
8	cancer	NN	O	cancer	dep	3	SENT_33	[p3l1308t3468r1583b3521],
9	for	IN	O	for	_	0	SENT_33	[p3l1613t3442r1733b3521],
10	selection	NN	O	selection	prep_for	8	SENT_33	[p3l1764t3442r2134b3521],
11	for	IN	O	for	_	0	SENT_33	[p3l11t3570r134b3649],
12	erlotinib	NN	O	erlotinib	nn	13	SENT_33	[p3l167t3570r534b3649],
13	therapy	NN	O	therapy	prep_for	10	SENT_33	[p3l572t3570r906b3671],
14	.	.	O	.	_	0	SENT_33	[p3l572t3570r906b3671],

1	Overall	RB	O	overall	advmod	23	SENT_34	[p3l947t3570r1277b3666],
2	,	,	O	,	_	0	SENT_34	[p3l947t3570r1277b3666],
3	the	DT	O	the	det	4	SENT_34	[p3l1319t3570r1452b3649],
4	rate	NN	O	rate	nsubj	23	SENT_34	[p3l1487t3587r1647b3649],
5	of	IN	O	of	_	0	SENT_34	[p3l1684t3570r1783b3649],
6	survival	NN	O	survival	prep_of	4	SENT_34	[p3l1802t3570r2134b3649],
7	of	IN	O	of	_	0	SENT_34	[p3l12t3698r112b3777],
8	patients	NNS	O	patient	prep_of	6	SENT_34	[p3l129t3699r470b3799],
9	carrying	VBG	O	carry	partmod	8	SENT_34	[p3l511t3699r874b3799],
10	an	DT	O	a	det	12	SENT_34	[p3l907t3724r1010b3777],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_34	[p3l1046t3705r1258b3778],
12	mutation	NN	O	mutation	dobj	9	SENT_34	[p3l1289t3699r1681b3777],
13	who	WP	O	who	nsubjpass	15	SENT_34	[p3l1715t3698r1897b3778],
14	were	VBD	O	be	auxpass	15	SENT_34	[p3l1931t3724r2133b3777],
15	treated	VBN	O	treat	rcmod	12	SENT_34	[p4l12t20r310b99],
16	with	IN	O	with	_	0	SENT_34	[p4l361t20r557b99],
17	the	DT	O	the	det	20	SENT_34	[p4l613t20r745b99],
18	tyrosine	NN	O	tyrosine	nn	20	SENT_34	[p4l802t21r1148b121],
19	kinase	NN	O	kinase	nn	20	SENT_34	[p4l1204t20r1483b100],
20	inhibitor	NN	O	inhibitor	prep_with	15	SENT_34	[p4l1538t20r1920b99],
21	was	VBD	O	be	cop	23	SENT_34	[p4l1969t47r2131b100],
22	relatively	RB	O	relatively	advmod	23	SENT_34	[p4l11t148r396b249],
23	high	JJ	O	high	_	0	SENT_34	[p4l427t148r645b249],
24	,	,	O	,	_	0	SENT_34	[p4l427t148r645b249],
25	as	IN	O	as	advmod	23	SENT_34	[p4l686t175r771b227],
26	compared	VBN	O	compare	_	0	SENT_34	[p4l810t148r1236b249],
27	with	IN	O	with	prepc_compared_with	23	SENT_34	[p4l1267t148r1462b227],
28	that	DT	O	that	pobj	23	SENT_34	[p4l1499t148r1671b227],
29	of	IN	O	of	_	0	SENT_34	[p4l1702t148r1802b227],
30	historical	JJ	O	historical	amod	32	SENT_34	[p4l1819t148r2132b227, p4l12t276r128b355],
31	control	JJ	O	control	amod	32	SENT_34	[p4l162t276r456b355],
32	subjects	NNS	O	subject	prep_of	28	SENT_34	[p4l490t276r816b377],
33	who	WP	O	who	nsubjpass	35	SENT_34	[p4l846t276r1025b356],
34	were	VBD	O	be	auxpass	35	SENT_34	[p4l1055t303r1251b355],
35	treated	VBN	O	treat	rcmod	32	SENT_34	[p4l1285t276r1572b355],
36	with	IN	O	with	_	0	SENT_34	[p4l1600t276r1790b356],
37	chemotherapy	NN	O	chemotherapy	prep_with	35	SENT_34	[p4l1823t276r2132b355, p4l12t404r344b505],
38	.	.	O	.	_	0	SENT_34	[p4l1823t276r2132b355, p4l12t404r344b505],

1	In	IN	O	in	_	0	SENT_35	[p4l392t412r481b482],
2	the	DT	O	the	det	3	SENT_35	[p4l525t404r658b483],
3	study	NN	O	study	prep_in	26	SENT_35	[p4l703t404r933b505],
4	by	IN	O	by	_	0	SENT_35	[p4l973t404r1070b505],
5	Mok	NNP	PERSON	Mok	prep_by	3	SENT_35	[p4l1106t404r1302b483],
6	et	FW	O	et	nn	7	SENT_35	[p4l1342t421r1419b483],
7	al.	FW	O	al.	dep	5	SENT_35	[p4l1457t404r1618b500],
8	,5	CD	NUMBER	,5	num	9	SENT_35	[p4l1457t404r1618b500],
9	patients	NNS	O	patient	nsubjpass	26	SENT_35	[p4l1664t405r2005b505],
10	of	IN	O	of	_	0	SENT_35	[p4l2052t404r2152b483],
11	East	JJ	MISC	east	amod	13	SENT_35	[p4l9t540r192b611],
12	Asian	JJ	MISC	asian	amod	13	SENT_35	[p4l217t533r461b611],
13	origin	NN	O	origin	prep_of	9	SENT_35	[p4l497t533r755b633],
14	with	IN	O	with	_	0	SENT_35	[p4l786t532r981b611],
15	adenocarcinoma	NN	O	adenocarcinoma	prep_with	13	SENT_35	[p4l1014t532r1729b611],
16	who	WP	O	who	nsubj	17	SENT_35	[p4l1758t532r1941b611],
17	had	VBD	O	have	rcmod	13	SENT_35	[p4l1977t532r2133b611],
18	little	JJ	O	little	amod	21	SENT_35	[p4l10t660r207b739],
19	or	CC	O	or	_	0	SENT_35	[p4l273t686r362b739],
20	no	DT	O	no	conj_or	18	SENT_35	[p4l424t686r529b739],
21	exposure	NN	O	exposure	dobj	17	SENT_35	[p4l596t686r982b761],
22	to	TO	O	to	_	0	SENT_35	[p4l1048t677r1129b739],
23	tobacco	NN	O	tobacco	nn	24	SENT_35	[p4l1197t660r1526b739],
24	smoke	NN	O	smoke	prep_to	17	SENT_35	[p4l1595t660r1870b740],
25	were	VBD	O	be	auxpass	26	SENT_35	[p4l1931t687r2133b739],
26	treated	VBN	O	treat	_	0	SENT_35	[p4l12t788r310b867],
27	with	IN	O	with	_	0	SENT_35	[p4l349t788r544b867],
28	either	CC	O	either	preconj	29	SENT_35	[p4l589t788r835b867],
29	gefitinib	NN	O	gefitinib	prep_with	26	SENT_35	[p4l876t788r1248b889],
30	or	CC	O	or	_	0	SENT_35	[p4l1293t814r1382b867],
31	standard	JJ	O	standard	amod	33	SENT_35	[p4l1424t788r1803b867],
32	double	JJ	O	double	amod	33	SENT_35	[p4l1847t788r2133b867],
33	chemotherapy	NN	O	chemotherapy	conj_or	29	SENT_35	[p4l12t916r635b1017],
34	.	.	O	.	_	0	SENT_35	[p4l12t916r635b1017],

1	Responses	NNS	O	response	nsubjpass	10	SENT_36	[p4l679t923r1132b1017],
2	to	TO	O	to	_	0	SENT_36	[p4l1174t933r1255b995],
3	the	DT	O	the	det	6	SENT_36	[p4l1297t916r1429b995],
4	tyrosine	NN	O	tyrosine	nn	6	SENT_36	[p4l1469t917r1815b1017],
5	kinase	NN	O	kinase	nn	6	SENT_36	[p4l1854t916r2133b996],
6	inhibitor	NN	O	inhibitor	prep_to	1	SENT_36	[p4l11t1044r393b1123],
7	were	VBD	O	be	auxpass	10	SENT_36	[p4l420t1070r621b1124],
8	almost	RB	O	almost	advmod	9	SENT_36	[p4l656t1044r953b1123],
9	entirely	RB	O	entirely	advmod	10	SENT_36	[p4l983t1044r1306b1145],
10	limited	VBN	O	limit	_	0	SENT_36	[p4l1335t1044r1644b1123],
11	to	TO	O	to	_	0	SENT_36	[p4l1679t1061r1760b1123],
12	the	DT	O	the	det	14	SENT_36	[p4l1797t1044r1929b1123],
13	mutation	NN	O	mutation	nn	14	SENT_36	[p4l1965t1070r2132b1123, p4l12t1173r628b1273],
14	—	NN	O	—	prep_to	10	SENT_36	[p4l1965t1070r2132b1123, p4l12t1173r628b1273],
15	positive	JJ	O	positive	amod	16	SENT_36	[p4l1965t1070r2132b1123, p4l12t1173r628b1273],
16	group	NN	O	group	dep	14	SENT_36	[p4l659t1198r934b1273],
17	,	,	O	,	_	0	SENT_36	[p4l659t1198r934b1273],
18	Whereas	IN	O	whereas	mark	23	SENT_36	[p4l967t1172r1319b1251],
19	mutation	NN	O	mutation	nsubj	23	SENT_36	[p4l1352t1173r2133b1273],
20	—	CD	NUMBER	—	num	22	SENT_36	[p4l1352t1173r2133b1273],
21	negative	JJ	O	negative	amod	22	SENT_36	[p4l1352t1173r2133b1273],
22	patients	NNS	O	patient	dep	19	SENT_36	[p4l10t1301r350b1401],
23	benefited	VBD	O	benefit	dep	10	SENT_36	[p4l388t1300r792b1379],
24	from	IN	O	from	_	0	SENT_36	[p4l826t1300r1036b1379],
25	chemotherapy	NN	O	chemotherapy	prep_from	23	SENT_36	[p4l1071t1300r1694b1401],
26	.	.	O	.	_	0	SENT_36	[p4l1071t1300r1694b1401],

1	However	RB	O	however	advmod	18	SENT_37	[p4l1733t1308r2128b1396],
2	,	,	O	,	_	0	SENT_37	[p4l1733t1308r2128b1396],
3	overall	JJ	O	overall	amod	4	SENT_37	[p4l12t1428r304b1507],
4	survival	NN	O	survival	nsubjpass	18	SENT_37	[p4l368t1428r731b1524],
5	,	,	O	,	_	0	SENT_37	[p4l368t1428r731b1524],
6	perhaps	RB	O	perhaps	advmod	11	SENT_37	[p4l799t1428r1146b1529],
7	the	DT	O	the	det	11	SENT_37	[p4l1213t1428r1347b1507],
8	most	RBS	O	most	advmod	9	SENT_37	[p4l1411t1445r1631b1507],
9	important	JJ	O	important	amod	11	SENT_37	[p4l1689t1429r2139b1529],
10	end	NN	O	end	nn	11	SENT_37	[p4l12t1556r165b1635],
11	point	NN	O	point	appos	4	SENT_37	[p4l196t1557r426b1657],
12	of	IN	O	of	_	0	SENT_37	[p4l456t1556r555b1635],
13	cancer	NN	O	cancer	nn	14	SENT_37	[p4l572t1582r852b1635],
14	treatment	NN	O	treatment	prep_of	11	SENT_37	[p4l883t1573r1327b1652],
15	,	,	O	,	_	0	SENT_37	[p4l883t1573r1327b1652],
16	was	VBD	O	be	auxpass	18	SENT_37	[p4l1361t1583r1524b1635],
17	not	RB	O	not	neg	18	SENT_37	[p4l1560t1573r1702b1635],
18	improved	VBN	O	improve	_	0	SENT_37	[p4l1730t1556r2134b1657],
19	by	IN	O	by	_	0	SENT_37	[p4l12t1684r110b1785],
20	gefitinib	NN	O	gefitinib	agent	18	SENT_37	[p4l158t1684r561b1785],
21	,	,	O	,	_	0	SENT_37	[p4l158t1684r561b1785],
22	for	IN	O	for	_	0	SENT_37	[p4l619t1684r745b1763],
23	reasons	NNS	O	reason	prep_for	18	SENT_37	[p4l794t1710r1127b1763],
24	not	RB	O	not	neg	25	SENT_37	[p4l1181t1701r1326b1763],
25	discussed	VBN	O	discuss	partmod	23	SENT_37	[p4l1374t1684r1799b1763],
26	by	IN	O	by	_	0	SENT_37	[p4l1851t1684r1950b1785],
27	the	DT	O	the	det	28	SENT_37	[p4l1998t1684r2133b1763],
28	authors	NNS	O	author	agent	25	SENT_37	[p4l11t1813r354b1892],
29	.	.	O	.	_	0	SENT_37	[p4l11t1813r354b1892],

1	Other	JJ	O	other	amod	2	SENT_38	[p4l140t1941r388b2020],
2	reports	NNS	O	report	nsubj	4	SENT_38	[p4l432t1958r739b2042],
3	have	VBP	O	have	aux	4	SENT_38	[p4l788t1941r977b2020],
4	indicated	VBN	O	indicate	_	0	SENT_38	[p4l1024t1941r1422b2020],
5	that	IN	O	that	complm	13	SENT_38	[p4l1469t1941r1641b2020],
6	the	DT	O	the	det	7	SENT_38	[p4l1684t1941r1817b2020],
7	use	NN	O	use	nsubj	13	SENT_38	[p4l1864t1968r2004b2020],
8	of	IN	O	of	_	0	SENT_38	[p4l2052t1941r2152b2020],
9	tyrosine	NN	O	tyrosine	nn	11	SENT_38	[p4l12t2070r367b2170],
10	kinase	NN	O	kinase	nn	11	SENT_38	[p4l411t2069r696b2148],
11	inhibitors	NNS	O	inhibitor	prep_of	7	SENT_38	[p4l740t2069r1173b2148],
12	may	MD	O	may	aux	13	SENT_38	[p4l1219t2095r1401b2170],
13	improve	VB	O	improve	ccomp	4	SENT_38	[p4l1440t2070r1795b2170],
14	overall	JJ	O	overall	amod	15	SENT_38	[p4l1841t2069r2134b2148],
15	survival	NN	O	survival	dobj	13	SENT_38	[p4l13t2197r329b2276],
16	of	IN	O	of	_	0	SENT_38	[p4l361t2197r459b2276],
17	certain	JJ	O	certain	amod	18	SENT_38	[p4l474t2198r760b2276],
18	subgroups	NNS	O	subgroup	prep_of	15	SENT_38	[p4l794t2197r1223b2298],
19	of	IN	O	of	_	0	SENT_38	[p4l1258t2197r1355b2276],
20	patients	NNS	O	patient	prep_of	18	SENT_38	[p4l1368t2198r1694b2298],
21	with	IN	O	with	_	0	SENT_38	[p4l1724t2197r1912b2277],
22	lung	NN	O	lung	nn	23	SENT_38	[p4l1943t2197r2137b2298],
23	cancer	NN	O	cancer	prep_with	13	SENT_38	[p4l12t2351r310b2421],
24	,	,	O	,	_	0	SENT_38	[p4l12t2351r310b2421],
25	independently	RB	O	independently	advmod	13	SENT_38	[p4l356t2325r969b2426],
26	of	IN	O	of	_	0	SENT_38	[p4l1006t2325r1106b2404],
27	the	DT	O	the	det	31	SENT_38	[p4l1129t2325r1261b2404],
28	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_38	[p4l1301t2332r1512b2405],
29	mutation	NN	O	mutation	nn	31	SENT_38	[p4l1547t2326r1939b2404],
30	status	NN	O	status	nn	31	SENT_38	[p4l1982t2342r2132b2404, p4l12t2459r202b2532],
31	.3	NN	NUMBER	.3	prep_of	25	SENT_38	[p4l1982t2342r2132b2404, p4l12t2459r202b2532],
32	It	PRP	O	it	nsubjpass	35	SENT_38	[p4l244t2461r309b2532],
33	has	VBZ	O	have	aux	35	SENT_38	[p4l345t2453r489b2532],
34	been	VBN	O	be	auxpass	35	SENT_38	[p4l533t2453r734b2532],
35	suggested	VBN	O	suggest	rcmod	31	SENT_38	[p4l777t2453r1203b2554],
36	that	IN	O	that	complm	39	SENT_38	[p4l1244t2453r1417b2532],
37	EGFR	NN	ORGANIZATION	egfr	nn	38	SENT_38	[p4l1450t2460r1662b2533],
38	mutations	NNS	O	mutation	nsubj	47	SENT_38	[p4l1697t2454r2131b2532],
39	represent	VBP	O	represent	ccomp	35	SENT_38	[p4l11t2598r413b2682],
40	favorable	JJ	O	favorable	amod	42	SENT_38	[p4l463t2581r851b2660],
41	prognostic	JJ	O	prognostic	amod	42	SENT_38	[p4l905t2582r1369b2682],
42	markers	NNS	O	marker	dobj	39	SENT_38	[p4l1423t2581r1774b2660],
43	of	IN	O	of	_	0	SENT_38	[p4l1832t2581r1932b2660],
44	survival	NN	O	survival	prep_of	42	SENT_38	[p4l1970t2608r2132b2660, p4l7t2709r202b2788],
45	and	CC	O	and	_	0	SENT_38	[p4l242t2709r399b2788],
46	are	VBP	O	be	cop	47	SENT_38	[p4l440t2735r569b2788],
47	predictive	JJ	O	predictive	ccomp	35	SENT_38	[p4l609t2709r1029b2810],
48	of	IN	O	of	_	0	SENT_38	[p4l1071t2709r1171b2788],
49	tumor	NN	O	tumor	nn	50	SENT_38	[p4l1194t2726r1462b2788],
50	shrinkage	NN	O	shrinkage	prep_of	47	SENT_38	[p4l1502t2709r1951b2810],
51	,	,	O	,	_	0	SENT_38	[p4l1502t2709r1951b2810],
52	but	CC	O	but	_	0	SENT_38	[p4l1998t2709r2138b2788],
53	the	DT	O	the	det	54	SENT_38	[p4l12t2837r144b2916],
54	evidence	NN	O	evidence	nsubj	69	SENT_38	[p4l194t2837r559b2916],
55	that	IN	O	that	complm	58	SENT_38	[p4l608t2837r777b2916],
56	they	PRP	O	they	nsubj	58	SENT_38	[p4l819t2837r999b2938],
57	can	MD	O	can	aux	58	SENT_38	[p4l1041t2863r1188b2916],
58	predict	VB	O	predict	dep	54	SENT_38	[p4l1233t2837r1530b2938],
59	a	DT	O	a	det	61	SENT_38	[p4l1571t2864r1616b2916],
60	differential	JJ	O	differential	amod	61	SENT_38	[p4l1662t2837r2133b2916],
61	effect	NN	O	effect	dobj	58	SENT_38	[p4l12t2965r248b3044],
62	of	IN	O	of	_	0	SENT_38	[p4l279t2965r378b3044],
63	tyrosine	NN	O	tyrosine	nn	65	SENT_38	[p4l395t2966r737b3066],
64	kinase	NN	O	kinase	nn	65	SENT_38	[p4l774t2965r1053b3044],
65	inhibitors	NNS	O	inhibitor	prep_of	61	SENT_38	[p4l1090t2965r1512b3044],
66	on	IN	O	on	_	0	SENT_38	[p4l1552t2991r1658b3044],
67	survival	NN	O	survival	prep_on	58	SENT_38	[p4l1698t2965r2029b3044],
68	is	VBZ	O	be	cop	69	SENT_38	[p4l2065t2966r2131b3044],
69	incomplete	JJ	O	incomplete	conj_but	4	SENT_38	[p4l11t3093r552b3194],
70	.6	CD	NUMBER	.6	num	72	SENT_38	[p4l11t3093r552b3194],
71	Several	JJ	O	several	amod	72	SENT_38	[p4l596t3093r895b3172],
72	questions	NNS	O	question	nsubj	73	SENT_38	[p4l936t3094r1346b3194],
73	remain	VBP	O	remain	ccomp	69	SENT_38	[p4l1389t3094r1695b3172],
74	to	TO	O	to	aux	76	SENT_38	[p4l1736t3110r1818b3172],
75	be	VB	O	be	auxpass	76	SENT_38	[p4l1861t3093r1957b3172],
76	answered	VBN	O	answer	xcomp	73	SENT_38	[p4l1997t3119r2132b3172, p4l13t3221r309b3300],
77	before	IN	O	before	mark	80	SENT_38	[p4l355t3221r623b3300],
78	We	PRP	O	we	nsubj	80	SENT_38	[p4l663t3248r781b3300],
79	can	MD	O	can	aux	80	SENT_38	[p4l827t3247r976b3300],
80	extrapolate	VB	O	extrapolate	advcl	76	SENT_38	[p4l1021t3221r1498b3322],
81	the	DT	O	the	det	82	SENT_38	[p4l1544t3221r1676b3300],
82	results	NNS	O	result	dobj	80	SENT_38	[p4l1721t3221r2004b3300],
83	of	IN	O	of	_	0	SENT_38	[p4l2051t3221r2151b3300],
84	the	DT	O	the	prep_of	82	SENT_38	[p4l12t3349r140b3428],
85	randomized	VBN	O	randomize	partmod	84	SENT_38	[p4l173t3349r674b3428],
86	East	JJ	MISC	east	amod	87	SENT_38	[p4l706t3357r882b3428],
87	Asian	JJ	MISC	asian	amod	88	SENT_38	[p4l906t3350r1141b3428],
88	trial	NN	O	trial	dobj	85	SENT_38	[p4l1174t3349r1344b3428],
89	to	TO	O	to	_	0	SENT_38	[p4l1377t3366r1456b3428],
90	a	DT	O	a	det	92	SENT_38	[p4l1490t3376r1534b3428],
91	Western	JJ	MISC	western	amod	92	SENT_38	[p4l1561t3357r1903b3428],
92	population	NN	O	population	prep_to	85	SENT_38	[p4l1934t3375r2132b3450, p4l11t3477r337b3556],
93	.	.	O	.	_	0	SENT_38	[p4l1934t3375r2132b3450, p4l11t3477r337b3556],

1	Is	VBZ	O	be	cop	5	SENT_39	[p4l385t3485r456b3556],
2	erlotinib	NN	O	erlotinib	nsubj	5	SENT_39	[p4l502t3477r869b3556],
3	a	DT	O	a	det	5	SENT_39	[p4l912t3504r956b3556],
4	suitable	JJ	O	suitable	amod	5	SENT_39	[p4l1000t3477r1331b3556],
5	substitute	NN	O	substitute	_	0	SENT_39	[p4l1375t3477r1796b3556],
6	for	IN	O	for	_	0	SENT_39	[p4l1840t3477r1963b3556],
7	gefitinib	NN	O	gefitinib	prep_for	5	SENT_39	[p4l2002t3504r2132b3578, p4l11t3602r304b3683],
8	?	.	O	?	_	0	SENT_39	[p4l2002t3504r2132b3578, p4l11t3602r304b3683],

1	Because	IN	O	because	mark	3	SENT_40	[p4l337t3611r668b3683],
2	there	EX	O	there	expl	3	SENT_40	[p4l703t3605r910b3683],
3	was	VBD	O	be	_	0	SENT_40	[p4l941t3631r1098b3684],
4	no	DT	O	no	det	5	SENT_40	[p4l1135t3630r1238b3683],
5	improvement	NN	O	improvement	nsubj	3	SENT_40	[p4l1273t3606r1825b3705],
6	in	IN	O	in	_	0	SENT_40	[p4l1854t3606r1934b3682],
7	survival	NN	O	survival	prep_in	5	SENT_40	[p4l1970t3631r2132b3683, p5l7t21r206b100],

1	in	IN	O	in	amod	2	SENT_41	[p5l247t22r331b99],
2	the	DT	O	the	nsubj	3	SENT_41	[p5l373t21r508b100],
3	randomized	VBN	O	randomize	dep	8	SENT_41	[p5l550t21r1081b100],
4	trial	NN	O	trial	dobj	3	SENT_41	[p5l1124t21r1329b117],
5	,	,	O	,	_	0	SENT_41	[p5l1124t21r1329b117],
6	is	VBZ	O	be	cop	8	SENT_41	[p5l1376t22r1443b100],
7	it	PRP	O	it	nsubj	8	SENT_41	[p5l1486t22r1546b100],
8	necessary	JJ	O	necessary	_	0	SENT_41	[p5l1583t47r2012b122],
9	to	TO	O	to	aux	10	SENT_41	[p5l2050t38r2132b100],
10	perform	VB	O	perform	xcomp	8	SENT_41	[p5l10t149r358b250],
11	mutational	JJ	O	mutational	amod	12	SENT_41	[p5l398t149r861b228],
12	analyses	NNS	O	analysis	dobj	10	SENT_41	[p5l899t149r1251b250],
13	in	IN	O	in	_	0	SENT_41	[p5l1293t150r1374b227],
14	selected	VBN	O	select	amod	17	SENT_41	[p5l1417t149r1748b228],
15	subpop	NN	O	subpop	nn	17	SENT_41	[p5l1789t149r2132b250],
16	—	NN	O	—	nn	17	SENT_41	[p5l1789t149r2132b250],
17	ulations	NNS	O	ulation	prep_in	10	SENT_41	[p5l11t277r381b372],
18	,	,	O	,	_	0	SENT_41	[p5l11t277r381b372],
19	or	CC	O	or	_	0	SENT_41	[p5l425t302r514b355],
20	can	MD	O	can	aux	23	SENT_41	[p5l550t302r699b355],
21	they	PRP	O	they	nsubjpass	23	SENT_41	[p5l737t277r919b377],
22	be	VB	O	be	auxpass	23	SENT_41	[p5l954t277r1050b355],
23	treated	VBN	O	treat	conj_or	8	SENT_41	[p5l1089t277r1387b355],
24	empirically	RB	O	empirically	advmod	23	SENT_41	[p5l1426t274r1937b377],
25	?	.	O	?	_	0	SENT_41	[p5l1426t274r1937b377],

1	The	DT	O	the	det	2	SENT_42	[p5l1973t277r2133b355],
2	lack	NN	O	lack	nsubj	9	SENT_42	[p5l10t405r185b485],
3	of	IN	O	of	_	0	SENT_42	[p5l228t405r328b484],
4	a	DT	O	a	det	5	SENT_42	[p5l355t432r399b484],
5	difference	NN	O	difference	prep_of	2	SENT_42	[p5l445t405r877b484],
6	in	IN	O	in	_	0	SENT_42	[p5l923t406r1006b483],
7	overall	JJ	O	overall	amod	8	SENT_42	[p5l1053t405r1338b484],
8	survival	NN	O	survival	prep_in	5	SENT_42	[p5l1386t405r1716b484],
9	suggests	VBZ	O	suggest	_	0	SENT_42	[p5l1764t422r2130b506],
10	that	IN	O	that	complm	19	SENT_42	[p5l12t533r180b612],
11	the	DT	O	the	det	12	SENT_42	[p5l212t533r343b612],
12	order	NN	O	order	nsubj	19	SENT_42	[p5l380t533r603b612],
13	of	IN	O	of	_	0	SENT_42	[p5l638t533r736b612],
14	drug	NN	O	drug	nn	15	SENT_42	[p5l755t533r955b634],
15	administration	NN	O	administration	prep_of	12	SENT_42	[p5l988t533r1620b612],
16	may	MD	O	may	aux	19	SENT_42	[p5l1656t559r1832b634],
17	not	RB	O	not	neg	19	SENT_42	[p5l1865t550r2005b612],
18	be	VB	O	be	cop	19	SENT_42	[p5l2037t533r2133b612],
19	important	JJ	O	important	ccomp	9	SENT_42	[p5l11t662r462b762],
20	,	,	O	,	_	0	SENT_42	[p5l11t662r462b762],
21	as	RB	O	as	advmod	22	SENT_42	[p5l504t688r588b740],
22	long	RB	O	long	advmod	32	SENT_42	[p5l626t661r814b762],
23	as	IN	O	as	dep	32	SENT_42	[p5l847t688r931b740],
24	patients	NNS	O	patient	nsubj	32	SENT_42	[p5l969t662r1302b762],
25	who	WP	O	who	nsubj	28	SENT_42	[p5l1337t661r1518b741],
26	do	VBP	O	do	aux	28	SENT_42	[p5l1556t661r1658b740],
27	not	RB	O	not	neg	28	SENT_42	[p5l1696t678r1836b740],
28	have	VB	O	have	rcmod	24	SENT_42	[p5l1868t661r2054b740],
29	a	DT	O	a	det	30	SENT_42	[p5l2091t688r2135b740],
30	response	NN	O	response	dobj	28	SENT_42	[p5l11t815r384b890],
31	can	MD	O	can	aux	32	SENT_42	[p5l420t815r567b868],
32	cross	VB	O	cross	ccomp	19	SENT_42	[p5l601t815r815b868],
33	over	IN	O	over	prep	32	SENT_42	[p5l852t815r1027b868],
34	to	TO	O	to	pcomp	33	SENT_42	[p5l1059t806r1139b868],
35	the	DT	O	the	det	38	SENT_42	[p5l1175t789r1306b868],
36	other	JJ	O	other	amod	38	SENT_42	[p5l1342t789r1564b868],
37	study	NN	O	study	nn	38	SENT_42	[p5l1597t789r1823b890],
38	group	NN	O	group	pobj	34	SENT_42	[p5l1853t815r2128b890],
39	.	.	O	.	_	0	SENT_42	[p5l1853t815r2128b890],

1	Despite	IN	O	despite	_	0	SENT_43	[p5l9t918r338b1018],
2	these	DT	O	these	det	4	SENT_43	[p5l383t917r612b996],
3	unanswered	JJ	O	unanswered	amod	4	SENT_43	[p5l656t917r1190b996],
4	questions	NNS	O	question	prep_despite	21	SENT_43	[p5l1236t918r1681b1018],
5	,	,	O	,	_	0	SENT_43	[p5l1236t918r1681b1018],
6	the	DT	O	the	det	9	SENT_43	[p5l1732t917r1867b996],
7	stud	NN	O	stud	nn	9	SENT_43	[p5l1913t917r2132b996],
8	—	NN	O	—	nn	9	SENT_43	[p5l1913t917r2132b996],
9	ies	NNS	O	ie	nsubj	21	SENT_43	[p5l11t1046r125b1124],
10	by	IN	O	by	_	0	SENT_43	[p5l182t1045r280b1146],
11	Rosell	NNP	PERSON	Rosell	prep_by	9	SENT_43	[p5l328t1045r602b1129],
12	et	FW	O	et	nn	13	SENT_43	[p5l656t1062r735b1124],
13	al.	FW	O	al.	dep	11	SENT_43	[p5l783t1045r883b1124],
14	and	CC	O	and	_	0	SENT_43	[p5l942t1045r1102b1124],
15	Mok	NNP	PERSON	Mok	conj_and	11	SENT_43	[p5l1154t1045r1352b1124],
16	et	FW	O	et	nn	17	SENT_43	[p5l1403t1062r1481b1124],
17	al.	FW	O	al.	dep	15	SENT_43	[p5l1530t1045r1629b1124],
18	and	CC	O	and	_	0	SENT_43	[p5l1689t1045r1849b1124],
19	other	JJ	O	other	amod	20	SENT_43	[p5l1904t1045r2137b1124],
20	reports	NNS	O	report	conj_and	17	SENT_43	[p5l11t1190r323b1274],
21	suggest	VBP	O	suggest	_	0	SENT_43	[p5l385t1190r719b1274],
22	that	IN	O	that	complm	31	SENT_43	[p5l772t1173r947b1252],
23	first	JJ	ORDINAL	first	amod	25	SENT_43	[p5l1000t1173r1380b1252],
24	—	NN	O	—	nn	25	SENT_43	[p5l1000t1173r1380b1252],
25	line	NN	O	line	nsubjpass	31	SENT_43	[p5l1000t1173r1380b1252],
26	tyrosine	NN	O	tyrosine	nn	28	SENT_43	[p5l1438t1174r1791b1274],
27	kinase	NN	O	kinase	nn	28	SENT_43	[p5l1849t1173r2133b1253],
28	therapy	NN	O	therapy	dep	25	SENT_43	[p5l12t1301r340b1402],
29	should	MD	O	should	aux	31	SENT_43	[p5l388t1301r680b1380],
30	be	VB	O	be	auxpass	31	SENT_43	[p5l732t1301r829b1380],
31	considered	VBN	O	consider	ccomp	21	SENT_43	[p5l881t1301r1354b1380],
32	for	IN	O	for	_	0	SENT_43	[p5l1405t1301r1530b1380],
33	carefully	RB	O	carefully	advmod	34	SENT_43	[p5l1579t1301r1964b1402],
34	selected	VBN	O	select	amod	35	SENT_43	[p5l2013t1328r2132b1380, p5l10t1429r267b1508],
35	subgroups	NNS	O	subgroup	prep_for	31	SENT_43	[p5l313t1429r767b1530],
36	of	IN	O	of	_	0	SENT_43	[p5l814t1429r915b1508],
37	patients	NNS	O	patient	prep_of	35	SENT_43	[p5l939t1430r1288b1530],
38	of	IN	O	of	_	0	SENT_43	[p5l1335t1429r1436b1508],
39	East	JJ	MISC	east	prep_of	37	SENT_43	[p5l1461t1437r1645b1508],
40	Asian	JJ	MISC	asian	amod	35	SENT_43	[p5l1681t1430r1929b1508],
41	and	CC	O	and	_	0	SENT_43	[p5l1973t1429r2133b1508],
42	non	JJ	O	non	amod	35	SENT_43	[p5l11t1565r412b1636],
43	.	.	O	.	_	0	SENT_43	[p5l11t1565r412b1636],

1	—	NN	O	—	_	0	SENT_44	[p5l11t1565r412b1636],
2	.	.	O	.	_	0	SENT_44	[p5l11t1565r412b1636],

1	East	JJ	MISC	east	amod	3	SENT_45	[p5l11t1565r412b1636],
2	Asian	JJ	MISC	asian	amod	3	SENT_45	[p5l445t1558r690b1636],
3	origin	NN	O	origin	_	0	SENT_45	[p5l733t1558r991b1658],
4	who	WP	O	who	nsubj	5	SENT_45	[p5l1030t1557r1212b1636],
5	have	VBP	O	have	rcmod	3	SENT_45	[p5l1255t1557r1445b1636],
6	non	JJ	O	non	amod	9	SENT_45	[p5l1488t1557r2134b1636],
7	—	JJ	O	—	amod	9	SENT_45	[p5l1488t1557r2134b1636],
8	small	JJ	O	small	amod	9	SENT_45	[p5l1488t1557r2134b1636],
9	—	NN	O	—	dobj	5	SENT_45	[p5l1488t1557r2134b1636],
10	cell	NN	O	cell	nn	12	SENT_45	[p5l1488t1557r2134b1636],
11	lung	NN	O	lung	nn	12	SENT_45	[p5l10t1685r207b1786],
12	cancer	NN	O	cancer	dep	9	SENT_45	[p5l244t1711r549b1764],
13	.	.	O	.	_	0	SENT_45	[p5l244t1711r549b1764],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_46	[p5l138t1820r350b1893],
2	signaling	NN	O	signaling	nsubj	3	SENT_46	[p5l412t1813r815b1914],
3	occurs	VBZ	O	occur	_	0	SENT_46	[p5l877t1839r1156b1892],
4	through	IN	O	through	_	0	SENT_46	[p5l1224t1813r1573b1914],
5	a	DT	O	a	det	6	SENT_46	[p5l1637t1840r1682b1892],
6	complex	NN	O	complex	prep_through	3	SENT_46	[p5l1747t1813r2128b1914],
7	,	,	O	,	_	0	SENT_46	[p5l1747t1813r2128b1914],
8	multidimensional	JJ	O	multidimensional	amod	9	SENT_46	[p5l11t1941r780b2020],
9	pathway	NN	O	pathway	appos	6	SENT_46	[p5l815t1941r1189b2042],
10	,	,	O	,	_	0	SENT_46	[p5l815t1941r1189b2042],
11	and	CC	O	and	_	0	SENT_46	[p5l1231t1941r1389b2020],
12	activation	NN	O	activation	nsubj	16	SENT_46	[p5l1426t1942r1843b2020],
13	of	IN	O	of	_	0	SENT_46	[p5l1881t1941r1981b2020],
14	the	DT	O	the	det	15	SENT_46	[p5l2001t1941r2133b2020],
15	pathway	NN	O	pathway	prep_of	12	SENT_46	[p5l10t2069r371b2170],
16	results	VBZ	O	result	conj_and	3	SENT_46	[p5l408t2069r691b2148],
17	in	IN	O	in	_	0	SENT_46	[p5l733t2070r817b2147],
18	downstream	JJ	O	downstream	amod	19	SENT_46	[p5l859t2069r1399b2149],
19	events	NNS	O	event	prep_in	16	SENT_46	[p5l1441t2086r1704b2148],
20	stimulating	VBG	O	stimulate	partmod	19	SENT_46	[p5l1749t2069r2132b2148, p5l11t2198r150b2298],
21	five	CD	NUMBER	five	dobj	20	SENT_46	[p5l183t2197r336b2276],
22	of	IN	O	of	_	0	SENT_46	[p5l373t2197r473b2276],
23	the	DT	O	the	det	25	SENT_46	[p5l492t2197r625b2276],
24	six	CD	NUMBER	six	num	25	SENT_46	[p5l663t2198r781b2276],
25	hallmarks	NNS	O	hallmark	prep_of	21	SENT_46	[p5l814t2197r1251b2277],
26	of	IN	O	of	_	0	SENT_46	[p5l1290t2197r1390b2276],
27	cancer	NN	O	cancer	nn	29	SENT_46	[p5l1409t2223r1689b2276],
28	(	CD	NUMBER	(	num	29	SENT_46	[p5l1729t2197r2132b2298, p5l12t2325r256b2404],
29	independence	NN	O	independence	prep_of	25	SENT_46	[p5l1729t2197r2132b2298, p5l12t2325r256b2404],
30	of	IN	O	of	_	0	SENT_46	[p5l291t2325r390b2404],
31	growth	NN	O	growth	nn	32	SENT_46	[p5l405t2325r719b2426],
32	signals	NNS	O	signal	prep_of	29	SENT_46	[p5l755t2325r1079b2426],
33	,	,	O	,	_	0	SENT_46	[p5l755t2325r1079b2426],
34	insensitivity	NN	O	insensitivity	appos	32	SENT_46	[p5l1117t2326r1640b2426],
35	to	TO	O	to	_	0	SENT_46	[p5l1670t2342r1751b2404],
36	growthinhibitory	JJ	O	growthinhibitory	amod	37	SENT_46	[p5l1786t2325r2132b2426, p5l11t2453r433b2554],
37	signals	NNS	O	signal	prep_to	20	SENT_46	[p5l465t2453r781b2554],
38	,	,	O	,	_	0	SENT_46	[p5l465t2453r781b2554],
39	resistance	NN	O	resistance	appos	37	SENT_46	[p5l823t2454r1241b2532],
40	to	TO	O	to	aux	41	SENT_46	[p5l1278t2470r1359b2532],
41	programmed	VBN	O	program	xcomp	20	SENT_46	[p5l1395t2453r1952b2554],
42	cell	NN	O	cell	nn	43	SENT_46	[p5l1988t2453r2134b2532],
43	iEGF	NN	O	iegf	dobj	41	SENT_46	[p6l218t113r588b160],
44	,	,	O	,	_	0	SENT_46	[p6l218t113r588b160],
45	TEF	NN	O	tef	appos	43	SENT_46	[p6l218t113r588b160],
46	‘	SYM	O	‘	dep	43	SENT_46	[p6l218t113r588b160],
47	-	:	O	-	_	0	SENT_46	[p6l218t113r588b160],
48	nmor	SYM	O	nmor	dep	52	SENT_46	[p6l218t113r588b160],
49	-	:	O	-	_	0	SENT_46	[p6l865t139r884b140],
50	,	,	O	,	_	0	SENT_46	[p6l1191t141r1200b152],
51	‘	CD	NUMBER	‘	nsubj	52	SENT_46	[p6l1230t126r1232b128],
52	ii	LS	O	ii	parataxis	41	SENT_46	[p6l1733t110r2003b156, p6l237t179r361b222],
53	.	.	O	.	_	0	SENT_46	[p6l1733t110r2003b156, p6l237t179r361b222],

1	Ilernl	NNP	O	Ilernl	_	0	SENT_47	[p6l1733t110r2003b156, p6l237t179r361b222],
2	:	:	O	:	_	0	SENT_47	[p6l1733t110r2003b156, p6l237t179r361b222],
3	nr	NN	O	nr	dep	1	SENT_47	[p6l1733t110r2003b156, p6l237t179r361b222],
4	.	.	O	.	_	0	SENT_47	[p6l1733t110r2003b156, p6l237t179r361b222],

1	aneother	NN	O	aneother	nn	2	SENT_48	[p6l1733t110r2003b156, p6l237t179r361b222],
2	ligands	NNS	O	ligand	_	0	SENT_48	[p6l380t179r546b237],
3	.	.	O	.	_	0	SENT_48	[p6l752t211r780b234],

1	;	:	O	;	_	0	SENT_49	[p6l752t211r780b234],
2	.	.	O	.	_	0	SENT_49	[p6l823t214r864b239],

1	_	NN	O	_	nsubj	2	SENT_50	[p6l823t214r864b239],
2	,	,	O	,	_	0	SENT_50	[p6l912t234r914b236],
3	.	.	O	.	_	0	SENT_50	[p6l950t210r965b233],

1	-	:	O	-	_	0	SENT_51	[p6l950t210r965b233],
2	*	NN	O	*	_	0	SENT_51	[p6l1012t220r1029b234],
3	’	CD	NUMBER	’	num	2	SENT_51	[p6l1056t207r1059b209],
4	i	FW	O	i	nn	8	SENT_51	[p6l1164t180r1166b183],
5	_	FW	O	_	nn	8	SENT_51	[p6l1232t238r1235b240],
6	ߜ	FW	O	ߜ	nn	8	SENT_51	[p6l1263t208r1297b233],
7	*	FW	O	*	nn	8	SENT_51	[p6l1263t208r1297b233],
8	i	FW	O	i	dep	2	SENT_51	[p6l1464t184r1466b186],
9	‘	FW	O	‘	dep	8	SENT_51	[p6l1500t195r1527b209],
10	.	.	O	.	_	0	SENT_51	[p6l1557t221r1575b239],

1	g	NN	O	g	_	0	SENT_52	[p6l1611t230r1613b233],
2	_	NN	O	_	dep	1	SENT_52	[p6l1642t229r1644b231],
3	tethered	JJ	O	tethered	amod	2	SENT_52	[p6l1767t179r1964b222],
4	‘	CD	NUMBER	‘	tmod	3	SENT_52	[p6l713t242r820b261],
5	"	``	O	"	punct	2	SENT_52	[p6l713t242r820b261],
6	'	''	O	'	_	0	SENT_52	[p6l713t242r820b261],
7	i	FW	O	i	nn	8	SENT_52	[p6l713t242r820b261],
8	T	NN	O	t	dep	2	SENT_52	[p6l920t242r969b263],
9	”	CD	NUMBER	”	number	10	SENT_52	[p6l920t242r969b263],
10	”	CD	NUMBER	”	num	13	SENT_52	[p6l1017t244r1026b253],
11	”	NN	O	”	nn	13	SENT_52	[p6l1584t245r1594b248],
12	T	NN	O	t	nn	13	SENT_52	[p6l1701t253r1702b256],
13	ﬁgands	NNS	O	ﬁgands	dep	8	SENT_52	[p6l1783t244r1949b302],

1	EGFFI	NN	O	egffus	nn	5	SENT_53	[p6l229t367r353b410],
2	or	CC	O	or	_	0	SENT_53	[p6l372t379r422b410],
3	othe-r	JJ	O	othe-r	conj_or	1	SENT_53	[p6l437t364r561b410],
4	P	NN	O	p	nn	5	SENT_53	[p6l716t337r753b410],
5	Ę	NN	O	ę	_	0	SENT_53	[p6l716t337r753b410],
6	*	CD	NUMBER	*	num	7	SENT_53	[p6l716t337r753b410],
7	>	JJR	O	>	dep	5	SENT_53	[p6l768t420r787b421],
8	*	CD	NUMBER	*	num	9	SENT_53	[p6l768t420r787b421],
9	Ř	NN	O	ř	dep	7	SENT_53	[p6l808t333r861b421],
10	*	CD	NUMBER	*	num	11	SENT_53	[p6l808t333r861b421],
11	T	NN	O	t	dep	7	SENT_53	[p6l908t337r931b364],
12	!	.	O	!	_	0	SENT_53	[p6l908t337r931b364],

1	i	LS	O	i	dep	3	SENT_54	[p6l946t333r954b407],
2	T	NN	O	t	nn	3	SENT_54	[p6l981t333r984b337],
3	P	NN	O	p	_	0	SENT_54	[p6l1005t344r1034b397],
4	*	CD	NUMBER	*	dep	3	SENT_54	[p6l1005t344r1034b397],
5	`	``	O	`	_	0	SENT_54	[p6l1521t333r1662b464],
6	ޜ	FW	O	ޜ	nn	9	SENT_54	[p6l1521t333r1662b464],
7	*	FW	O	*	nn	9	SENT_54	[p6l1521t333r1662b464],
8	Famllli	FW	O	famllli	nn	9	SENT_54	[p6l202t429r345b487],
9	”	FW	O	”	dep	4	SENT_54	[p6l360t433r584b476],
10	1E	NN	O	1e	nn	14	SENT_54	[p6l360t433r584b476],
11	‘	NN	O	‘	nn	14	SENT_54	[p6l360t433r584b476],
12	mhe	NN	O	mhe	nn	14	SENT_54	[p6l360t433r584b476],
13	"	''	O	"	punct	14	SENT_54	[p6l360t433r584b476],
14	‘	NN	O	‘	dep	3	SENT_54	[p6l360t433r584b476],
15	5	CD	NUMBER	5	dep	14	SENT_54	[p6l360t433r584b476],
16	,	,	O	,	_	0	SENT_54	[p6l715t437r724b499],
17	,	,	O	,	_	0	SENT_54	[p6l746t483r754b495],
18	P	NN	O	p	nn	19	SENT_54	[p6l955t453r983b471],
19	*	NN	O	*	dep	14	SENT_54	[p6l955t453r983b471],
20	,	,	O	,	_	0	SENT_54	[p6l1046t490r1047b493],
21	Sheddiases	NNP	O	Sheddiases	tmod	14	SENT_54	[p6l1209t445r1460b487],
22	—	CD	NUMBER	—	num	21	SENT_54	[p6l1479t468r1610b483],
23	.	.	O	.	_	0	SENT_54	[p6l1479t468r1610b483],

1	‘	NN	O	‘	_	0	SENT_55	[p6l1634t442r1643b486],

1	Transcription	NN	O	transcription	nn	2	SENT_56	[p6l938t1646r1252b1703],
2	Proliferation	NN	O	proliferation	_	0	SENT_56	[p6l1486t1645r1775b1692],

1	Evasion	NN	O	evasion	nsubj	2	SENT_57	[p6l156t1823r333b1865],
2	eat	VBP	O	eat	_	0	SENT_57	[p6l349t1819r403b1865],
3	"	``	O	"	punct	7	SENT_57	[p6l349t1819r403b1865],
4	A	NN	O	a	nn	7	SENT_57	[p6l489t1805r491b1807],
5	Sustained	JJ	O	sustained	amod	7	SENT_57	[p6l557t1819r788b1865],
6	Ii	NN	O	ii	nn	7	SENT_57	[p6l862t1801r882b1821],
7	Resistance	NN	O	resistance	conj_and	7	SENT_57	[p6l919t1823r1171b1865],
8	to	TO	O	to	_	0	SENT_57	[p6l1186t1827r1232b1865],
9	Invasion	NNP	O	Invasion	prep_to	7	SENT_57	[p6l1328t1823r1521b1865],
10	and	CC	O	and	_	0	SENT_57	[p6l1540t1819r1625b1865],
11	if	IN	O	if	_	0	SENT_57	[p6l1668t1796r1671b1811],
12	Self-suffieie-nay	NN	O	self-suffieie-nay	prep_if	7	SENT_57	[p6l1702t1819r2061b1877],

1	1	CD	NUMBER	1	num	2	SENT_58	[p6l80t1907r87b1927],
2	‘	CD	NUMBER	‘	_	0	SENT_58	[p6l80t1907r87b1927],
3	msnptosis	NN	O	msnptosis	nn	5	SENT_58	[p6l157t1892r388b1943],
4	*	NN	O	*	nn	5	SENT_58	[p6l471t1905r487b1951],
5	angingenesis	NN	O	angingenesis	dep	2	SENT_58	[p6l518t1892r827b1946],
6	by	IN	O	by	_	0	SENT_58	[p6l881t1894r888b1951],
7	antigrowth	JJ	O	antigrowth	prep_by	5	SENT_58	[p6l946t1888r1202b1946],
8	,	,	O	,	_	0	SENT_58	[p6l1286t1940r1288b1942],
9	in	IN	O	in	_	0	SENT_58	[p6l1768t1892r1807b1931],
10	gr	NN	O	gr	nn	12	SENT_58	[p6l1825t1888r1991b1946],
11	'	''	O	'	_	0	SENT_58	[p6l1825t1888r1991b1946],
12	owt	NN	O	owt	prep_in	5	SENT_58	[p6l1825t1888r1991b1946],
13	‘	CD	NUMBER	‘	num	16	SENT_58	[p6l1825t1888r1991b1946],
14	h	NN	O	h	nn	16	SENT_58	[p6l1825t1888r1991b1946],
15	l	NN	O	l	nn	16	SENT_58	[p6l869t1954r870b1957],
16	signals	NNS	O	signal	dep	5	SENT_58	[p6l993t1954r1155b2012],
17	ll	NN	O	ll	nn	18	SENT_58	[p6l1674t1955r1688b1959],
18	signals	NNS	O	signal	dep	2	SENT_58	[p6l1798t1954r1961b2012],

1	Hallmarks	NNS	O	hallmark	nsubj	2	SENT_59	[p6l803t2077r1074b2128],
2	ofcanr	VBP	O	ofcanr	_	0	SENT_59	[p6l1093t2077r1348b2128],

1	Figure	NNP	O	Figure	_	0	SENT_60	[p6l65t2232r228b2294],
2	1	CD	NUMBER	1	dep	1	SENT_60	[p6l251t2235r293b2279],
3	.	.	O	.	_	0	SENT_60	[p6l251t2235r293b2279],

1	Targeting	NN	O	targeting	_	0	SENT_61	[p6l314t2232r566b2294],
2	the	DT	O	the	det	6	SENT_61	[p6l583t2231r668b2279],
3	Epidermal	NNP	O	Epidermal	nn	6	SENT_61	[p6l692t2231r958b2293],
4	Growth	NN	O	growth	nn	6	SENT_61	[p6l981t2231r1178b2279],
5	Factor	NN	O	factor	nn	6	SENT_61	[p6l1205t2235r1370b2279],
6	Receptor	NN	O	receptor	dep	1	SENT_61	[p6l1392t2235r1627b2293],
7	(	CD	NUMBER	(	num	8	SENT_61	[p6l1649t2235r1831b2295],
8	EGFR	NN	ORGANIZATION	egfr	dep	6	SENT_61	[p6l1649t2235r1831b2295],
9	)	CD	NUMBER	)	num	11	SENT_61	[p6l1649t2235r1831b2295],
10	Signaling	NN	O	signaling	nn	11	SENT_61	[p6l1855t2231r2102b2294],
11	Pathway	NN	O	pathway	dep	6	SENT_61	[p6l65t2311r296b2375],
12	.	.	O	.	_	0	SENT_61	[p6l65t2311r296b2375],

1	The	DT	O	the	det	2	SENT_62	[p6l60t2407r159b2456],
2	family	NN	O	family	nsubj	10	SENT_62	[p6l180t2407r341b2471],
3	of	IN	O	of	_	0	SENT_62	[p6l361t2407r419b2456],
4	surface-receptor	JJ	O	surface-receptor	amod	6	SENT_62	[p6l433t2407r874b2470],
5	tyrosine	NN	O	tyrosine	nn	6	SENT_62	[p6l892t2412r1105b2471],
6	kinases	NNS	O	kinase	prep_of	2	SENT_62	[p6l1130t2407r1322b2456],
7	encoded	VBN	O	encode	partmod	6	SENT_62	[p6l1346t2407r1571b2456],
8	by	IN	O	by	_	0	SENT_62	[p6l1598t2407r1653b2471],
9	EGFR	NN	ORGANIZATION	egfr	agent	7	SENT_62	[p6l1677t2411r1819b2456],
10	consists	VBZ	O	consist	_	0	SENT_62	[p6l1840t2412r2057b2456],
11	offour	NN	O	offour	nn	12	SENT_62	[p6l62t2487r241b2536],
12	members	NNS	O	member	dobj	10	SENT_62	[p6l263t2488r513b2536],
13	that	WDT	O	that	nsubj	14	SENT_62	[p6l535t2488r640b2536],
14	form	VBP	O	form	rcmod	12	SENT_62	[p6l660t2487r784b2536],
15	homodimers	NNS	O	homodimer	dobj	14	SENT_62	[p6l811t2488r1152b2536],
16	or	CC	O	or	_	0	SENT_62	[p6l1176t2505r1230b2536],
17	heterodimers	NNS	O	heterodimer	dobj	14	SENT_62	[p6l1252t2488r1607b2536],
18	after	IN	O	after	_	0	SENT_62	[p6l1632t2487r1754b2536],
19	ligand	NN	O	ligand	nn	20	SENT_62	[p6l1776t2488r1932b2552],
20	binding	NN	O	binding	prep_after	14	SENT_62	[p6l1960t2488r2092b2536, p6l64t2572r156b2632],
21	.	.	O	.	_	0	SENT_62	[p6l1960t2488r2092b2536, p6l64t2572r156b2632],

1	Dimerization	NN	O	dimerization	nsubj	2	SENT_63	[p6l184t2572r527b2617],
2	results	VBZ	O	result	_	0	SENT_63	[p6l555t2568r729b2617],
3	in	IN	O	in	_	0	SENT_63	[p6l755t2573r796b2616],
4	the	DT	O	the	det	7	SENT_63	[p6l819t2568r903b2616],
5	activation	NN	O	activation	nn	7	SENT_63	[p6l925t2572r1182b2617],
6	oftyrosine	NN	O	oftyrosine	nn	7	SENT_63	[p6l1208t2567r1489b2631],
7	kinases	NNS	O	kinase	prep_in	2	SENT_63	[p6l1514t2568r1722b2625],
8	,	,	O	,	_	0	SENT_63	[p6l1514t2568r1722b2625],
9	which	WDT	O	which	nsubjpass	11	SENT_63	[p6l1744t2568r1898b2617],
10	is	VBZ	O	be	auxpass	11	SENT_63	[p6l1925t2573r1962b2617],
11	followed	VBN	O	follow	rcmod	7	SENT_63	[p6l1984t2567r2069b2616, p6l65t2648r216b2697],
12	by	IN	O	by	_	0	SENT_63	[p6l243t2648r298b2712],
13	stimulation	NN	O	stimulation	nn	17	SENT_63	[p6l320t2648r620b2697],
14	ofthree	NN	O	ofthree	nn	17	SENT_63	[p6l645t2648r850b2697],
15	major	JJ	O	major	amod	17	SENT_63	[p6l875t2653r1028b2712],
16	signaling	NN	O	signaling	nn	17	SENT_63	[p6l1049t2648r1288b2712],
17	pathways	NNS	O	pathway	agent	11	SENT_63	[p6l1311t2648r1570b2712],
18	,	,	O	,	_	0	SENT_63	[p6l1311t2648r1570b2712],
19	eventually	RB	O	eventually	advmod	20	SENT_63	[p6l1595t2648r1863b2712],
20	leading	VBG	O	lead	xcomp	11	SENT_63	[p6l1886t2648r2077b2712],
21	to	TO	O	to	_	0	SENT_63	[p6l61t2738r111b2777],
22	the	DT	O	the	det	23	SENT_63	[p6l132t2729r216b2777],
23	activation	NN	O	activation	prep_to	20	SENT_63	[p6l238t2733r496b2777],
24	of	IN	O	of	_	0	SENT_63	[p6l520t2728r578b2777],
25	five	CD	NUMBER	five	num	28	SENT_63	[p6l590t2728r683b2777],
26	ofthe	NN	O	ofthe	nn	28	SENT_63	[p6l706t2728r858b2777],
27	six	CD	NUMBER	six	num	28	SENT_63	[p6l881t2733r947b2777],
28	hallmarks	NNS	O	hallmark	prep_of	23	SENT_63	[p6l970t2729r1227b2777],
29	of	IN	O	of	_	0	SENT_63	[p6l1250t2728r1308b2777],
30	cancer	NN	O	cancer	nn	31	SENT_63	[p6l1320t2746r1496b2777],
31	(	NN	O	(	prep_of	28	SENT_63	[p6l1521t2729r1647b2792],
32	with	IN	O	with	_	0	SENT_63	[p6l1521t2729r1647b2792],
33	the	DT	O	the	det	34	SENT_63	[p6l1670t2729r1754b2777],
34	exception	NN	O	exception	prep_with	31	SENT_63	[p6l1776t2733r2028b2792],
35	of	IN	O	of	_	0	SENT_63	[p6l2053t2728r2111b2777],
36	limitless	JJ	O	limitless	amod	37	SENT_63	[p6l65t2809r283b2857],
37	replication	NN	O	replication	prep_of	34	SENT_63	[p6l309t2808r650b2872],
38	)	CD	NUMBER	)	number	39	SENT_63	[p6l309t2808r650b2872],
39	.7	CD	NUMBER	.7	dobj	20	SENT_63	[p6l309t2808r650b2872],
40	The	DT	O	the	det	42	SENT_63	[p6l670t2809r769b2857],
41	classic	JJ	O	classic	amod	42	SENT_63	[p6l791t2809r965b2857],
42	mutations	NNS	O	mutation	nsubj	43	SENT_63	[p6l989t2813r1257b2857],
43	ofthe	VBP	O	ofthe	rcmod	39	SENT_63	[p6l1281t2808r1433b2857],
44	EGFR	NN	ORGANIZATION	egfr	nn	46	SENT_63	[p6l1458t2813r1600b2857],
45	kinase	NN	O	kinase	nn	46	SENT_63	[p6l1624t2809r1788b2857],
46	domain	NN	O	domain	nsubj	47	SENT_63	[p6l1810t2809r2010b2857],
47	result	VBP	O	result	ccomp	43	SENT_63	[p6l2037t2826r2102b2857, p6l64t2889r158b2937],
48	in	IN	O	in	_	0	SENT_63	[p6l181t2894r223b2937],
49	ligand-independent	JJ	O	ligand-independent	amod	52	SENT_63	[p6l250t2889r774b2953],
50	activation	NN	O	activation	nn	52	SENT_63	[p6l796t2894r1053b2937],
51	ofthe	NN	O	ofthe	nn	52	SENT_63	[p6l1078t2889r1230b2937],
52	pathway	NN	O	pathway	prep_in	47	SENT_63	[p6l1254t2889r1482b2953],
53	.	.	O	.	_	0	SENT_63	[p6l1254t2889r1482b2953],

1	Tyrosine	NN	O	tyrosine	nn	3	SENT_64	[p6l1504t2894r1726b2953],
2	kinase	NN	O	kinase	nn	3	SENT_64	[p6l1750t2889r1915b2937],
3	inhibitors	NNS	O	inhibitor	nsubj	11	SENT_64	[p6l1939t2889r2103b2937, p6l61t2979r178b3026],
4	,	,	O	,	_	0	SENT_64	[p6l1939t2889r2103b2937, p6l61t2979r178b3026],
5	such	JJ	O	such	_	0	SENT_64	[p6l204t2970r324b3018],
6	as	IN	O	as	_	0	SENT_64	[p6l349t2986r402b3018],
7	erlotinib	NN	O	erlotinib	prep_such_as	3	SENT_64	[p6l426t2970r647b3018],
8	and	CC	O	and	_	0	SENT_64	[p6l670t2970r763b3018],
9	gefitinib	NN	O	gefitinib	prep_such_as	3	SENT_64	[p6l788t2969r1020b3033],
10	,	,	O	,	_	0	SENT_64	[p6l788t2969r1020b3033],
11	interfere	VBP	O	interfere	_	0	SENT_64	[p6l1047t2969r1270b3018],
12	with	IN	O	with	_	0	SENT_64	[p6l1290t2970r1400b3018],
13	the	DT	O	the	det	17	SENT_64	[p6l1423t2970r1507b3018],
14	kinase	NN	O	kinase	nn	17	SENT_64	[p6l1531t2970r1696b3018],
15	activity	NN	O	activity	nn	17	SENT_64	[p6l1718t2974r1908b3033],
16	ofthe	NN	O	ofthe	nn	17	SENT_64	[p6l1928t2969r2080b3018],
17	gene	NN	O	gene	prep_with	11	SENT_64	[p6l63t3066r188b3113],
18	and	CC	O	and	_	0	SENT_64	[p6l210t3050r304b3098],
19	prevent	VB	O	prevent	conj_and	11	SENT_64	[p6l331t3059r529b3113],
20	downstream	JJ	O	downstream	amod	21	SENT_64	[p6l550t3050r880b3098],
21	signaling	NN	O	signaling	dobj	19	SENT_64	[p6l906t3050r1158b3113],
22	.	.	O	.	_	0	SENT_64	[p6l906t3050r1158b3113],

1	Activation	NN	O	activation	nsubj	6	SENT_65	[p6l1180t3053r1448b3098],
2	of	IN	O	of	_	0	SENT_65	[p6l1473t3049r1531b3098],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_65	[p6l1547t3053r1689b3098],
4	signaling	NN	O	signaling	prep_of	1	SENT_65	[p6l1712t3050r1950b3113],
5	also	RB	O	also	advmod	6	SENT_65	[p6l1972t3050r2076b3098],
6	leads	VBZ	O	lead	_	0	SENT_65	[p6l65t3130r198b3178],
7	to	TO	O	to	_	0	SENT_65	[p6l220t3139r271b3178],
8	an	DT	O	a	det	10	SENT_65	[p6l294t3147r352b3178],
9	autocrine	JJ	O	autocrine	amod	10	SENT_65	[p6l378t3134r627b3178],
10	loop	NN	O	loop	prep_to	6	SENT_65	[p6l652t3130r765b3193],
11	resulting	VBG	O	result	partmod	10	SENT_65	[p6l791t3130r1022b3194],
12	from	IN	O	from	_	0	SENT_65	[p6l1041t3129r1165b3178],
13	the	DT	O	the	det	17	SENT_65	[p6l1189t3130r1272b3178],
14	formation	NN	O	formation	nn	17	SENT_65	[p6l1293t3129r1555b3178],
15	and	CC	O	and	_	0	SENT_65	[p6l1581t3130r1674b3178],
16	release	NN	O	release	nn	17	SENT_65	[p6l1702t3130r1885b3178],
17	ofligands	NNS	O	ofligand	prep_from	11	SENT_65	[p6l1907t3129r2055b3194, p6l63t3210r203b3258],
18	.	.	O	.	_	0	SENT_65	[p6l1907t3129r2055b3194, p6l63t3210r203b3258],

1	The	DT	O	the	det	2	SENT_66	[p6l224t3210r323b3258],
2	ligands	NNS	O	ligand	nsubj	3	SENT_66	[p6l348t3210r534b3274],
3	require	VBP	O	require	_	0	SENT_66	[p6l561t3215r744b3273],
4	release	NN	O	release	dobj	3	SENT_66	[p6l769t3210r952b3258],
5	from	IN	O	from	_	0	SENT_66	[p6l973t3210r1097b3258],
6	their	PRP$	O	they	poss	9	SENT_66	[p6l1120t3210r1244b3258],
7	membrane-bound	JJ	O	membrane-bound	amod	9	SENT_66	[p6l1266t3210r1748b3259],
8	precursor	NN	O	precursor	nn	9	SENT_66	[p6l1775t3227r2031b3273],
9	forms	NNS	O	form	prep_from	3	SENT_66	[p6l61t3290r216b3339],
10	by	IN	O	by	_	0	SENT_66	[p6l242t3290r297b3354],
11	the	DT	O	the	det	12	SENT_66	[p6l316t3290r399b3339],
12	activity	NN	O	activity	prep_by	3	SENT_66	[p6l422t3295r611b3354],
13	of	IN	O	of	_	0	SENT_66	[p6l632t3290r689b3339],
14	sheddase	NN	O	sheddase	nn	15	SENT_66	[p6l703t3290r954b3339],
15	proteins	NNS	O	protein	prep_of	12	SENT_66	[p6l979t3295r1209b3353],
16	.	.	O	.	_	0	SENT_66	[p6l979t3295r1209b3353],

1	Only	RB	O	only	advmod	3	SENT_67	[p6l1234t3290r1358b3354],
2	nodal	JJ	O	nodal	amod	3	SENT_67	[p6l1381t3290r1523b3339],
3	points	NNS	O	point	nsubjpass	8	SENT_67	[p6l1551t3295r1715b3353],
4	in	IN	O	in	_	0	SENT_67	[p6l1740t3295r1782b3338],
5	the	DT	O	the	det	6	SENT_67	[p6l1805t3290r1888b3339],
6	pathway	NN	O	pathway	prep_in	3	SENT_67	[p6l1913t3290r2046b3353, p6l60t3388r159b3434],
7	are	VBP	O	be	auxpass	8	SENT_67	[p6l181t3388r259b3419],
8	displayed	VBN	O	display	_	0	SENT_67	[p6l280t3370r544b3434],
9	,	,	O	,	_	0	SENT_67	[p6l280t3370r544b3434],
10	indicating	VBG	O	indicate	xcomp	8	SENT_67	[p6l571t3371r833b3434],
11	targets	NNS	O	target	nn	12	SENT_67	[p6l852t3380r1037b3434],
12	oftherapies	NNS	O	oftherapy	dobj	10	SENT_67	[p6l1060t3370r1376b3434],
13	in	IN	O	in	_	0	SENT_67	[p6l1402t3375r1443b3418],
14	current	JJ	DATE	current	amod	16	SENT_67	[p6l1468t3380r1660b3419],
15	clinical	JJ	O	clinical	amod	16	SENT_67	[p6l1681t3371r1862b3419],
16	use	NN	O	use	prep_in	12	SENT_67	[p6l1889t3388r1976b3419],
17	or	CC	O	or	_	0	SENT_67	[p6l1999t3388r2052b3419],
18	in	IN	O	in	_	0	SENT_67	[p6l65t3455r106b3499],
19	trials	NNS	O	trial	prep_in	12	SENT_67	[p6l129t3451r259b3499],
20	(	CD	NUMBER	(	num	22	SENT_67	[p6l288t3451r386b3514],
21	red	JJ	O	red	amod	22	SENT_67	[p6l288t3451r386b3514],
22	arrows	NNS	O	arrow	dep	12	SENT_67	[p6l411t3455r622b3514],
23	)	RB	O	)	advmod	10	SENT_67	[p6l411t3455r622b3514],
24	.	.	O	.	_	0	SENT_67	[p6l411t3455r622b3514],

1	Akt	NN	O	akt	nsubj	2	SENT_68	[p6l644t3451r734b3499],
2	denotes	VBZ	O	denote	_	0	SENT_68	[p6l755t3451r966b3499],
3	protein	NN	O	protein	nn	5	SENT_68	[p6l992t3455r1176b3514],
4	kinase	NN	O	kinase	nn	5	SENT_68	[p6l1203t3451r1368b3499],
5	B	NN	O	b	dobj	2	SENT_68	[p6l1394t3455r1438b3508],
6	,	,	O	,	_	0	SENT_68	[p6l1394t3455r1438b3508],
7	P	NN	O	p	nn	10	SENT_68	[p6l1467t3455r1582b3499],
8	|	CD	NUMBER	|	num	10	SENT_68	[p6l1467t3455r1582b3499],
9	3K	NN	O	3k	nn	10	SENT_68	[p6l1467t3455r1582b3499],
10	phosphatidylinositol	NN	O	phosphatidylinositol	conj_and	5	SENT_68	[p6l1606t3451r2097b3514, p6l61t3531r125b3580],
11	3-kinase	NN	O	3-kinase	dep	10	SENT_68	[p6l151t3531r385b3588],
12	,	,	O	,	_	0	SENT_68	[p6l151t3531r385b3588],
13	PTEN	NNP	O	PTEN	nn	14	SENT_68	[p6l413t3535r555b3579],
14	phosphatase	NN	O	phosphatase	conj_and	5	SENT_68	[p6l585t3531r924b3594],
15	and	CC	O	and	_	0	SENT_68	[p6l947t3531r1041b3580],
16	tensin	NN	O	tensin	nn	17	SENT_68	[p6l1063t3536r1224b3580],
17	homologue	NN	O	homologue	conj_and	14	SENT_68	[p6l1251t3531r1569b3595],
18	,	,	O	,	_	0	SENT_68	[p6l1251t3531r1569b3595],
19	MAPK	NN	O	mapk	dobj	2	SENT_68	[p6l1597t3534r1758b3579],
20	mitogenactivated	JJ	O	mitogenactivated	amod	22	SENT_68	[p6l1782t3536r2018b3595, p6l63t3611r300b3660],
21	protein	NN	O	protein	nn	22	SENT_68	[p6l328t3616r512b3674],
22	kinase	NN	O	kinase	dep	19	SENT_68	[p6l539t3611r718b3668],
23	,	,	O	,	_	0	SENT_68	[p6l539t3611r718b3668],
24	mTOR	NN	O	mtor	nn	26	SENT_68	[p6l745t3615r910b3660],
25	mammalian	JJ	O	mammalian	amod	26	SENT_68	[p6l935t3611r1248b3660],
26	target	NN	O	target	appos	22	SENT_68	[p6l1271t3621r1427b3675],
27	of	IN	O	of	_	0	SENT_68	[p6l1449t3611r1506b3660],
28	rapamycin	NN	O	rapamycin	prep_of	26	SENT_68	[p6l1522t3616r1809b3675],
29	,	,	O	,	_	0	SENT_68	[p6l1522t3616r1809b3675],
30	P	NN	O	p	nn	31	SENT_68	[p6l1838t3616r1865b3659],
31	phosphorylation	NN	O	phosphorylation	dobj	2	SENT_68	[p6l1890t3611r2035b3674, p6l65t3692r383b3755],
32	,	,	O	,	_	0	SENT_68	[p6l1890t3611r2035b3674, p6l65t3692r383b3755],
33	STAT	NN	O	stat	nn	35	SENT_68	[p6l408t3695r543b3740],
34	signal	NN	O	signal	nn	35	SENT_68	[p6l565t3692r715b3755],
35	transducer	NN	O	transducer	dobj	2	SENT_68	[p6l739t3692r1028b3740],
36	and	CC	O	and	_	0	SENT_68	[p6l1048t3692r1141b3740],
37	activator	NN	O	activator	nn	38	SENT_68	[p6l1167t3696r1399b3740],
38	oftranscription	NN	O	oftranscription	conj_and	35	SENT_68	[p6l1419t3691r1847b3755],
39	,	,	O	,	_	0	SENT_68	[p6l1419t3691r1847b3755],
40	and	CC	O	and	_	0	SENT_68	[p6l1872t3692r1965b3740],
41	TG	NN	O	tg	nn	42	SENT_68	[p6l60t3776r134b3820],
42	F-oz	NN	O	f-oz	dobj	2	SENT_68	[p6l146t3776r229b3820],
43	transforming	VBG	O	transform	partmod	42	SENT_68	[p6l250t3771r602b3834],
44	growth	NN	O	growth	nn	45	SENT_68	[p6l623t3772r806b3834],
45	factor	NN	O	factor	dobj	43	SENT_68	[p6l830t3771r987b3820],
46	a.	IN	O	a.	prep	43	SENT_68	[p6l1005t3791r1055b3820],

1	death	NN	O	death	dep	24	SENT_69	[p7l12t208r206b279],
2	,	,	O	,	_	0	SENT_69	[p7l12t208r206b279],
3	angiogenesis	NN	O	angiogenesis	conj_and	1	SENT_69	[p7l248t209r683b283],
4	,	,	O	,	_	0	SENT_69	[p7l248t209r683b283],
5	and	CC	O	and	_	0	SENT_69	[p7l725t208r843b267],
6	metastasis	NN	O	metastasis	nn	7	SENT_69	[p7l881t209r1258b279],
7	)	NN	O	)	conj_and	1	SENT_69	[p7l881t209r1258b279],
8	;	:	O	;	_	0	SENT_69	[p7l881t209r1258b279],
9	the	DT	O	the	det	11	SENT_69	[p7l1300t208r1399b267],
10	sixth	JJ	ORDINAL	sixth	amod	11	SENT_69	[p7l1439t208r1596b266],
11	hallmark	NN	O	hallmark	nsubj	24	SENT_69	[p7l11t303r322b374],
12	,	,	O	,	_	0	SENT_69	[p7l11t303r322b374],
13	which	WDT	O	which	nsubjpass	16	SENT_69	[p7l365t303r561b362],
14	is	VBZ	O	be	auxpass	16	SENT_69	[p7l602t304r651b361],
15	not	RB	O	not	neg	16	SENT_69	[p7l695t315r801b362],
16	activated	VBN	O	activate	rcmod	11	SENT_69	[p7l838t303r1121b362],
17	in	IN	O	in	_	0	SENT_69	[p7l1162t304r1224b361],
18	this	DT	O	this	det	19	SENT_69	[p7l1266t303r1385b361],
19	pathway	NN	O	pathway	prep_in	16	SENT_69	[p7l1427t303r1595b378, p7l8t418r142b473],
20	,	,	O	,	_	0	SENT_69	[p7l1427t303r1595b378, p7l8t418r142b473],
21	is	VBZ	O	be	cop	24	SENT_69	[p7l173t399r222b456],
22	a	DT	O	a	det	24	SENT_69	[p7l250t418r283b456],
23	limitless	JJ	O	limitless	amod	24	SENT_69	[p7l308t398r583b457],
24	potential	NN	O	potential	_	0	SENT_69	[p7l610t398r900b473],
25	to	TO	O	to	_	0	SENT_69	[p7l927t410r987b457],
26	replicate7	NN	O	replicate7	nn	28	SENT_69	[p7l1015t398r1317b473],
27	(	CD	NUMBER	(	num	28	SENT_69	[p7l1349t399r1485b473],
28	Fig	NN	O	fig	prep_to	24	SENT_69	[p7l1349t399r1485b473],
29	.	.	O	.	_	0	SENT_69	[p7l1349t399r1485b473],

1	1	CD	NUMBER	1	_	0	SENT_70	[p7l1520t403r1592b466],
2	)	NN	O	)	dep	1	SENT_70	[p7l1520t403r1592b466],
3	.	.	O	.	_	0	SENT_70	[p7l1520t403r1592b466],

1	Thus	RB	O	thus	advmod	15	SENT_71	[p7l9t493r184b564],
2	,	,	O	,	_	0	SENT_71	[p7l9t493r184b564],
3	inhibition	NN	O	inhibition	nsubj	15	SENT_71	[p7l230t493r550b552],
4	of	IN	O	of	_	0	SENT_71	[p7l593t493r668b552],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_71	[p7l695t498r854b553],
6	signaling	NN	O	signaling	prep_of	3	SENT_71	[p7l893t493r1207b568],
7	,	,	O	,	_	0	SENT_71	[p7l893t493r1207b568],
8	the	DT	O	the	det	10	SENT_71	[p7l1255t493r1354b552],
9	poster	NN	O	poster	nn	10	SENT_71	[p7l1395t505r1598b568],
10	child	NN	O	child	appos	3	SENT_71	[p7l12t588r170b647],
11	for	IN	O	for	_	0	SENT_71	[p7l199t588r290b647],
12	personalized	JJ	O	personalized	amod	13	SENT_71	[p7l316t588r732b663],
13	medicine	NN	O	medicine	prep_for	10	SENT_71	[p7l761t588r1071b659],
14	,	,	O	,	_	0	SENT_71	[p7l761t588r1071b659],
15	presents	VBZ	O	present	_	0	SENT_71	[p7l1102t600r1370b663],
16	multiple	JJ	O	multiple	amod	17	SENT_71	[p7l1401t588r1595b647, p7l10t683r103b758],
17	opportunities	NNS	O	opportunity	dobj	15	SENT_71	[p7l136t684r573b758],
18	for	IN	O	for	_	0	SENT_71	[p7l607t683r699b742],
19	testing	VBG	O	test	prepc_for	15	SENT_71	[p7l730t684r952b758],
20	a	DT	O	a	det	21	SENT_71	[p7l982t703r1015b741],
21	wealth	NN	O	wealth	dobj	19	SENT_71	[p7l1042t683r1259b742],
22	of	IN	O	of	_	0	SENT_71	[p7l1292t683r1367b742],
23	targeted	VBN	O	target	amod	24	SENT_71	[p7l1386t695r1595b758, p7l12t778r84b837],
24	therapies	NNS	O	therapy	prep_of	21	SENT_71	[p7l116t778r425b853],
25	.	.	O	.	_	0	SENT_71	[p7l116t778r425b853],

1	The	DT	O	the	det	2	SENT_72	[p7l459t778r579b837],
2	pathway	NN	O	pathway	nsubjpass	4	SENT_72	[p7l610t778r880b853],
3	is	VBZ	O	be	auxpass	4	SENT_72	[p7l908t779r957b836],
4	deregulated	VBN	O	deregulate	_	0	SENT_72	[p7l992t778r1370b853],
5	in	IN	O	in	_	0	SENT_72	[p7l1402t779r1464b836],
6	the	DT	O	the	det	7	SENT_72	[p7l1496t778r1595b837],
7	majority	NN	O	majority	prep_in	4	SENT_72	[p7l11t874r281b948],
8	of	IN	O	of	_	0	SENT_72	[p7l307t873r382b932],
9	non	JJ	O	non	amod	15	SENT_72	[p7l398t873r878b932],
10	—	JJ	O	—	amod	15	SENT_72	[p7l398t873r878b932],
11	small	JJ	O	small	amod	15	SENT_72	[p7l398t873r878b932],
12	—	NN	O	—	nn	15	SENT_72	[p7l398t873r878b932],
13	cell	NN	O	cell	nn	15	SENT_72	[p7l398t873r878b932],
14	lung	NN	O	lung	nn	15	SENT_72	[p7l907t873r1051b948],
15	tumors	NNS	O	tumor	prep_of	7	SENT_72	[p7l1079t885r1308b932],
16	and	CC	O	and	_	0	SENT_72	[p7l1339t873r1457b932],
17	cell	NN	O	cell	nn	18	SENT_72	[p7l1487t873r1596b932],
18	lines	NNS	O	line	prep_of	7	SENT_72	[p7l10t968r211b1027],
19	.8	CD	NUMBER	.8	nsubj	29	SENT_72	[p7l10t968r211b1027],
20	In	IN	O	in	_	0	SENT_72	[p7l239t974r305b1026],
21	a	DT	DURATION	a	det	23	SENT_72	[p7l333t988r366b1026],
22	few	JJ	DURATION	few	amod	23	SENT_72	[p7l393t968r508b1027],
23	years	NNS	DURATION	year	prep_in	19	SENT_72	[p7l530t988r712b1043],
24	,	,	O	,	_	0	SENT_72	[p7l530t988r712b1043],
25	an	DT	O	a	det	26	SENT_72	[p7l744t987r820b1026],
26	oncologist	NN	O	oncologist	appos	23	SENT_72	[p7l849t968r1186b1043],
27	may	MD	O	may	aux	29	SENT_72	[p7l1210t987r1343b1043],
28	be	VB	O	be	cop	29	SENT_72	[p7l1369t968r1440b1027],
29	able	JJ	O	able	rcmod	15	SENT_72	[p7l1468t968r1595b1027],
30	to	TO	O	to	aux	31	SENT_72	[p7l12t1075r72b1122],
31	order	VB	O	order	xcomp	29	SENT_72	[p7l113t1063r283b1122],
32	a	DT	O	a	det	34	SENT_72	[p7l320t1083r353b1121],
33	molecular	JJ	O	molecular	amod	34	SENT_72	[p7l391t1063r715b1122],
34	analysis	NN	O	analysis	dobj	31	SENT_72	[p7l752t1063r1005b1138],
35	of	IN	O	of	_	0	SENT_72	[p7l1047t1063r1122b1122],
36	the	DT	O	the	det	37	SENT_72	[p7l1148t1063r1247b1122],
37	EGFR	NN	ORGANIZATION	egfr	prep_of	34	SENT_72	[p7l1285t1068r1444b1123],
38	and	CC	O	and	advmod	31	SENT_72	[p7l1478t1063r1596b1122],

1	N	NN	O	n	nn	3	SENT_73	[p7l538t1223r552b1238],
2	ENGLJ	NN	O	englj	nn	3	SENT_73	[p7l567t1223r644b1245],
3	MED	NN	O	med	_	0	SENT_73	[p7l659t1223r711b1238],
4	361	CD	NUMBER	361	dep	3	SENT_73	[p7l721t1217r799b1245],
5	;	:	O	;	_	0	SENT_73	[p7l721t1217r799b1245],
6	1o	CD	NUMBER	1o	num	8	SENT_73	[p7l721t1217r799b1245],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_73	[p7l834t1223r958b1245],
8	SEPTEMBER	NN	DATE	september	dep	4	SENT_73	[p7l993t1223r1132b1238],
9	3	CD	DATE	3	dep	8	SENT_73	[p7l1142t1223r1160b1245],
10	,	,	DATE	,	_	0	SENT_73	[p7l1142t1223r1160b1245],
11	2009	CD	DATE	2009	num	12	SENT_73	[p7l1172t1223r1236b1244],
12	1019	CD	DATE	1019	appos	8	SENT_73	[p7l1940t1213r2016b1236],

1	EDITORIAL	NN	O	editorial	_	0	SENT_74	[p7l991t1444r1168b1463],

1	other	JJ	O	other	amod	2	SENT_75	[p7l12t1657r240b1736],
2	pathways	NNS	O	pathway	nsubj	9	SENT_75	[p7l280t1657r679b1758],
3	in	IN	O	in	_	0	SENT_75	[p7l725t1658r809b1735],
4	the	DT	O	the	det	5	SENT_75	[p7l854t1657r986b1736],
5	patient	NN	O	patient	poss	8	SENT_75	[p7l1031t1658r1394b1758],
6	’s	POS	O	’s	_	0	SENT_75	[p7l1031t1658r1394b1758],
7	tumor	NN	O	tumor	nn	8	SENT_75	[p7l1441t1674r1709b1736],
8	cells	NNS	O	cell	prep_in	2	SENT_75	[p7l1751t1657r1938b1736],
9	(	VBP	O	(	_	0	SENT_75	[p7l1990t1658r2133b1748, p7l12t1785r335b1886],
10	including	VBG	O	include	_	0	SENT_75	[p7l1990t1658r2133b1748, p7l12t1785r335b1886],
11	key	JJ	O	key	amod	12	SENT_75	[p7l372t1785r516b1886],
12	mutations	NNS	O	mutation	prep_including	9	SENT_75	[p7l552t1786r1011b1881],
13	,	,	O	,	_	0	SENT_75	[p7l552t1786r1011b1881],
14	copy	NN	O	copy	nn	17	SENT_75	[p7l1058t1785r1623b1886],
15	—	NN	O	—	nn	17	SENT_75	[p7l1058t1785r1623b1886],
16	number	NN	O	number	nn	17	SENT_75	[p7l1058t1785r1623b1886],
17	changes	NNS	O	change	appos	12	SENT_75	[p7l1662t1785r2009b1886],
18	of	IN	O	of	_	0	SENT_75	[p7l2053t1785r2152b1864],
19	genes	NNS	O	gene	prep_of	17	SENT_75	[p7l12t1939r278b2014],
20	,	,	O	,	_	0	SENT_75	[p7l12t1939r278b2014],
21	and	CC	O	and	_	0	SENT_75	[p7l334t1913r492b1992],
22	expression	NN	O	expression	nsubj	27	SENT_75	[p7l544t1914r1000b2014],
23	and	CC	O	and	_	0	SENT_75	[p7l1051t1913r1209b1992],
24	activation	NN	O	activation	nsubj	27	SENT_75	[p7l1259t1914r1676b1992],
25	of	IN	O	of	_	0	SENT_75	[p7l1729t1913r1829b1992],
26	genes	NNS	O	gene	prep_of	22	SENT_75	[p7l1861t1920r2129b2014],
27	)	VBP	O	)	conj_and	9	SENT_75	[p7l1861t1920r2129b2014],
28	for	IN	O	for	_	0	SENT_75	[p7l12t2041r135b2120],
29	a	DT	O	a	det	31	SENT_75	[p7l168t2068r212b2120],
30	modest	JJ	O	modest	amod	31	SENT_75	[p7l247t2041r566b2120],
31	cost	NN	O	cost	prep_for	27	SENT_75	[p7l598t2058r794b2120],
32	.	.	O	.	_	0	SENT_75	[p7l598t2058r794b2120],

1	It	PRP	O	it	nsubj	4	SENT_76	[p7l834t2049r899b2120],
2	may	MD	O	may	aux	4	SENT_76	[p7l930t2067r1109b2142],
3	be	VB	O	be	cop	4	SENT_76	[p7l1142t2041r1238b2120],
4	possible	JJ	O	possible	dep	21	SENT_76	[p7l1274t2041r1624b2142],
5	to	TO	O	to	aux	6	SENT_76	[p7l1662t2058r1743b2120],
6	perform	VB	O	perform	xcomp	4	SENT_76	[p7l1779t2041r2134b2142],
7	such	JJ	O	such	amod	8	SENT_76	[p7l13t2169r204b2248],
8	assays	NNS	O	assay	dobj	6	SENT_76	[p7l240t2196r500b2270],
9	without	IN	O	without	_	0	SENT_76	[p7l533t2169r866b2248],
10	the	DT	O	the	det	11	SENT_76	[p7l898t2169r1029b2248],
11	necessity	NN	O	necessity	prep_without	6	SENT_76	[p7l1066t2170r1447b2270],
12	of	IN	O	of	_	0	SENT_76	[p7l1480t2169r1578b2248],
13	invasive	JJ	O	invasive	amod	14	SENT_76	[p7l1596t2170r1923b2248],
14	procedures	NNS	O	procedure	prep_of	11	SENT_76	[p7l1957t2195r2133b2270, p7l12t2297r401b2376],
15	.9	CD	NUMBER	.9	num	17	SENT_76	[p7l1957t2195r2133b2270, p7l12t2297r401b2376],
16	Individualized	JJ	O	individualized	amod	17	SENT_76	[p7l449t2297r1070b2376],
17	therapy	NN	O	therapy	nsubjpass	21	SENT_76	[p7l1120t2297r1441b2398],
18	would	MD	O	would	aux	21	SENT_76	[p7l1481t2297r1747b2376],
19	then	RB	O	then	advmod	21	SENT_76	[p7l1797t2297r1987b2376],
20	be	VB	O	be	auxpass	21	SENT_76	[p7l2037t2297r2134b2376],
21	selected	VBN	O	select	_	0	SENT_76	[p7l13t2425r353b2504],
22	from	IN	O	from	_	0	SENT_76	[p7l388t2425r598b2504],
23	a	DT	O	a	det	24	SENT_76	[p7l634t2452r678b2504],
24	battery	NN	O	battery	prep_from	21	SENT_76	[p7l712t2425r1014b2526],
25	of	IN	O	of	_	0	SENT_76	[p7l1046t2425r1146b2504],
26	highly	RB	O	highly	advmod	27	SENT_76	[p7l1163t2425r1435b2526],
27	active	JJ	O	active	amod	28	SENT_76	[p7l1466t2426r1706b2504],
28	therapies	NNS	O	therapy	prep_of	24	SENT_76	[p7l1743t2425r2132b2526],
29	after	IN	O	after	_	0	SENT_76	[p7l11t2553r213b2632],
30	integrating	VBG	O	integrate	prepc_after	21	SENT_76	[p7l249t2554r733b2654],
31	the	DT	O	the	det	35	SENT_76	[p7l770t2553r903b2632],
32	genomic	JJ	O	genomic	amod	35	SENT_76	[p7l943t2554r1312b2654],
33	or	CC	O	or	_	0	SENT_76	[p7l1352t2579r1441b2632],
34	proteomic	JJ	O	proteomic	conj_or	32	SENT_76	[p7l1476t2554r1917b2654],
35	profile	NN	O	profile	dobj	30	SENT_76	[p7l1955t2579r2133b2654, p7l12t2681r151b2760],
36	with	IN	O	with	_	0	SENT_76	[p7l187t2681r383b2761],
37	clinical	JJ	O	clinical	amod	40	SENT_76	[p7l423t2681r737b2760],
38	and	CC	O	and	_	0	SENT_76	[p7l776t2681r933b2760],
39	demographic	JJ	O	demographic	amod	40	SENT_76	[p7l974t2681r1541b2782],
40	data	NNS	O	datum	prep_with	35	SENT_76	[p7l1582t2681r1787b2760],
41	.	.	O	.	_	0	SENT_76	[p7l1582t2681r1787b2760],

1	Targeting	NN	O	targeting	nsubj	7	SENT_77	[p7l1829t2687r2133b2782, p7l11t2810r151b2910],
2	of	IN	O	of	_	0	SENT_77	[p7l183t2809r283b2888],
3	the	DT	O	the	det	5	SENT_77	[p7l300t2809r433b2888],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_77	[p7l466t2816r678b2889],
5	pathway	NN	O	pathway	prep_of	1	SENT_77	[p7l705t2809r1066b2910],
6	may	MD	O	may	aux	7	SENT_77	[p7l1097t2835r1275b2910],
7	have	VB	O	have	_	0	SENT_77	[p7l1306t2809r1495b2888],
8	the	DT	O	the	det	10	SENT_77	[p7l1531t2809r1663b2888],
9	additional	JJ	O	additional	amod	10	SENT_77	[p7l1698t2809r2135b2888],
10	benefit	NN	O	benefit	dobj	7	SENT_77	[p7l12t2937r318b3016],
11	of	IN	O	of	_	0	SENT_77	[p7l358t2937r458b3016],
12	overcoming	VBG	O	overcome	prepc_of	10	SENT_77	[p7l486t2938r994b3038],
13	the	DT	O	the	det	14	SENT_77	[p7l1036t2937r1169b3016],
14	radioresistance	NN	O	radioresistance	dobj	12	SENT_77	[p7l1215t2937r1867b3016],
15	associated	VBN	O	associate	partmod	14	SENT_77	[p7l1912t2963r2133b3016, p7l12t3065r265b3144],
16	with	IN	O	with	_	0	SENT_77	[p7l306t3065r501b3144],
17	increased	VBN	O	increase	amod	19	SENT_77	[p7l547t3065r955b3144],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_77	[p7l1000t3072r1213b3145],
19	expression	NN	O	expression	prep_with	15	SENT_77	[p7l1253t3066r1733b3166],
20	,	,	O	,	_	0	SENT_77	[p7l1253t3066r1733b3166],
21	whereas	IN	O	whereas	mark	24	SENT_77	[p7l1780t3065r2132b3144],
22	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_77	[p7l10t3200r223b3273],
23	mutations	NNS	O	mutation	nsubj	24	SENT_77	[p7l253t3194r688b3272],
24	abrogate	VBP	O	abrogate	advcl	7	SENT_77	[p7l727t3193r1098b3294],
25	such	JJ	O	such	amod	27	SENT_77	[p7l1137t3193r1331b3272],
26	radioprotection	NN	O	radioprotection	nn	27	SENT_77	[p7l1368t3193r2134b3294],
27	.1	NN	NUMBER	.1	dobj	24	SENT_77	[p7l1368t3193r2134b3294],
28	°	CD	NUMBER	°	num	30	SENT_77	[p7l1368t3193r2134b3294],
29	Therapeutic	JJ	O	therapeutic	amod	30	SENT_77	[p7l137t3321r651b3422],
30	applications	NNS	O	application	nsubj	33	SENT_77	[p7l701t3321r1221b3422],
31	of	IN	O	of	_	0	SENT_77	[p7l1276t3321r1376b3400],
32	radiotherapy	NN	O	radiotherapy	prep_of	30	SENT_77	[p7l1408t3321r1955b3422],
33	began	VBD	O	begin	rcmod	27	SENT_77	[p7l2003t3321r2133b3400, p7l12t3475r170b3550],
34	shortly	RB	O	shortly	advmod	33	SENT_77	[p7l216t3449r515b3550],
35	after	IN	O	after	_	0	SENT_77	[p7l555t3449r757b3528],
36	Wilhelm	NNP	PERSON	Wilhelm	nn	37	SENT_77	[p7l796t3449r1169b3528],
37	Roentgen	NNP	PERSON	Roentgen	poss	39	SENT_77	[p7l1213t3455r1687b3550],
38	’s	POS	O	’s	_	0	SENT_77	[p7l1213t3455r1687b3550],
39	discovery	NN	O	discovery	prep_after	33	SENT_77	[p7l1735t3449r2138b3550],
40	of	IN	O	of	_	0	SENT_77	[p7l12t3577r113b3656],
41	x	CC	O	x	_	0	SENT_77	[p7l139t3604r383b3678],
42	—	CD	NUMBER	—	num	43	SENT_77	[p7l139t3604r383b3678],
43	rays	NNS	O	ray	prep_of	39	SENT_77	[p7l139t3604r383b3678],
44	in	IN	O	in	_	0	SENT_77	[p7l432t3578r515b3655],
45	1895	CD	DATE	1895	prep_in	43	SENT_77	[p7l567t3583r786b3673],
46	,	,	O	,	_	0	SENT_77	[p7l567t3583r786b3673],
47	and	CC	O	and	_	0	SENT_77	[p7l839t3577r997b3656],
48	the	DT	O	the	det	49	SENT_77	[p7l1045t3577r1177b3656],
49	realization	NN	O	realization	prep_of	39	SENT_77	[p7l1226t3577r1688b3656],
50	that	WDT	O	that	dobj	54	SENT_77	[p7l1736t3577r1909b3656],
51	cancers	NNS	O	cancer	nsubjpass	54	SENT_77	[p7l1952t3603r2133b3656, p7l12t3731r182b3784],
52	could	MD	O	could	aux	54	SENT_77	[p7l230t3705r469b3784],
53	be	VB	O	be	auxpass	54	SENT_77	[p7l515t3705r612b3784],
54	treated	VBN	O	treat	dep	49	SENT_77	[p7l658t3705r963b3784],
55	by	IN	O	by	_	0	SENT_77	[p7l1009t3705r1107b3806],
56	pharmacologic	JJ	O	pharmacologic	amod	58	SENT_77	[p7l1147t3705r1807b3806],
57	agents	NNS	O	agent	nn	58	SENT_77	[p7l1851t3722r2132b3806],
58	dates	NNS	O	date	agent	54	SENT_77	[p8l12t20r237b99],
59	back	RB	O	back	advmod	54	SENT_77	[p8l282t20r484b100],
60	to	TO	O	to	_	0	SENT_77	[p8l522t37r604b99],
61	the	DT	DATE	the	det	62	SENT_77	[p8l648t20r782b99],
62	1940s	NNS	DATE	1940	prep_to	59	SENT_77	[p8l827t26r1104b99],
63	.	.	O	.	_	0	SENT_77	[p8l827t26r1104b99],

1	By	IN	O	by	_	0	SENT_78	[p8l1150t27r1255b121],
2	contrast	NN	O	contrast	prep_by	6	SENT_78	[p8l1293t37r1674b116],
3	,	,	O	,	_	0	SENT_78	[p8l1293t37r1674b116],
4	personalized	JJ	O	personalized	amod	5	SENT_78	[p8l1720t20r2133b121, p8l11t148r192b227],
5	medicine	NN	O	medicine	nsubj	6	SENT_78	[p8l239t148r630b227],
6	is	VBZ	O	be	_	0	SENT_78	[p8l676t149r742b227],
7	still	RB	O	still	advmod	6	SENT_78	[p8l792t148r954b227],
8	in	IN	O	in	_	0	SENT_78	[p8l998t149r1082b226],
9	its	PRP$	O	its	poss	10	SENT_78	[p8l1127t149r1225b227],
10	infancy	NN	O	infancy	prep_in	6	SENT_78	[p8l1273t148r1607b249],
11	.	.	O	.	_	0	SENT_78	[p8l1273t148r1607b249],

1	Clearly	RB	O	clearly	advmod	4	SENT_79	[p8l1659t148r1969b249],
2	,	,	O	,	_	0	SENT_79	[p8l1659t148r1969b249],
3	we	PRP	O	we	nsubj	4	SENT_79	[p8l2016t175r2134b228],
4	have	VBP	O	have	_	0	SENT_79	[p8l12t276r202b355],
5	to	TO	O	to	aux	6	SENT_79	[p8l240t293r322b355],
6	develop	VB	O	develop	xcomp	4	SENT_79	[p8l362t276r684b377],
7	better	JJR	O	better	amod	8	SENT_79	[p8l724t276r977b355],
8	drugs	NNS	O	drug	dobj	6	SENT_79	[p8l1012t276r1280b377],
9	,	,	O	,	_	0	SENT_79	[p8l1012t276r1280b377],
10	learn	VB	O	learn	conj_and	6	SENT_79	[p8l1323t276r1541b355],
11	how	WRB	O	how	advmod	13	SENT_79	[p8l1579t276r1764b355],
12	to	TO	O	to	aux	13	SENT_79	[p8l1798t293r1880b355],
13	combine	VB	O	combine	ccomp	10	SENT_79	[p8l1920t302r2133b355, p8l12t404r197b483],
14	individual	JJ	O	individual	dobj	13	SENT_79	[p8l250t404r691b484],
15	targeted	VBN	O	target	partmod	14	SENT_79	[p8l743t404r1106b505],
16	therapies	NNS	O	therapy	dobj	15	SENT_79	[p8l1160t404r1557b505],
17	with	IN	O	with	_	0	SENT_79	[p8l1608t404r1806b483],
18	others	NNS	O	other	prep_with	15	SENT_79	[p8l1860t404r2133b483],
19	and	CC	O	and	_	0	SENT_79	[p8l11t532r171b611],
20	with	IN	O	with	_	0	SENT_79	[p8l216t532r411b612],
21	cytotoxic	JJ	O	cytotoxic	amod	22	SENT_79	[p8l459t533r847b633],
22	agents	NNS	O	agent	conj_and	18	SENT_79	[p8l893t549r1193b633],
23	,	,	O	,	_	0	SENT_79	[p8l893t549r1193b633],
24	and	CC	O	and	_	0	SENT_79	[p8l1245t532r1403b611],
25	overcome	VB	O	overcome	conj_and	6	SENT_79	[p8l1451t558r1858b611],
26	resistance	NN	O	resistance	dobj	25	SENT_79	[p8l1906t533r2133b611, p8l12t677r264b739],
27	.	.	O	.	_	0	SENT_79	[p8l1906t533r2133b611, p8l12t677r264b739],

1	However	RB	O	however	advmod	26	SENT_80	[p8l312t668r706b756],
2	,	,	O	,	_	0	SENT_80	[p8l312t668r706b756],
3	the	DT	O	the	det	4	SENT_80	[p8l755t660r888b739],
4	plethora	NN	O	plethora	nsubj	26	SENT_80	[p8l929t660r1289b761],
5	of	IN	O	of	_	0	SENT_80	[p8l1330t660r1430b739],
6	targets	NNS	O	target	prep_of	4	SENT_80	[p8l1455t677r1750b761],
7	that	WDT	O	that	nsubjpass	9	SENT_80	[p8l1796t660r1968b739],
8	are	VBP	O	be	auxpass	9	SENT_80	[p8l2005t686r2134b739],
9	presented	VBN	O	present	rcmod	6	SENT_80	[p8l11t788r429b889],
10	by	IN	O	by	_	0	SENT_80	[p8l474t788r571b889],
11	cancer	NN	O	cancer	nn	12	SENT_80	[p8l610t814r891b867],
12	cells	NNS	O	cell	agent	9	SENT_80	[p8l932t788r1119b867],
13	and	CC	O	and	_	0	SENT_80	[p8l1164t788r1322b867],
14	the	DT	O	the	det	16	SENT_80	[p8l1366t788r1498b867],
15	large	JJ	O	large	amod	16	SENT_80	[p8l1542t788r1755b889],
16	number	NN	O	number	conj_and	6	SENT_80	[p8l1800t788r2137b867],
17	of	IN	O	of	_	0	SENT_80	[p8l12t916r113b995],
18	agents	NNS	O	agent	prep_of	16	SENT_80	[p8l132t933r407b1017],
19	currently	RB	DATE	currently	advmod	20	SENT_80	[p8l448t916r838b1017],
20	in	IN	O	in	dep	16	SENT_80	[p8l870t917r953b994],
21	clinical	JJ	O	clinical	amod	22	SENT_80	[p8l992t916r1305b995],
22	trials	NNS	O	trial	pobj	20	SENT_80	[p8l1343t916r1562b995],
23	or	CC	O	or	_	0	SENT_80	[p8l1603t942r1692b995],
24	being	VBG	O	be	auxpass	25	SENT_80	[p8l1727t916r1968b1017],
25	developed	VBN	O	develop	dep	16	SENT_80	[p8l2003t916r2133b995, p8l7t1044r336b1145],
26	offer	VBP	O	offer	_	0	SENT_80	[p8l380t1044r586b1123],
27	the	DT	O	the	det	28	SENT_80	[p8l626t1044r759b1123],
28	promise	NN	O	promise	dobj	26	SENT_80	[p8l801t1045r1152b1145],
29	of	IN	O	of	_	0	SENT_80	[p8l1196t1044r1296b1123],
30	a	DT	O	a	det	32	SENT_80	[p8l1320t1071r1365b1123],
31	bright	JJ	O	bright	amod	32	SENT_80	[p8l1407t1044r1671b1145],
32	future	NN	DATE	future	prep_of	28	SENT_80	[p8l1708t1044r1971b1123],
33	for	IN	O	for	_	0	SENT_80	[p8l2014t1044r2138b1123],
34	cancer	NN	O	cancer	nn	35	SENT_80	[p8l12t1198r293b1251],
35	therapy	NN	O	therapy	prep_for	32	SENT_80	[p8l328t1172r663b1273],
36	.	.	O	.	_	0	SENT_80	[p8l328t1172r663b1273],

1	Dr.	NNP	O	Dr.	nn	2	SENT_81	[p8l96t1326r194b1380],
2	Gazdar	NNP	PERSON	Gazdar	nsubj	3	SENT_81	[p8l219t1321r454b1380],
3	reports	VBZ	O	report	_	0	SENT_81	[p8l471t1334r700b1396],
4	receiving	VBG	O	receive	xcomp	3	SENT_81	[p8l722t1322r1015b1397],
5	consulting	NN	O	consulting	nn	6	SENT_81	[p8l1032t1321r1378b1397],
6	fees	NNS	O	fee	dobj	4	SENT_81	[p8l1395t1321r1519b1379],
7	from	IN	O	from	_	0	SENT_81	[p8l1540t1321r1698b1380],
8	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	4	SENT_81	[p8l1715t1326r2130b1392],
9	,	,	O	,	_	0	SENT_81	[p8l1715t1326r2130b1392],
10	Genentech	NNP	ORGANIZATION	Genentech	conj_and	8	SENT_81	[p8l11t1406r379b1477],
11	,	,	O	,	_	0	SENT_81	[p8l11t1406r379b1477],
12	and	CC	O	and	_	0	SENT_81	[p8l414t1406r533b1465],
13	Boehringer	NNP	PERSON	Boehringer	nn	14	SENT_81	[p8l564t1406r930b1482],
14	Ingelheim	NNP	PERSON	Ingelheim	prep_from	4	SENT_81	[p8l959t1406r1308b1482],
15	.	.	O	.	_	0	SENT_81	[p8l959t1406r1308b1482],

1	No	DT	O	no	det	4	SENT_82	[p8l1343t1411r1439b1465],
2	other	JJ	O	other	amod	4	SENT_82	[p8l1472t1406r1644b1465],
3	potential	JJ	O	potential	amod	4	SENT_82	[p8l1672t1406r1960b1481],
4	conﬂict	NN	O	conﬂict	nsubjpass	12	SENT_82	[p8l1993t1425r2134b1465, p8l11t1493r138b1552],
5	of	IN	O	of	_	0	SENT_82	[p8l162t1493r238b1552],
6	interest	NN	O	interest	prep_of	4	SENT_82	[p8l250t1494r496b1552],
7	relevant	JJ	O	relevant	amod	6	SENT_82	[p8l519t1493r776b1553],
8	to	TO	O	to	_	0	SENT_82	[p8l800t1506r860b1552],
9	this	DT	O	this	det	10	SENT_82	[p8l888t1493r1004b1552],
10	article	NN	O	article	prep_to	7	SENT_82	[p8l1032t1493r1230b1552],
11	was	VBD	O	be	auxpass	12	SENT_82	[p8l1254t1513r1376b1553],
12	reported	VBN	O	report	_	0	SENT_82	[p8l1405t1493r1697b1568],
13	.	.	O	.	_	0	SENT_82	[p8l1405t1493r1697b1568],

1	This	DT	O	this	det	2	SENT_83	[p8l7t1591r149b1652],
2	article	NN	O	article	nsubjpass	9	SENT_83	[p8l174t1591r380b1652],
3	(	CD	NUMBER	(	number	4	SENT_83	[p8l410t1595r1273b1671],
4	10.1056	CD	NUMBER	10.1056	num	2	SENT_83	[p8l410t1595r1273b1671],
5	/	:	O	/	punct	7	SENT_83	[p8l410t1595r1273b1671],
6	NEJMe0905763	NN	O	nejme0905763	nn	7	SENT_83	[p8l410t1595r1273b1671],
7	)	NN	O	)	dep	2	SENT_83	[p8l410t1595r1273b1671],
8	was	VBD	O	be	auxpass	9	SENT_83	[p8l1300t1612r1425b1652],
9	published	VBN	O	publish	_	0	SENT_83	[p8l1453t1591r1779b1671],
10	on	IN	O	on	_	0	SENT_83	[p8l1806t1612r1884b1652],
11	August	NNP	DATE	August	prep_on	9	SENT_83	[p8l1908t1595r2150b1672],
12	19	CD	DATE	19	num	11	SENT_83	[p8l15t1695r102b1762],
13	,	,	DATE	,	_	0	SENT_83	[p8l15t1695r102b1762],
14	2009	CD	DATE	2009	num	11	SENT_83	[p8l129t1694r310b1762],
15	,	,	O	,	_	0	SENT_83	[p8l129t1694r310b1762],
16	at	IN	O	at	_	0	SENT_83	[p8l338t1702r398b1751],
17	NEJM.org	NN	O	nejm.org	prep_at	9	SENT_83	[p8l427t1695r769b1771],
18	.	.	O	.	_	0	SENT_83	[p8l427t1695r769b1771],

1	From	IN	O	from	dep	21	SENT_84	[p8l16t1901r183b1957],
2	the	DT	O	the	det	4	SENT_84	[p8l217t1895r323b1957],
3	Hamon	NNP	ORGANIZATION	Hamon	nn	4	SENT_84	[p8l362t1901r608b1957],
4	Center	NNP	ORGANIZATION	Center	pobj	1	SENT_84	[p8l645t1900r869b1957],
5	for	IN	ORGANIZATION	for	_	0	SENT_84	[p8l898t1895r992b1957],
6	Therapeutic	JJ	ORGANIZATION	therapeutic	amod	8	SENT_84	[p8l1021t1895r1430b1975],
7	Oncology	NNP	ORGANIZATION	Oncology	nn	8	SENT_84	[p8l1463t1895r1790b1976],
8	Research	NNP	ORGANIZATION	Research	prep_for	4	SENT_84	[p8l1828t1895r2146b1967],
9	,	,	O	,	_	0	SENT_84	[p8l1828t1895r2146b1967],
10	Simmons	NNP	ORGANIZATION	Simmons	nn	12	SENT_84	[p8l11t1997r331b2054],
11	Cancer	NNP	ORGANIZATION	Cancer	nn	12	SENT_84	[p8l375t1997r609b2054],
12	Center	NNP	ORGANIZATION	Center	prep_for	4	SENT_84	[p8l648t1997r883b2064],
13	,	,	O	,	_	0	SENT_84	[p8l648t1997r883b2064],
14	and	CC	O	and	_	0	SENT_84	[p8l928t1992r1047b2054],
15	the	DT	O	the	det	16	SENT_84	[p8l1088t1992r1194b2054],
16	Department	NNP	ORGANIZATION	Department	prep_for	4	SENT_84	[p8l1240t1998r1651b2072],
17	of	IN	ORGANIZATION	of	_	0	SENT_84	[p8l1691t1992r1763b2054],
18	Pathology	NNP	ORGANIZATION	Pathology	prep_of	16	SENT_84	[p8l1798t1992r2146b2073],
19	,	,	O	,	_	0	SENT_84	[p8l1798t1992r2146b2073],
20	University	NNP	ORGANIZATION	University	nn	21	SENT_84	[p8l15t2095r353b2170],
21	ofTexas	NNP	ORGANIZATION	ofTexas	_	0	SENT_84	[p8l376t2089r643b2151],
22	Southwestern	NNP	ORGANIZATION	Southwestern	nn	24	SENT_84	[p8l671t2089r1136b2151],
23	Medical	NNP	ORGANIZATION	Medical	nn	24	SENT_84	[p8l1170t2089r1429b2151],
24	Center	NNP	ORGANIZATION	Center	dep	21	SENT_84	[p8l1457t2094r1693b2161],
25	,	,	O	,	_	0	SENT_84	[p8l1457t2094r1693b2161],
26	Dallas	NNP	LOCATION	Dallas	dep	21	SENT_84	[p8l1726t2089r1948b2151],
27	.	.	O	.	_	0	SENT_84	[p8l1726t2089r1948b2151],

1	1	LS	NUMBER	1	_	0	SENT_85	[p8l12t2304r62b2355],
2	.	.	O	.	_	0	SENT_85	[p8l12t2304r62b2355],

1	Sharma	FW	PERSON	sharma	nn	2	SENT_86	[p8l142t2297r395b2356],
2	SV	FW	O	sv	dep	5	SENT_86	[p8l440t2301r532b2368],
3	,	,	O	,	_	0	SENT_86	[p8l440t2301r532b2368],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_86	[p8l580t2297r706b2355],
5	DW	NNP	ORGANIZATION	DW	_	0	SENT_86	[p8l750t2302r883b2368],
6	,	,	O	,	_	0	SENT_86	[p8l750t2302r883b2368],
7	Settleman	NNP	O	Settleman	nn	8	SENT_86	[p8l935t2297r1267b2356],
8	J	NNP	O	J	appos	5	SENT_86	[p8l1304t2302r1348b2368],
9	,	,	O	,	_	0	SENT_86	[p8l1304t2302r1348b2368],
10	Haber	NNP	O	Haber	nn	11	SENT_86	[p8l1397t2297r1601b2356],
11	DA	NNP	O	DA	appos	5	SENT_86	[p8l1642t2302r1760b2356],
12	.	.	O	.	_	0	SENT_86	[p8l1642t2302r1760b2356],

1	Epidermal	JJ	O	epidermal	amod	5	SENT_87	[p8l1808t2297r2151b2372],
2	growth	NN	O	growth	nn	5	SENT_87	[p8l9t2393r251b2469],
3	factor	NN	O	factor	nn	5	SENT_87	[p8l273t2392r466b2452],
4	receptor	NN	O	receptor	nn	5	SENT_87	[p8l486t2405r761b2469],
5	mutations	NNS	O	mutation	_	0	SENT_87	[p8l780t2394r1116b2453],
6	in	IN	O	in	_	0	SENT_87	[p8l1138t2394r1202b2452],
7	lung	NN	O	lung	nn	8	SENT_87	[p8l1223t2393r1372b2469],
8	cancer	NN	O	cancer	prep_in	5	SENT_87	[p8l1391t2413r1623b2452],
9	.	.	O	.	_	0	SENT_87	[p8l1391t2413r1623b2452],

1	Nat	NNP	O	Nat	nn	3	SENT_88	[p8l1647t2398r1766b2453],
2	Rev	NN	O	rev	nn	3	SENT_88	[p8l1782t2398r1903b2456],
3	Cancer	NN	O	cancer	_	0	SENT_88	[p8l1922t2397r2152b2452],
4	2007	CD	DATE	2007	dep	3	SENT_88	[p8l9t2494r480b2562],
5	;	:	O	;	_	0	SENT_88	[p8l9t2494r480b2562],
6	7:169	CD	NUMBER	7:169	num	7	SENT_88	[p8l9t2494r480b2562],
7	-81	CD	NUMBER	-81	dep	3	SENT_88	[p8l9t2494r480b2562],
8	.	.	O	.	_	0	SENT_88	[p8l9t2494r480b2562],

1	2	LS	NUMBER	2	_	0	SENT_89	[p8l8t2594r63b2645],
2	.	.	O	.	_	0	SENT_89	[p8l8t2594r63b2645],

1	Cappuzzo	NNP	PERSON	Cappuzzo	nn	2	SENT_90	[p8l139t2591r461b2662],
2	F	NN	O	f	_	0	SENT_90	[p8l484t2592r535b2658],
3	,	,	O	,	_	0	SENT_90	[p8l484t2592r535b2658],
4	Varella-Garcia	NNP	O	Varella-Garcia	nn	5	SENT_90	[p8l561t2587r1027b2646],
5	M	NNP	O	M	appos	2	SENT_90	[p8l1047t2592r1129b2658],
6	,	,	O	,	_	0	SENT_90	[p8l1047t2592r1129b2658],
7	Shigematsu	NNP	PERSON	Shigematsu	nn	8	SENT_90	[p8l1158t2587r1536b2662],
8	H	NNP	O	H	appos	2	SENT_90	[p8l1559t2592r1631b2658],
9	,	,	O	,	_	0	SENT_90	[p8l1559t2592r1631b2658],
10	et	FW	O	et	nn	11	SENT_90	[p8l1659t2600r1718b2645],
11	al.	FW	O	al.	appos	2	SENT_90	[p8l1737t2587r1810b2646],
12	.	.	O	.	_	0	SENT_90	[p8l1737t2587r1810b2646],

1	Increased	VBN	O	increase	amod	3	SENT_91	[p8l1837t2587r2150b2646],
2	HER2	NN	O	her2	nn	3	SENT_91	[p8l9t2687r201b2746],
3	gene	NN	O	gene	nsubjpass	7	SENT_91	[p8l224t2703r377b2759],
4	copy	NN	O	copy	nn	5	SENT_91	[p8l400t2703r552b2759],
5	number	NN	O	number	tmod	7	SENT_91	[p8l571t2683r830b2743],
6	is	VBZ	O	be	auxpass	7	SENT_91	[p8l850t2684r900b2742],
7	associated	VBN	O	associate	_	0	SENT_91	[p8l924t2683r1268b2742],
8	with	IN	O	with	_	0	SENT_91	[p8l1286t2683r1437b2744],
9	response	NN	O	response	prep_with	7	SENT_91	[p8l1459t2703r1753b2759],
10	to	TO	O	to	_	0	SENT_91	[p8l1776t2695r1837b2742],
11	gefitinib	NN	O	gefitinib	nn	12	SENT_91	[p8l1861t2682r2148b2759],
12	therapy	NN	O	therapy	prep_to	7	SENT_91	[p8l10t2780r258b2856],
13	in	IN	O	in	_	0	SENT_91	[p8l279t2781r343b2839],
14	epidermal	JJ	O	epidermal	amod	16	SENT_91	[p8l368t2780r701b2856],
15	growth	NN	O	growth	nn	16	SENT_91	[p8l725t2780r967b2856],
16	factor	NN	O	factor	prep_in	12	SENT_91	[p8l992t2779r1185b2839],
17	receptor-positive	JJ	O	receptor-positive	amod	21	SENT_91	[p8l1208t2781r1763b2856],
18	nonsmallcell	JJ	O	nonsmallcell	amod	21	SENT_91	[p8l1788t2780r2149b2839, p8l11t2877r123b2935],
19	lung	NN	O	lung	nn	21	SENT_91	[p8l147t2877r297b2952],
20	cancer	NN	O	cancer	nn	21	SENT_91	[p8l320t2896r537b2935],
21	patients	NNS	O	patient	dep	16	SENT_91	[p8l560t2878r843b2952],
22	.	.	O	.	_	0	SENT_91	[p8l560t2878r843b2952],

1	J	NNP	O	J	nn	3	SENT_92	[p8l866t2882r895b2945],
2	Clin	NNP	O	Clin	nn	3	SENT_92	[p8l919t2877r1056b2936],
3	Oncol	NNP	O	Oncol	_	0	SENT_92	[p8l1082t2877r1277b2936],
4	2005	CD	DATE	2005	num	3	SENT_92	[p8l1303t2881r1859b2948],
5	;	:	O	;	_	0	SENT_92	[p8l1303t2881r1859b2948],
6	23:5007	CD	NUMBER	23:5007	number	7	SENT_92	[p8l1303t2881r1859b2948],
7	—	CD	NUMBER	—	dep	3	SENT_92	[p8l1303t2881r1859b2948],
8	18	CD	NUMBER	18	dep	7	SENT_92	[p8l1303t2881r1859b2948],
9	.	.	O	.	_	0	SENT_92	[p8l1303t2881r1859b2948],

1	3	LS	NUMBER	3	_	0	SENT_93	[p8l10t2980r60b3031],
2	.	.	O	.	_	0	SENT_93	[p8l10t2980r60b3031],

1	Shepherd	NNP	ORGANIZATION	Shepherd	nn	2	SENT_94	[p8l142t2973r448b3048],
2	FA	NNP	ORGANIZATION	FA	_	0	SENT_94	[p8l470t2978r573b3044],
3	,	,	O	,	_	0	SENT_94	[p8l470t2978r573b3044],
4	Rodrigues	NNP	PERSON	Rodrigues	nn	6	SENT_94	[p8l598t2973r939b3048],
5	Pereira	NNP	PERSON	Pereira	nn	6	SENT_94	[p8l962t2974r1193b3031],
6	J	NNP	PERSON	J	appos	2	SENT_94	[p8l1207t2978r1251b3044],
7	,	,	O	,	_	0	SENT_94	[p8l1207t2978r1251b3044],
8	Ciuleanu	NNP	O	Ciuleanu	nn	9	SENT_94	[p8l1278t2973r1571b3033],
9	T	NN	O	t	appos	2	SENT_94	[p8l1591t2977r1650b3044],
10	,	,	O	,	_	0	SENT_94	[p8l1591t2977r1650b3044],
11	et	FW	O	et	nn	12	SENT_94	[p8l1677t2985r1736b3031],
12	al.	FW	O	al.	appos	2	SENT_94	[p8l1755t2973r1830b3032],
13	.	.	O	.	_	0	SENT_94	[p8l1755t2973r1830b3032],

1	Erlotinib	NNP	O	Erlotinib	nsubj	4	SENT_95	[p8l1855t2973r2149b3032],
2	in	IN	O	in	prep	1	SENT_95	[p8l9t3069r73b3127],
3	previously	RB	DATE	previously	pcomp	2	SENT_95	[p8l104t3069r444b3144],
4	treated	VBN	O	treat	_	0	SENT_95	[p8l473t3069r704b3128],
5	non	JJ	O	non	amod	8	SENT_95	[p8l735t3069r1216b3128],
6	—	JJ	O	—	amod	8	SENT_95	[p8l735t3069r1216b3128],
7	small	JJ	O	small	amod	8	SENT_95	[p8l735t3069r1216b3128],
8	—	NN	O	—	tmod	4	SENT_95	[p8l735t3069r1216b3128],
9	cell	NN	O	cell	nn	11	SENT_95	[p8l735t3069r1216b3128],
10	lung	NN	O	lung	nn	11	SENT_95	[p8l1246t3069r1395b3144],
11	cancer	NN	O	cancer	dep	8	SENT_95	[p8l1425t3088r1656b3128],
12	.	.	O	.	_	0	SENT_95	[p8l1425t3088r1656b3128],

1	N	NN	O	n	nn	3	SENT_96	[p8l1691t3074r1748b3128],
2	Engl	NNP	O	Engl	nn	3	SENT_96	[p8l1777t3069r1979b3144],
3	]	NNP	O	]	nsubj	4	SENT_96	[p8l1777t3069r1979b3144],
4	Med	VBD	O	med	_	0	SENT_96	[p8l2007t3069r2150b3128],
5	2005	CD	DATE	2005	dobj	4	SENT_96	[p8l9t3169r569b3237],
6	;	:	O	;	_	0	SENT_96	[p8l9t3169r569b3237],
7	353:123	CD	NUMBER	353:123	num	8	SENT_96	[p8l9t3169r569b3237],
8	-32	CD	NUMBER	-32	dep	5	SENT_96	[p8l9t3169r569b3237],
9	.	.	O	.	_	0	SENT_96	[p8l9t3169r569b3237],

1	4	LS	NUMBER	4	_	0	SENT_97	[p8l8t3270r62b3321],
2	.	.	O	.	_	0	SENT_97	[p8l8t3270r62b3321],

1	Rosell	NNP	PERSON	Rosell	nn	2	SENT_98	[p8l138t3262r345b3325],
2	R	NNP	PERSON	R	_	0	SENT_98	[p8l369t3267r435b3334],
3	,	,	O	,	_	0	SENT_98	[p8l369t3267r435b3334],
4	Moran	NNP	PERSON	Moran	nn	5	SENT_98	[p8l463t3267r682b3321],
5	T	NN	O	t	appos	2	SENT_98	[p8l705t3266r764b3334],
6	,	,	O	,	_	0	SENT_98	[p8l705t3266r764b3334],
7	Queralt	NN	O	queralt	nn	8	SENT_98	[p8l793t3262r1043b3337],
8	C	NN	O	c	appos	2	SENT_98	[p8l1065t3266r1129b3334],
9	,	,	O	,	_	0	SENT_98	[p8l1065t3266r1129b3334],
10	et	FW	O	et	nn	11	SENT_98	[p8l1159t3275r1219b3321],
11	al.	FW	O	al.	appos	2	SENT_98	[p8l1240t3262r1315b3321],
12	.	.	O	.	_	0	SENT_98	[p8l1240t3262r1315b3321],

1	Screening	VBG	O	screen	_	0	SENT_99	[p8l1347t3263r1675b3338],
2	for	IN	O	for	_	0	SENT_99	[p8l1698t3261r1793b3321],
3	epidermal	JJ	O	epidermal	amod	7	SENT_99	[p8l1817t3262r2150b3338],
4	growth	NN	O	growth	nn	7	SENT_99	[p8l9t3359r251b3435],
5	factor	NN	O	factor	nn	7	SENT_99	[p8l281t3358r474b3418],
6	receptor	NN	O	receptor	nn	7	SENT_99	[p8l501t3371r776b3435],
7	mutations	NNS	O	mutation	prep_for	1	SENT_99	[p8l803t3360r1138b3419],
8	in	IN	O	in	_	0	SENT_99	[p8l1169t3360r1233b3418],
9	lung	NN	O	lung	nn	10	SENT_99	[p8l1261t3359r1410b3435],
10	cancer	NN	O	cancer	prep_in	7	SENT_99	[p8l1437t3379r1668b3418],
11	.	.	O	.	_	0	SENT_99	[p8l1437t3379r1668b3418],

1	N	NN	O	n	nn	3	SENT_100	[p8l1699t3364r1756b3419],
2	Engl	NNP	O	Engl	nn	3	SENT_100	[p8l1784t3359r1932b3435],
3	J	NNP	O	J	nsubj	4	SENT_100	[p8l1954t3364r1982b3428],
4	Med	VBD	O	med	_	0	SENT_100	[p8l2007t3359r2151b3418],
5	2009	CD	DATE	2009	dobj	4	SENT_100	[p8l9t3460r567b3528],
6	;	:	O	;	_	0	SENT_100	[p8l9t3460r567b3528],
7	361:958	CD	NUMBER	361:958	num	8	SENT_100	[p8l9t3460r567b3528],
8	-67	CD	NUMBER	-67	dep	5	SENT_100	[p8l9t3460r567b3528],
9	.	.	O	.	_	0	SENT_100	[p8l9t3460r567b3528],

1	5	CD	NUMBER	5	_	0	SENT_101	[p8l11t3561r60b3612],
2	.	.	O	.	_	0	SENT_101	[p8l11t3561r60b3612],

1	Mok	NN	O	mok	nn	2	SENT_102	[p8l137t3553r288b3613],
2	TS	NN	O	t	_	0	SENT_102	[p8l312t3557r414b3625],
3	,	,	O	,	_	0	SENT_102	[p8l312t3557r414b3625],
4	Wu	NNP	PERSON	Wu	nn	5	SENT_102	[p8l446t3558r557b3613],
5	Y-L	NNP	PERSON	Y-L	appos	2	SENT_102	[p8l585t3558r705b3625],
6	,	,	O	,	_	0	SENT_102	[p8l585t3558r705b3625],
7	Thongprasert	NNP	O	Thongprasert	nn	8	SENT_102	[p8l738t3553r1194b3629],
8	S	NNP	O	S	appos	2	SENT_102	[p8l1222t3557r1275b3625],
9	,	,	O	,	_	0	SENT_102	[p8l1222t3557r1275b3625],
10	et	FW	O	et	nn	11	SENT_102	[p8l1310t3565r1369b3612],
11	al.	FW	O	al.	appos	2	SENT_102	[p8l1395t3553r1471b3612],
12	.	.	O	.	_	0	SENT_102	[p8l1395t3553r1471b3612],

1	Gefitinib	NN	O	gefitinib	_	0	SENT_103	[p8l1505t3552r1809b3612],
2	or	CC	O	or	_	0	SENT_103	[p8l1841t3573r1909b3612],
3	carboplatin	NN	O	carboplatin	conj_or	1	SENT_103	[p8l1938t3553r2149b3612, p8l8t3650r565b3725],
4	—	CD	NUMBER	—	num	5	SENT_103	[p8l1938t3553r2149b3612, p8l8t3650r565b3725],
5	paclitaxel	NN	O	paclitaxel	dep	1	SENT_103	[p8l1938t3553r2149b3612, p8l8t3650r565b3725],
6	in	IN	O	in	_	0	SENT_103	[p8l596t3650r660b3708],
7	pulmonary	JJ	O	pulmonary	amod	8	SENT_103	[p8l691t3650r1060b3725],
8	adenocarcinoma	NN	O	adenocarcinoma	prep_in	5	SENT_103	[p8l1087t3650r1657b3709],
9	.	.	O	.	_	0	SENT_103	[p8l1087t3650r1657b3709],

1	N	NN	O	n	nn	3	SENT_104	[p8l1691t3655r1748b3709],
2	Engl	NNP	O	Engl	nn	3	SENT_104	[p8l1777t3650r1927b3725],
3	J	NNP	O	J	nsubj	4	SENT_104	[p8l1951t3655r1979b3718],
4	Med	VBD	O	med	_	0	SENT_104	[p8l2007t3650r2150b3709],

1	2009	CD	DATE	2009	_	0	SENT_105	[p9l9t19r559b87],
2	;	:	O	;	_	0	SENT_105	[p9l9t19r559b87],
3	361:947	CD	NUMBER	361:947	number	4	SENT_105	[p9l9t19r559b87],
4	-57	CD	NUMBER	-57	dep	1	SENT_105	[p9l9t19r559b87],
5	.	.	O	.	_	0	SENT_105	[p9l9t19r559b87],

1	6	CD	NUMBER	6	_	0	SENT_106	[p9l10t119r62b171],
2	.	.	O	.	_	0	SENT_106	[p9l10t119r62b171],

1	Shepherd	NNP	ORGANIZATION	Shepherd	nn	6	SENT_107	[p9l141t112r448b188],
2	FA	NNP	ORGANIZATION	FA	nn	6	SENT_107	[p9l470t117r572b184],
3	,	,	O	,	_	0	SENT_107	[p9l470t117r572b184],
4	Tsao	NNP	PERSON	Tsao	appos	6	SENT_107	[p9l596t116r748b171],
5	MS.	NNP	O	MS.	nn	6	SENT_107	[p9l770t116r891b171],
6	Unraveling	NNP	O	Unraveling	_	0	SENT_107	[p9l918t112r1283b188],
7	the	DT	O	the	det	8	SENT_107	[p9l1303t112r1405b171],
8	mystery	NN	O	mystery	dep	6	SENT_107	[p9l1427t124r1689b188],
9	of	IN	O	of	_	0	SENT_107	[p9l1708t111r1784b171],
10	prognostic	JJ	O	prognostic	amod	13	SENT_107	[p9l1791t113r2151b188],
11	and	CC	O	and	_	0	SENT_107	[p9l9t209r131b268],
12	predictive	JJ	O	predictive	conj_and	10	SENT_107	[p9l155t209r480b285],
13	factors	NNS	O	factor	prep_of	8	SENT_107	[p9l507t208r731b268],
14	in	IN	O	in	_	0	SENT_107	[p9l758t210r822b268],
15	epidermal	JJ	O	epidermal	amod	19	SENT_107	[p9l849t209r1182b285],
16	growth	NN	O	growth	nn	19	SENT_107	[p9l1208t209r1450b285],
17	factor	NN	O	factor	nn	19	SENT_107	[p9l1477t208r1670b268],
18	receptor	NN	O	receptor	nn	19	SENT_107	[p9l1694t222r1969b285],
19	therapy	NN	O	therapy	prep_in	6	SENT_107	[p9l1993t209r2149b268, p9l9t325r132b381],
20	.	.	O	.	_	0	SENT_107	[p9l1993t209r2149b268, p9l9t325r132b381],

1	J	NNP	O	J	nn	3	SENT_108	[p9l155t311r183b374],
2	Clin	NNP	O	Clin	nn	3	SENT_108	[p9l207t306r344b365],
3	Oncol	NNP	O	Oncol	_	0	SENT_108	[p9l370t306r565b365],
4	2006	CD	DATE	2006	num	3	SENT_108	[p9l591t310r1154b377],
5	;	:	O	;	_	0	SENT_108	[p9l591t310r1154b377],
6	24:1219	CD	NUMBER	24:1219	number	7	SENT_108	[p9l591t310r1154b377],
7	—	CD	NUMBER	—	dep	3	SENT_108	[p9l591t310r1154b377],
8	20	CD	NUMBER	20	dep	7	SENT_108	[p9l591t310r1154b377],
9	.	.	O	.	_	0	SENT_108	[p9l591t310r1154b377],

1	7	CD	NUMBER	7	_	0	SENT_109	[p9l11t410r55b461],
2	.	.	O	.	_	0	SENT_109	[p9l11t410r55b461],

1	Hanahan	NN	PERSON	hanahan	nn	2	SENT_110	[p9l139t402r446b461],
2	D	NN	O	d	_	0	SENT_110	[p9l484t407r552b474],
3	,	,	O	,	_	0	SENT_110	[p9l484t407r552b474],
4	Weinberg	NNP	PERSON	Weinberg	nn	5	SENT_110	[p9l592t402r914b478],
5	RA	NN	O	ra	appos	2	SENT_110	[p9l949t407r1068b465],
6	.	.	O	.	_	0	SENT_110	[p9l949t407r1068b465],

1	The	DT	O	the	det	2	SENT_111	[p9l1108t402r1231b461],
2	hallmarks	NNS	O	hallmark	_	0	SENT_111	[p9l1270t402r1606b462],
3	of	IN	O	of	_	0	SENT_111	[p9l1647t401r1724b461],
4	cancer	NN	O	cancer	prep_of	2	SENT_111	[p9l1749t422r1980b461],
5	.	.	O	.	_	0	SENT_111	[p9l1749t422r1980b461],

1	Cell	NN	O	cell	_	0	SENT_112	[p9l2023t402r2150b461],
2	2000	CD	DATE	2000	num	1	SENT_112	[p9l9t503r527b571],
3	;	:	O	;	_	0	SENT_112	[p9l9t503r527b571],
4	100:57	CD	NUMBER	100:57	number	5	SENT_112	[p9l9t503r527b571],
5	-70	CD	NUMBER	-70	dep	1	SENT_112	[p9l9t503r527b571],
6	.	.	O	.	_	0	SENT_112	[p9l9t503r527b571],

1	8	CD	NUMBER	8	_	0	SENT_113	[p9l9t602r62b656],
2	.	.	O	.	_	0	SENT_113	[p9l9t602r62b656],

1	Gandhi	NNP	PERSON	Gandhi	nn	2	SENT_114	[p9l139t596r388b655],
2	J	NNP	PERSON	J	_	0	SENT_114	[p9l413t601r457b668],
3	,	,	O	,	_	0	SENT_114	[p9l413t601r457b668],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_114	[p9l493t596r705b672],
5	J	NNP	PERSON	J	appos	2	SENT_114	[p9l728t601r772b668],
6	,	,	O	,	_	0	SENT_114	[p9l728t601r772b668],
7	Xie	NNP	O	Xie	nn	8	SENT_114	[p9l806t597r911b655],
8	Y	NN	O	y	appos	2	SENT_114	[p9l941t601r996b668],
9	,	,	O	,	_	0	SENT_114	[p9l941t601r996b668],
10	et	FW	O	et	nn	11	SENT_114	[p9l1034t609r1094b655],
11	al.	FW	O	al.	appos	2	SENT_114	[p9l1122t596r1198b655],
12	.	.	O	.	_	0	SENT_114	[p9l1122t596r1198b655],

1	Alterations	NNS	O	alteration	_	0	SENT_115	[p9l1232t596r1599b655],
2	in	IN	O	in	_	0	SENT_115	[p9l1634t597r1697b655],
3	genes	NNS	O	gene	prep_in	1	SENT_115	[p9l1730t616r1917b672],
4	of	IN	O	of	_	0	SENT_115	[p9l1952t595r2028b655],
5	the	DT	O	the	det	8	SENT_115	[p9l2048t596r2149b655],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_115	[p9l8t697r205b755],
7	signaling	NN	O	signaling	nn	8	SENT_115	[p9l220t693r532b768],
8	pathway	NN	O	pathway	prep_of	3	SENT_115	[p9l550t693r828b768],
9	and	CC	O	and	_	0	SENT_115	[p9l846t693r967b752],
10	their	PRP$	O	they	poss	11	SENT_115	[p9l989t693r1146b751],
11	relationship	NN	O	relationship	prep_of	3	SENT_115	[p9l1166t693r1564b768],
12	to	TO	O	to	_	0	SENT_115	[p9l1588t705r1650b752],
13	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_115	[p9l1672t697r1868b755],
14	tyrosine	NN	O	tyrosine	nn	17	SENT_115	[p9l1882t694r2150b768],
15	kinase	NN	O	kinase	nn	17	SENT_115	[p9l9t789r224b849],
16	inhibitor	NN	O	inhibitor	nn	17	SENT_115	[p9l256t789r552b848],
17	sensitivity	NN	O	sensitivity	prep_to	1	SENT_115	[p9l584t789r919b864],
18	in	IN	O	in	_	0	SENT_115	[p9l948t790r1012b847],
19	lung	NN	O	lung	nn	22	SENT_115	[p9l1043t789r1192b864],
20	cancer	NN	O	cancer	nn	22	SENT_115	[p9l1222t808r1439b847],
21	cell	NN	O	cell	nn	22	SENT_115	[p9l1469t789r1583b847],
22	lines	NNS	O	line	prep_in	17	SENT_115	[p9l1613t789r1789b848],
23	.	.	O	.	_	0	SENT_115	[p9l1613t789r1789b848],

1	PLoS	NNP	O	PLoS	_	0	SENT_116	[p9l1824t793r1984b848],
2	One	CD	NUMBER	one	num	1	SENT_116	[p9l2018t793r2149b848],
3	2009	CD	DATE	2009	dep	1	SENT_116	[p9l9t889r552b957],
4	;	:	O	;	_	0	SENT_116	[p9l9t889r552b957],
5	4	CD	NUMBER	4	num	6	SENT_116	[p9l9t889r552b957],
6	(	NN	O	(	dep	1	SENT_116	[p9l9t889r552b957],
7	2	CD	NUMBER	2	num	8	SENT_116	[p9l9t889r552b957],
8	)	NN	O	)	dep	6	SENT_116	[p9l9t889r552b957],
9	:	:	O	:	_	0	SENT_116	[p9l9t889r552b957],
10	e4576	NN	O	e4576	dep	6	SENT_116	[p9l9t889r552b957],
11	.	.	O	.	_	0	SENT_116	[p9l9t889r552b957],

1	9	CD	NUMBER	9	_	0	SENT_117	[p9l9t988r60b1040],
2	.	.	O	.	_	0	SENT_117	[p9l9t988r60b1040],

1	Sequist	NNP	O	Sequist	nn	2	SENT_118	[p9l142t982r382b1057],
2	LV	NNP	O	LV	_	0	SENT_118	[p9l406t987r497b1053],
3	,	,	O	,	_	0	SENT_118	[p9l406t987r497b1053],
4	Engelman	NNP	ORGANIZATION	Engelman	nn	5	SENT_118	[p9l529t982r865b1057],
5	IA	NNP	ORGANIZATION	IA	appos	2	SENT_118	[p9l887t987r981b1053],
6	,	,	O	,	_	0	SENT_118	[p9l887t987r981b1053],
7	Lynch	NNP	PERSON	Lynch	nn	9	SENT_118	[p9l1013t982r1209b1057],
8	T	NN	O	t	nn	9	SENT_118	[p9l1235t986r1322b1050],
9	]	NN	O	]	appos	5	SENT_118	[p9l1235t986r1322b1050],
10	.	.	O	.	_	0	SENT_118	[p9l1235t986r1322b1050],

1	Toward	IN	O	toward	_	0	SENT_119	[p9l1352t982r1601b1042],
2	noninvasive	JJ	O	noninvasive	amod	6	SENT_119	[p9l1630t982r2019b1042],
3	ge	NN	O	ge	nn	6	SENT_119	[p9l2049t1001r2149b1057],
4	—	NN	O	—	nn	6	SENT_119	[p9l2049t1001r2149b1057],
5	nomic	JJ	O	nomic	amod	6	SENT_119	[p9l10t1079r216b1137],
6	screening	NN	O	screening	pobj	1	SENT_119	[p9l247t1079r570b1154],
7	of	IN	O	of	_	0	SENT_119	[p9l598t1077r675b1137],
8	lung	NN	O	lung	nn	10	SENT_119	[p9l691t1078r839b1154],
9	cancer	NN	O	cancer	nn	10	SENT_119	[p9l868t1098r1085b1137],
10	patients	NNS	O	patient	prep_of	6	SENT_119	[p9l1112t1079r1395b1154],
11	.	.	O	.	_	0	SENT_119	[p9l1112t1079r1395b1154],

1	J	NNP	O	J	nn	3	SENT_120	[p9l1422t1083r1451b1147],
2	Clin	NNP	O	Clin	nn	3	SENT_120	[p9l1480t1078r1616b1137],
3	Oncol	NNP	O	Oncol	_	0	SENT_120	[p9l1646t1078r1842b1137],
4	2009	CD	DATE	2009	num	3	SENT_120	[p9l1872t1082r2147b1150],
5	;	:	O	;	_	0	SENT_120	[p9l1872t1082r2147b1150],
6	27	CD	NUMBER	27	num	8	SENT_120	[p9l1872t1082r2147b1150],
7	:	:	O	:	_	0	SENT_120	[p9l1872t1082r2147b1150],
8	2589-91	CD	NUMBER	2589-91	dep	3	SENT_120	[p9l9t1179r292b1234],
9	.	.	O	.	_	0	SENT_120	[p9l9t1179r292b1234],

1	10	CD	NUMBER	10	_	0	SENT_121	[p9l12t1278r98b1331],
2	.	.	O	.	_	0	SENT_121	[p9l12t1278r98b1331],

1	Chen	NNP	PERSON	Chen	nn	3	SENT_122	[p9l139t1272r311b1331],
2	D	NNP	O	D	nn	3	SENT_122	[p9l336t1277r430b1344],
3	]	NN	O	]	_	0	SENT_122	[p9l336t1277r430b1344],
4	,	,	O	,	_	0	SENT_122	[p9l336t1277r430b1344],
5	Nirodi	NNP	O	Nirodi	nn	6	SENT_122	[p9l458t1272r679b1332],
6	CS	NNP	O	CS	appos	3	SENT_122	[p9l705t1276r810b1331],
7	.	.	O	.	_	0	SENT_122	[p9l705t1276r810b1331],

1	The	DT	O	the	det	5	SENT_123	[p9l838t1272r963b1331],
2	epidermal	JJ	O	epidermal	amod	5	SENT_123	[p9l990t1272r1329b1348],
3	growth	NN	O	growth	nn	5	SENT_123	[p9l1356t1272r1601b1348],
4	factor	NN	O	factor	nn	5	SENT_123	[p9l1628t1271r1826b1331],
5	receptor	NN	O	receptor	_	0	SENT_123	[p9l1850t1284r2148b1348],
6	:	:	O	:	_	0	SENT_123	[p9l1850t1284r2148b1348],
7	a	DT	O	a	det	8	SENT_123	[p9l9t1389r43b1428],
8	role	NN	O	role	dep	5	SENT_123	[p9l73t1369r197b1428],
9	in	IN	O	in	_	0	SENT_123	[p9l225t1370r290b1428],
10	repair	NN	O	repair	prep_in	8	SENT_123	[p9l319t1370r517b1445],
11	of	IN	O	of	_	0	SENT_123	[p9l545t1368r622b1428],
12	radiation-induced	JJ	O	radiation-induced	amod	14	SENT_123	[p9l637t1369r1229b1429],
13	DNA	NN	O	dna	nn	14	SENT_123	[p9l1257t1374r1416b1429],
14	damage	NN	O	damage	prep_of	10	SENT_123	[p9l1444t1369r1722b1445],
15	.	.	O	.	_	0	SENT_123	[p9l1444t1369r1722b1445],

1	Clin	NNP	O	Clin	nn	3	SENT_124	[p9l1756t1369r1892b1428],
2	Cancer	NNP	O	Cancer	nn	3	SENT_124	[p9l1922t1373r2152b1428],
3	Res	NNP	O	Res	_	0	SENT_124	[p9l8t1471r124b1529],
4	2007	CD	DATE	2007	num	3	SENT_124	[p9l152t1470r711b1538],
5	;	:	O	;	_	0	SENT_124	[p9l152t1470r711b1538],
6	l3	CD	NUMBER	l3	dep	3	SENT_124	[p9l152t1470r711b1538],
7	:6555	CD	NUMBER	:6555	num	8	SENT_124	[p9l152t1470r711b1538],
8	-60	CD	NUMBER	-60	dep	6	SENT_124	[p9l152t1470r711b1538],
9	.	.	O	.	_	0	SENT_124	[p9l152t1470r711b1538],

1	Copyright	NN	O	copyright	_	0	SENT_125	[p9l12t1555r267b1619],
2	©	CD	NUMBER	©	num	6	SENT_125	[p9l291t1560r345b1614],
3	2009	CD	DATE	2009	num	6	SENT_125	[p9l372t1558r507b1604],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_125	[p9l528t1554r913b1604],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_125	[p9l936t1554r1146b1604],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_125	[p9l1167t1557r1365b1619],
7	.	.	O	.	_	0	SENT_125	[p9l1167t1557r1365b1619],

1	1020	CD	DATE	1020	num	3	SENT_126	[p9l149t1694r225b1715],
2	NENGLJ	NNP	O	NENGLJ	nn	3	SENT_126	[p9l930t1704r1036b1726],
3	MED361	NN	O	med361	_	0	SENT_126	[p9l1051t1698r1191b1726],
4	;	:	O	;	_	0	SENT_126	[p9l1051t1698r1191b1726],
5	1o	NN	O	1o	nn	7	SENT_126	[p9l1051t1698r1191b1726],
6	NEjM.ORG	NN	O	nejm.org	nn	7	SENT_126	[p9l1226t1704r1350b1726],
7	sEPTEMBER3	NN	O	september3	dep	3	SENT_126	[p9l1385t1704r1627b1726],
8	,2	CD	NUMBER	,2	num	9	SENT_126	[p9l1385t1704r1627b1726],
9	oo9	NN	O	oo9	dep	7	SENT_126	[p9l1385t1704r1627b1726],

